
<html lang="en"     class="pb-page"  data-request-id="40efee83-5403-4aaf-9943-c979edc7d137"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm100690x;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2010.53.issue-17;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)" /></meta><meta name="dc.Creator" content="Montse  Llinàs-Brunet" /></meta><meta name="dc.Creator" content="Murray D.  Bailey" /></meta><meta name="dc.Creator" content="Nathalie  Goudreau" /></meta><meta name="dc.Creator" content="Punit K.  Bhardwaj" /></meta><meta name="dc.Creator" content="Josée  Bordeleau" /></meta><meta name="dc.Creator" content="Michael  Bös" /></meta><meta name="dc.Creator" content="Yves  Bousquet" /></meta><meta name="dc.Creator" content="Michael G.  Cordingley" /></meta><meta name="dc.Creator" content="Jiamin  Duan" /></meta><meta name="dc.Creator" content="Pat  Forgione" /></meta><meta name="dc.Creator" content="Michel  Garneau" /></meta><meta name="dc.Creator" content="Elise  Ghiro" /></meta><meta name="dc.Creator" content="Vida  Gorys" /></meta><meta name="dc.Creator" content="Sylvie  Goulet" /></meta><meta name="dc.Creator" content="Ted  Halmos" /></meta><meta name="dc.Creator" content="Stephen H.  Kawai" /></meta><meta name="dc.Creator" content="Julie  Naud" /></meta><meta name="dc.Creator" content="Marc-André  Poupart" /></meta><meta name="dc.Creator" content="Peter W.  White" /></meta><meta name="dc.Description" content="C-Terminal carboxylic acid containing inhibitors of the NS3 protease are reported. A novel series of linear tripeptide inhibitors that are very potent and selective against the NS3 protease are des..." /></meta><meta name="Description" content="C-Terminal carboxylic acid containing inhibitors of the NS3 protease are reported. A novel series of linear tripeptide inhibitors that are very potent and selective against the NS3 protease are des..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="August 17, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm100690x" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm100690x" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm100690x" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm100690x" /></link>
        
    
    

<title>Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335) | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm100690x" /></meta><meta property="og:title" content="Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/large/jm-2010-00690x_0005.jpeg" /></meta><meta property="og:description" content="C-Terminal carboxylic acid containing inhibitors of the NS3 protease are reported. A novel series of linear tripeptide inhibitors that are very potent and selective against the NS3 protease are described. A substantial contribution to the potency of these linear inhibitors arises from the introduction of a C8 substituent on the B-ring of the quinoline moiety found on the P2 of these inhibitors. The introduction of a C8 methyl group results not only in a modest increase in the cell-based potency of these inhibitors but more importantly in a much better pharmacokinetic profile in rats as well. Exploration of C8-substitutions led to the identification of the bromo derivative as the best group at this position, resulting in a significant increase in the cell-based potency of this class of inhibitors. Structure−activity studies on the C8-bromo derivatives ultimately led to the discovery of clinical candidate 29 (BI 201335), a very potent and selective inhibitor of genotype1 NS3 protease with a promising PK profile in rats." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm100690x"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm100690x">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm100690x&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm100690x&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm100690x&amp;href=/doi/10.1021/jm100690x" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 17</span><span class="cit-fg-pageRange">, 6466-6476</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/17" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm1007853" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm1006484" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Montse++Llin%C3%A0s-Brunet">Montse Llinàs-Brunet</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Murray+D.++Bailey">Murray D. Bailey</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nathalie++Goudreau">Nathalie Goudreau</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Punit+K.++Bhardwaj">Punit K. Bhardwaj</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jos%C3%A9e++Bordeleau">Josée Bordeleau</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++B%C3%B6s">Michael Bös</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yves++Bousquet">Yves Bousquet</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+G.++Cordingley">Michael G. Cordingley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiamin++Duan">Jiamin Duan</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pat++Forgione">Pat Forgione</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michel++Garneau">Michel Garneau</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Elise++Ghiro">Elise Ghiro</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vida++Gorys">Vida Gorys</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sylvie++Goulet">Sylvie Goulet</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ted++Halmos">Ted Halmos</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+H.++Kawai">Stephen H. Kawai</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Naud">Julie Naud</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marc-Andr%C3%A9++Poupart">Marc-André Poupart</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+W.++White">Peter W. White</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info"><span class="aff-text">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: (450) 682-4640. Fax: (450) 682-4189. E-mail: <a href="/cdn-cgi/l/email-protection#82efedecf6f1e7aceeeeebece3f1afe0f0f7ece7f6c2e0ede7eaf0ebece5e7f0afebece5e7eeeae7ebeface1edef"><span class="__cf_email__" data-cfemail="187577766c6b7d3674747176796b357a6a6d767d6c587a777d706a71767f7d6a3571767f7d74707d7175367b7775">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm100690x&amp;href=/doi/10.1021%2Fjm100690x" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 17</span><span class="cit-pageRange">, 6466–6476</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">August 17, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 June 2010</li><li><span class="item_label"><b>Published</b> online</span>17 August 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 9 September 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm100690x" title="DOI URL">https://doi.org/10.1021/jm100690x</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6466%26pageCount%3D11%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMontse%2BLlin%25C3%25A0s-Brunet%252C%2BMurray%2BD.%2BBailey%252C%2BNathalie%2BGoudreau%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D17%26contentID%3Djm100690x%26title%3DDiscovery%2Bof%2Ba%2BPotent%2Band%2BSelective%2BNoncovalent%2BLinear%2BInhibitor%2Bof%2Bthe%2BHepatitis%2BC%2BVirus%2BNS3%2BProtease%2B%2528BI%2B201335%2529%26numPages%3D11%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D6476%26publicationDate%3DSeptember%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm100690x"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2331</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">74</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm100690x" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of a Potent and Selective Noncovalent Linear Inhibitor of the Hepatitis C Virus NS3 Protease (BI 201335)&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Montse&quot;,&quot;last_name&quot;:&quot;Llinàs-Brunet&quot;},{&quot;first_name&quot;:&quot;Murray&quot;,&quot;last_name&quot;:&quot;D. Bailey&quot;},{&quot;first_name&quot;:&quot;Nathalie&quot;,&quot;last_name&quot;:&quot;Goudreau&quot;},{&quot;first_name&quot;:&quot;Punit&quot;,&quot;last_name&quot;:&quot;K. Bhardwaj&quot;},{&quot;first_name&quot;:&quot;Josée&quot;,&quot;last_name&quot;:&quot;Bordeleau&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Bös&quot;},{&quot;first_name&quot;:&quot;Yves&quot;,&quot;last_name&quot;:&quot;Bousquet&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;G. Cordingley&quot;},{&quot;first_name&quot;:&quot;Jiamin&quot;,&quot;last_name&quot;:&quot;Duan&quot;},{&quot;first_name&quot;:&quot;Pat&quot;,&quot;last_name&quot;:&quot;Forgione&quot;},{&quot;first_name&quot;:&quot;Michel&quot;,&quot;last_name&quot;:&quot;Garneau&quot;},{&quot;first_name&quot;:&quot;Elise&quot;,&quot;last_name&quot;:&quot;Ghiro&quot;},{&quot;first_name&quot;:&quot;Vida&quot;,&quot;last_name&quot;:&quot;Gorys&quot;},{&quot;first_name&quot;:&quot;Sylvie&quot;,&quot;last_name&quot;:&quot;Goulet&quot;},{&quot;first_name&quot;:&quot;Ted&quot;,&quot;last_name&quot;:&quot;Halmos&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;H. Kawai&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Naud&quot;},{&quot;first_name&quot;:&quot;Marc-André&quot;,&quot;last_name&quot;:&quot;Poupart&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;W. White&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;08&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;17&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;6466-6476&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm100690x&quot;},&quot;abstract&quot;:&quot;C-Terminal carboxylic acid containing inhibitors of the NS3 protease are reported. A novel series of linear tripeptide inhibitors that are very potent and selective against the NS3 protease are described. A substantial contribution to the potency of these linear inhibitors arises from the introduction of a C8 substituent on the B-ring of the quinoline moiety found on the P2 of these inhibitors. The introduction of a C8 methyl group results not only in a modest increase in the cell-based potency of these inhibitors but more importantly in a much better pharmacokinetic profile in rats as well. Exploration of C8-substitutions led to the identification of the bromo derivative as the best group at this position, resulting in a significant increase in the cell-based potency of this class of inhibitors. Structure−activity studies on the C8-bromo derivatives ultimately led to the discovery of clinical candidate 29 (BI 201335), a very potent and selective inhibitor of genotype1 NS3 protease with a promising PK profile&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100690x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100690x" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100690x&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100690x" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm100690x&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100690x" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm100690x&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm100690x&amp;href=/doi/10.1021/jm100690x" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm100690x" /></input><a href="/doi/pdf/10.1021/jm100690x" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1022 KB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm100690x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm100690x%26sid%3Dliteratum%253Aachs%26pmid%3D20715823%26genre%3Darticle%26aulast%3DLlin%25C3%25A0s-Brunet%26date%3D2010%26atitle%3DDiscovery%2Bof%2Ba%2BPotent%2Band%2BSelective%2BNoncovalent%2BLinear%2BInhibitor%2Bof%2Bthe%2BHepatitis%2BC%2BVirus%2BNS3%2BProtease%2B%2528BI%2B201335%2529%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D17%26spage%3D6466%26epage%3D6476%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290676" title="Substituents">Substituents</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/17" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jmcmar.2010.53.issue-17/production/jmcmar.2010.53.issue-17.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/medium/jm-2010-00690x_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/large/jm-2010-00690x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100690x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">C-Terminal carboxylic acid containing inhibitors of the NS3 protease are reported. A novel series of linear tripeptide inhibitors that are very potent and selective against the NS3 protease are described. A substantial contribution to the potency of these linear inhibitors arises from the introduction of a C8 substituent on the B-ring of the quinoline moiety found on the P2 of these inhibitors. The introduction of a C8 methyl group results not only in a modest increase in the cell-based potency of these inhibitors but more importantly in a much better pharmacokinetic profile in rats as well. Exploration of C8-substitutions led to the identification of the bromo derivative as the best group at this position, resulting in a significant increase in the cell-based potency of this class of inhibitors. Structure−activity studies on the C8-bromo derivatives ultimately led to the discovery of clinical candidate <b>29</b> (BI 201335), a very potent and selective inhibitor of genotype1 NS3 protease with a promising PK profile in rats.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div id="ac_i1" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i1"> </h2><div class="NLM_p">Hepatitis C virus (HCV) infects an estimated 130−170 million people worldwide<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> and is one of the major reasons for liver transplantation.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Although the virus was discovered over 20 years ago,<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> no direct-acting antiviral has yet reached the market. Current therapy consists of treatment with pegylated interferon in combination with ribavirin.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> This treatment is usually accompanied by side effects and, most importantly, is only effective in ∼40−50% of the patients infected with HCV genotype 1. The quest for virus-specific therapies to treat HCV infections began shortly after discovery of the virus and continues to be major focus of pharmaceutical research.</div><div class="NLM_p">HCV is a positive strand RNA virus belonging to the Flaviviridae family. The HCV genome consists of a 9.6 kb RNA which encodes a polyprotein of ∼3000 amino acids. This polyprotein is cleaved co- and post-translationally by both host and viral proteases. The structural proteins are processed by host peptidases, whereas the nonstructural (NS) proteins are processed by two virally encoded proteases, the NS2/3 and the NS3 proteases. The NS2/3 protease is responsible for a single cleavage between NS2 and NS3, while the NS3 protease is responsible for the release of the remaining downstream nonstructural proteins.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Several viral proteins have been shown to be essential for viral replication in chimpanzees and are thus considered validated targets for antivirals.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">The NS3 protease, located at the N-terminal third of the NS3 protein, is a 180-amino acid chymotrypsin-like serine protease, and it was one of the first viral proteins investigated as a target for antiviral development.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> In 2002, the first proof-of-concept in man for a direct acting anti-HCV drug was achieved with the Boehringer Ingelheim NS3 protease inhibitor BILN 2061 (ciluprevir, <b>1</b>)<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a> To date, no HCV inhibitor has reached the market, although several compounds are currently in clinical trials, with the NS3 protease inhibitors telaprevir<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and boceprevir,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> in phase III, being the most advanced.</div><div class="NLM_p">Inhibitors of serine proteases are typically peptidic compounds containing an electrophilic moiety that reacts with the active site serine to form a reversible or irreversible covalent bond.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> For example, telaprevir and boceprevir both feature α-ketoamides that form a covalent reversible bond with the active site residue serine 139.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> A distinctive feature of the NS3 protease is that it is also susceptible to product inhibition by the N-terminal cleavage product of peptide substrates.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> The carboxylic acid terminus of cleavage products can establish crucial interactions with the enzyme active site, which are unusual among serine proteases and thus also impart selectivity with respect to other serine proteases.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16, 17)</a> These are noncovalent inhibitors that have only ionic interactions with the catalytic site on the NS3 protease</div><div class="NLM_p">We have reported several series of C-terminus carboxylic acid containing HCV NS3 protease inhibitors, initially leading to the discovery of <b>1</b>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> a compound belonging to noncovalent series of inhibitors (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and containing (1<i>R</i>,2<i>S</i>)-1-amino-2-vinylcyclopropylcarboxylic acid (vinyl-ACCA)<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> as the P1<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> residue. However, the development of this compound was discontinued because of the observation of cardiotoxicity in high-dose monkey toxicology studies.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> These discoveries fueled an intensive effort to discover novel, noncovalent NS3 protease inhibitors.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> Several compounds from these studies have entered clinical development. Clinical candidates RG-7227/ITMN-191,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> TMC43530,<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> MK-7009,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and BMS-650032 all belong to this class of noncovalent inhibitors containing a derivative of vinyl- or ethyl-ACCA at P1 and a cyclopropylacylsulfonamide at P1′.</div><div class="NLM_p">We decided to continue our work on the C-terminal carboxylic acid, vinyl-ACCA containing inhibitors, since in addition to providing very good potency, it also provides excellent selectivity and better solubility than observed for other classes of inhibitors. In addition to the macrocyclic inhibitor <b>1</b>, we have also published our work on a related series of linear inhibitors, with compound <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) being representative of this class.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> One advantage of the linear series of inhibitors lies in the fact that the synthetic challenges and costs associated with the production of the drug substance are significantly reduced.</div><div class="NLM_p">In an attempt to merge both series, we introduced the quinoline moiety found in <b>1</b> into the linear derivative <b>2</b>. This resulted in compound <b>3</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) which displayed more than a 10-fold improvement in potency in the replicon assay, providing the first noncovalent linear tripeptide inhibitor with cellular activity below 100 nM. With this encouraging result, our goal was to further increase the cell-based potency of this linear series while evaluating and improving its ADME/PK<a class="ref internalNav" href="#fnabbrev" aria-label="a">a</a><div class="NLM_fn" id="fnabbrev">a<p class="last">Abbreviations: ADME, administration, distribution, metabolism, and excretion; AUC<sub>0−∞</sub>, area under the curve; DCM, dichloromethane; DIPEA. diisopropylethylamine; DMAP, dimethylaminopyridine ; DMSO, dimethyl sulfoxide; EtOAc, ethyl acetate; HPLC, high pressure liquid chromatography; PK, pharmacokinetic; MES, 2-(<i>N</i>-morpholino)ethanesulfonic acid; TBTU, <i>O</i>-(benzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium tetrafluoroborate; TCEP, tris(2-carboxyethyl)phosphine; TFA, trifluoroacetic acid; THF, tetrahydrofuran; Tris, tris(hydroxymethyl)aminomethane.</p></div> profile. In this paper, we report our optimization studies that have focused on the N-terminal end of the molecule (capping group) and the P2 aminothiazolquinoline moiety that have culminated in the discovery of compound <b>29</b> (BI 201335), a potent and selective noncovalent linear tripeptide inhibitor currently being investigated in phase IIb clinical trials.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Early Inhibitors of the HCV NS3 Protease</div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/medium/jm-2010-00690x_0006.gif" alt="" id="fx1" /></img></td></tr></tbody></table></div></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Synthesis of Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57506" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57506" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The synthesis of the compounds shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> was performed in solution by sequential coupling of each amino acid derivative using a previously described procedure.<a onclick="showRef(event, 'ref18 ref27'); return false;" href="javascript:void(0);" class="ref ref18 ref27">(18, 27)</a> Since most of our SAR efforts focused on variations of the 4<i>R</i>-hydroxyproline substituents, represented by the compounds shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, we wanted to develop the synthesis of an advanced intermediate that would allow us to introduce variations of this group as late as possible in the synthetic sequence. Tripeptide <b>7</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) containing a good leaving group at the 4-oxoproline was chosen as such an intermediate. The desired compounds shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> were then synthesized by introducing, via an S<sub>N</sub>2 reaction, the required 2-carbomethoxy-4-hydroxyquinoline derivative resulting in an inversion of configuration at the 4-hydroxyproline. The synthesis of tripeptide <b>6</b> was performed in solution by sequential coupling of each amino acid derivative, as described previously.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> The synthesis of (1<i>R</i>,2<i>S</i>)-1-amino-2-vinylcyclopropylcarboxylic acid methyl ester used in the preparation of these compounds and the synthesis of dipeptide <b>5</b> have also both been reported.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a></div><figure id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/medium/jm-2010-00690x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/large/jm-2010-00690x_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Route for Inhibitors of Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/large/jm-2010-00690x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100690x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TBTU, DIPEA, DCM, room temp, 14 h; (b) 1 equiv of LiOH, H<sub>2</sub>O/THF, 0 °C, 3 h; (c) brosyl chloride, DMAP, DCM, 0 °C to room temp; (d) <b>11a</b>−<b>11c</b>, Cs<sub>2</sub>CO<sub>3</sub>, NMP, 70 °C, 7 h; (e) 1.1 equiv of 1 N NaOH, H<sub>2</sub>O−THF, 0 °C to room temp; (f) IBCF, TEA, THF, 0 °C to room temp; (g) CH<sub>2</sub>N<sub>2</sub>, Et<sub>2</sub>O, 0 °C to room temp; (h) HBr (48% aq), THF; (i) <b>14a</b>−<b>g</b>, <i>i</i>-PrOH, 50 °C, 1 h; (j) LiOH, H<sub>2</sub>O−MeOH−THF.</p></p></figure><div class="NLM_p">Coupling of dipeptide derivative <b>5</b> to the <i>tert</i>-leucine cyclopentyl carbamate <b>4</b> yielded tripeptide <b>6</b>. Next, the <i>p</i>-nitrobenzoate group in <b>6</b> was hydrolyzed and the resulting free hydroxyl group was converted to the brosylate <b>7</b> by treatment with <i>p</i>-bromobenzensulfonyl chloride. The brosylate group was displaced with the appropriately 8-substituted 2-carbomethoxy 4-hydroxy-7-methoxyquinoline derivatives <b>11a</b>−<b>e</b> to afford tripeptides <b>12a</b>−<b>e</b>. Next, conversion of the quinoline 2-carbomethoxy moiety of tripeptides <b>12a</b>−<b>e</b> into the final aminothiazole derivatives was carried out by a selective hydrolysis of the methyl ester, followed by conversion of the resulting carboxylic acid to the various diazoketones and then to the corresponding bromoketones <b>13a</b>−<b>e</b>. Conversion to diazoketones is carried out using diazomethane, and extreme caution should be used since diazomehane gas may explode violently. The bromoketones <b>13a</b>−<b>e</b> were then treated with the properly substituted thioureas <b>14a</b>−<b>g</b> to produce the required aminothiazole derivatives. Finally the C-terminal esters were hydrolyzed under basic conditions to produce the compounds shown in Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>.</div><div class="NLM_p">The synthesis of different 8-substituted 2-carbomethoxy 4-hydroxy-7-methoxyquinoline derivatives was carried out from the corresponding anilines according to a reported procedure<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><figure id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/medium/jm-2010-00690x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/large/jm-2010-00690x_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Different 8-Substituted 2-Carbomethoxy-4-hydroxy-7-methoxyquinoline Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/large/jm-2010-00690x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100690x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>8a</b>−<b>e</b>, MeOH, 70 °C, 5 h; (b) Ph<sub>2</sub>O, 240 °C, 6−8 min.</p></p></figure><div class="NLM_p last">Commercially or readily available anisidines (<b>8a</b>−<b>e</b>) were treated with dimethylacetylene dicarboxylate <b>9</b> to form aducts <b>10a</b>−<b>e</b> which, upon heating at ∼250 °C, underwent cyclization to produce the different 8-substituted 2-carbomethoxy 4-hydroxy-7-methoxyquinoline derivatives <b>11a</b>−<b>e</b>.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i6">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23526" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23526" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compound <b>3</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>), which resulted from the introduction of the compound <b>1</b> quinoline moiety into our linear, tripeptidyl series of inhibitors, was selected as the starting point for further optimization. From the outset, the peptide backbone was retained, as we had already shown that it makes optimal interactions with the enzyme which mimic the canonical substrate binding mode, with both the NH and CO groups of the P3 residue and the NH group of the P1 moiety being involved in key hydrogen bonds with the protein.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> In addition, both the vinyl-ACCA derivative at P1 and the <i>tert</i>-butylglycine moiety at P3 were kept constant, as they already had been subjected to extensive optimization in the past and found to be optimal. The C-terminal carboxylic acid makes key interactions with the catalytic triad and the oxyanion hole,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> providing not only good potency but also specificity toward NS3 versus human and other serine proteases.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> In addition, another advantage over the other classes of reported NS3 protease inhibitors is the increase in solubility at high pH for this series. The <i>tert</i>-leucine found at P3 was also maintained. One of the main roles of the P3 <i>tert</i>-butyl side chain is to rigidify the peptidic backbone and to favor the overall extended conformation, found in the bound state, for the inhibitor in solution.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Therefore, the current study focused essentially on optimizing both the capping group and the P2 aminothiazolquinoline moiety. First, truncating the compound to the hydroxyl dipeptide <b>15</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>) resulted in a substantial loss in potency. Urea derivatives were also evaluated but, as observed in previous series, did not provide any significant advantage.<a onclick="showRef(event, 'ref18 ref26'); return false;" href="javascript:void(0);" class="ref ref18 ref26">(18, 26)</a> Carbamate substituents, other than the cyclopentyl, were next investigated. The derivative <b>16</b> containing a <i>tert</i>-butyl carbamate was found to be less potent, while the corresponding four-membered ring (<b>17</b>) and six-membered ring (<b>18</b>) carbamates displayed similar potency to the cyclopentyl analogue (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). However, in the cellular assay the cyclopentyl derivative <b>3</b> was found to be the best, displaying a 2-fold improved activity compared to the other cyclic carbamates. Ultimately, this group was maintained throughout our subsequent SAR efforts, since we had shown previously that it fits well in the S4 binding pocket and also imparts good properties to the inhibitor including chemical stability.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a></div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Capping Group Optimization</div></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/medium/jm-2010-00690x_0009.gif" alt="" id="fx2" /></img></td></tr></tbody></table></div></div><div class="NLM_p">We evaluated the pharmacokinetic properties of reference compound <b>3</b> in rats in order to see if the linear tripeptide series had the potential to provide good oral bioavailability. Compound <b>3</b> which was quite stable (<i>T</i><sub>1/2</sub> > 100 min) upon incubation in both human and rat liver microsomes was found to have a good pharmacokinetic profile in rats, with an oral bioavailability of 54% (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Specifically, compound <b>3</b> displayed a maximum plasma concentration (<i>C</i><sub>max</sub>) of 0.79 μM and an AUC<sub>0−∞</sub> of 2.4 μM·h after an oral dose of 5 mg/kg in rats, as well as a half-life (<i>T</i><sub>1/2</sub>) of 2.6 h and a moderate clearance (Cl) of 24 (mL/min)/kg following an intravenous (iv) dose of 2 mg/kg. Encouraged by this very promising profile, we focused on improving the cell-based potency of this linear tripeptide series, setting a target of EC<sub>50</sub> < 10 nM while maintaining/improving ADME/PK properties. On the basis of past success with the macrocyclic series,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> we felt that modifying the P2 aminothiazol-quinoline moiety might also represent the most attractive way of achieving this goal.</div><div class="NLM_p">A quick evaluation of the SAR at the aminothiazol moiety revealed that an acetyl group as in compound <b>19</b> was well tolerated providing a compound with slightly improved potency over the reference compound <b>3</b> bearing an isopropyl, as shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. Increasing the size of the acyl group to a <i>tert</i>-butylacetyl moiety as in <b>20</b> led to a partial loss in both the enzymatic and cellular potencies. At this point, the potency of these inhibitors still had to be improved by at least 10-fold, and we reasoned that this gain would likely not come solely through modification of the aminothiazol substituent. We had previously shown in a tetrapeptide series that substitutions around the B-ring of the quinoline were only tolerated at the C7 and C8 positions, with the introduction of either a C7- or a C8-methoxy producing a significant increase in potency and giving rise to inhibitors with almost equipotent activities.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Unfortunately, combining both the C7- and C8-methoxy substituents into the same analogue was found to be detrimental to activity, not providing the desired additive effect. Nevertheless, we felt that it might be worth revisiting disubstitution of the quinoline ring at C7 and C8, with the introduction this time of smaller substituents at C8 while maintaining the methoxy moiety at C7. Specifically, the introduction of a methyl group at C8 was found to be well tolerated in both the alkyl and acyl aminothiazol series (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Indeed, the introduction of a C8-methyl to the reference analogue <b>3</b> resulted in <b>21</b>, an equipotent inhibitor. Interestingly, the introduction of the C8-methyl on the aminothiazole acyl derivative <b>19</b> resulted in an increase in the cell-based potency of the corresponding inhibitor (<b>22</b>, EC<sub>50</sub> = 19 nM). Extending the acetyl chain by one carbon to the propionyl (compound <b>23)</b> was also well tolerated, giving rise to an equipotent analogue. Compounds <b>22</b> and <b>23</b> represented our first examples of acyclic tripeptide inhibitors displaying EC<sub>50</sub> < 20 nM in the replicon assay.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Impact of Substitution on the A-Ring</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/medium/jm-2010-00690x_0001.gif" alt="" id="fx3" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/medium/jm-2010-00690x_0002.gif" alt="" id="fx4" /></img></td></tr></tbody></table></div></div><div class="NLM_p">Encouraged by these results, we then evaluated the pharmacokinetic parameters of these new analogues in order to see if we had been able to maintain or improve their overall PK profile through the simple chemical modifications we had introduced. Surprisingly, compound <b>19</b>, which was found to be stable (<i>T</i><sub>1/2</sub> > 100 min) upon incubation in both human and rat liver microsomes, did not achieve significant plasma levels when dosed orally in rats at 5 mg/kg, in contrast to the reference derivative <b>3</b>. We generally found throughout our optimization efforts that the rat oral absorption of these linear compounds was greatly influenced by the nature of the substitution on the amino group of the aminothiazole moiety. Small alkyl (e.g., methyl) or acyl groups (such as in <b>19</b>) produced quite potent compounds that unfortunately displayed very low oral absorption in rats or higher species (data not shown). Increasing the size of the alkyl or acyl group led, in most cases, to an increase in rat oral absorption. For instance, compounds containing either an isopropyl such as reference compound <b>3</b> or a <i>tert</i>-butylacetyl moiety as <b>20</b> showed good oral PK profile when dosed in rats as highlighted in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Interestingly, while an oral dose of 5 mg/kg showed a similar profile for both compounds, an intravenous dose of 2 mg/kg led to somewhat different parameters, with <b>20</b> showing a slower clearance (14 (mL/min)/kg) and a smaller volume of distribution (<i>V</i><sub>ss</sub>= 0.83 vs 3.7 L/kg).</div><div class="NLM_p">As mentioned earlier, the introduction of a C8-methyl on the quinoline ring of the aminothiazol acyl series resulted in an improvement in the cell-based potency of these inhibitors, with <b>22</b> and <b>23</b> both displaying EC<sub>50</sub> < 20 nM. However, the full benefit of introducing the C8-Me became more evident when we profiled the ADME properties of these inhibitors. For instance, compound <b>22</b>, when dosed orally in rats at 4 mg/kg, achieved plasma concentrations of 0.3 and 0.4 μM at 1 h and 2 h postdosing. This represented a clear advantage over compound <b>19</b> which did not show significant plasma levels (<0.02 μM) at a similar dose. Similarly, when compound <b>21</b> was dosed orally in rats (4 mg/kg), respective plasma concentrations of 0.9 and 1.2 μM were detected at 1 and 2 h time points postdosing. Compound <b>23</b>, containing a propionyl group instead of the acetyl group, showed the best overall profile, and its full rat PK evaluation is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Very good oral absorption was observed for this compound with a <i>C</i><sub>max</sub> of 0.82 μM and an AUC<sub>0−∞</sub> of 3.5 μM·h achieved after administration of dose of 5 mg/kg. Its iv profile was also quite interesting with a half-life (<i>T</i><sub>1/2</sub>) of 1.7 h and a clearance (Cl) of 15 (mL/min)/kg following a 2 mg/kg dose. In addition to displaying a good overall PK profile in rat, with a bioavailability of 56%, another advantage of compound <b>23</b> over the other analogues was its potency of <20 nM in the replicon assay. Analogue <b>23</b> therefore became our new reference compound.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Pharmacokinetic Parameters in Rats after Oral and Intravenous Administration</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">oral, 5 mg/kg</th><th class="colsep0 rowsep0" colspan="3" align="center" char=".">iv, 2 mg/kg</th><th class="colsep0 rowsep0" align="center" char="."> </th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0−∞</sub> (μM·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Cl ((mL/min)/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char=".">0.79</td><td class="colsep0 rowsep0" align="char" char=".">2.4</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">3.7</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">54</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">2.8</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">0.83</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">0.82</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">56</td></tr></tbody></table></div></div><div class="NLM_p">Having observed an increase in potency and rat bioavailability by introducing the C8-Me, we wanted to investigate the effect of other substituents such as halogen at this position. As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>, replacement of the C8-methyl moiety of <b>23</b> by a fluoro, chloro, or bromo substituent was well tolerated, providing inhibitors with equipotent activities in the enzymatic assay (IC<sub>50</sub> = 7 nM). The effect of these substituents on the cellular potency was slightly different, with the C8-fluoro analogue <b>24</b> being 2-fold less potent while both the C8-chloro and C8-bromo analogues (<b>25</b> and <b>26</b>) showed improved activities. Ultimately, the introduction of the C8-bromo substituent was found to be optimal, with analogue <b>26</b> exhibiting an EC<sub>50</sub> of 5 nM which represented our first observation of single-digit nanomolar activity in the replicon assay for a linear tripeptide inhibitor. The effect of the C8-bromo substituent on the overall ADME properties was subsequently evaluated and is shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Effect of C8-Substitution on the Potency of the Inhibitors</div><p class="last"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/medium/jm-2010-00690x_0003.gif" alt="" id="fx5" /></img></p></div></div><div class="scrollable-table-wrap"><table class="table single-image" border="0"><colgroup><col align="center" /></col></colgroup><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="center"><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/medium/jm-2010-00690x_0004.gif" alt="" id="fx6" /></img></td></tr></tbody></table></div></div><div class="NLM_p">Compound <b>26</b> was found to have human and rat liver microsome stablilities (<i>T</i><sub>1/2</sub> > 300 min) comparable to that of reference compound <b>23</b>. However, when the bromo derivative <b>26</b> was dosed orally in rats, a significantly lower overall plasma exposure was observed. Indeed, after oral dosing at 5 mg/kg, the <i>C</i><sub>max</sub> (0.13 μM) and AUC<sub>0−∞</sub> (0.34 μM·h) achieved for <b>26</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>) were found to be considerably lower (7- to 10-fold) than those observed for the C8-methyl analogue <b>23</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>). Following an iv dose of 2 mg/kg, a similar half-life and volume of distribution were observed for both compounds, although <b>26</b> showed a much faster clearance (28 (mL/min)/kg), which may have contributed to the substantial decrease in overall bioavailability (<i>F</i> = 11%). Having nevertheless achieved the desired level of potency with derivative <b>26</b>, we decided to keep the C8-bromo substituent and revisit the SAR at the amonothiazole moiety with the goal of finding a substituent that might display a better balance between potency and ADME profile. A wide variety of substituents were tolerated on the aminothiazole moiety in the C8-bromo series, which ultimately enabled us to identify several derivatives that fulfilled the desired potency criteria (EC<sub>50</sub> < 10 nM). Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> highlights three of these inhibitors, such as the methyl and isopropyl carbamate derivatives <b>27</b> and <b>28</b>, respectively, and the acyl analogue <b>29</b>. This last compound displayed the best overall potency with IC<sub>50</sub> and EC<sub>50</sub> values of 3 nM. Moreover, the in vitro ADME profile of these three compounds revealed that they were all quite stable in human (<i>T</i><sub>1/2</sub> > 100 min) and rat liver microsomes (<i>T</i><sub>1/2</sub> > 300 min). Unfortunately, the two aminothiazole carbamate derivatives did not achieve good plasma exposure when dosed orally in rats, as was earlier observed for compound <b>26</b>. For instance, analogue <b>27</b> showed a plasma level of only 0.1 μM at 1 h postdosing (4 mg/kg oral dose). Only a marginal improvement was observed for compound <b>28</b> over <b>26</b> when its full PK profile was evaluated in rat following an oral dose of 5 mg/kg (<i>C</i><sub>max</sub> = 0.13 μM, AUC<sub>0−∞</sub> = 0.90 μM·h) and a 2 mg/kg iv dose (<i>T</i><sub>1/2</sub> = 2.9 h, Cl = 6 (mL/min)/kg), resulting in an oral bioavailability of 29% (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). However, the aminothiazole acyl derivative <b>29</b> was demonstrated to possess an improved PK profile when evaluated at these oral and intravenous doses (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Indeed, the oral exposure was significantly improved with respect to the other C8-bromo containing derivatives with a <i>C</i><sub>max</sub> of 0.60 μM, AUC<sub>0−∞</sub> = 1.7 μM·h. The <i>T</i><sub>1/2</sub> was found to be 1.2 h with moderate clearance. The overall oral bioavailability in rats for compound <b>29</b> was 40%. Although the PK profile of <b>29</b> was not as good as that of <b>23</b> (<i>F</i> = 56%), its superior potency in both the enzymatic and replicon assays made it a more interesting candidate for further development. A further beneficial feature of compound <b>29</b> lies in the fact that the compound partitions favorably into the liver in rats with a 40-fold increase in liver versus plasma concentration after oral dosing. Moreover, differences in the cross-species PK profile of these compounds further supported the selection of <b>29</b> (manuscript in preparation). For all these reasons <b>29</b> was selected for further advancement in development, and the complete preclinical profile of this compound will be published elsewhere. Compound <b>29</b> is currently being evaluated in phase IIb clinical trials.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Pharmacokinetic Parameters in Rats after Oral and Intravenous Administration</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center" char=".">oral, 5 mg/kg</th><th class="colsep0 rowsep0" colspan="4" align="center" char=".">iv, 2 mg/kg</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>max</sub> (μM)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0−∞</sub> (μM·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>ss</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">Cl ((mL/min)/kg)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i> (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">0.34</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">28</td><td class="colsep0 rowsep0" align="char" char=".">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">0.13</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="char" char=".">40</td></tr></tbody></table></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Very potent and specific linear tripeptide inhibitors of the NS3 serine protease have been identified. Our initial goal of obtaining linear inhibitors with cell-based potencies less than 10 nM and with good overall ADME profiles was achieved. Crucial to these achievements was the discovery of the impact of the C8-substituent of the P2 quinoline moiety of these inhibitors on the properties of the present inhibitors. The introduction of a C8-Me group was beneficial to increasing the plasma exposure in rats after oral dosing and, in some cases, also improved the potency of the inhibitors. Scanning different substituents at the C8-position of the quinoline revealed that the bromo group was optimal for increasing the cell-based potency of this series. Several derivatives with different substitutions at the aminothiazole moiety met our potency criteria. Differentiation of these inhibitors was possible based on their rat PK profiles, and compound <b>29</b> was ultimately selected for development. Initial four-week antiviral results for this promising drug candidate have been reported in both treatment-naive patients and in patients who failed previous treatment with current gold-standard therapy.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Compound <b>29</b> is now being evaluated in phase IIb clinical trials, and this compound could become the first noncovalent linear NS3 protease inhibitor available for treatment of HCV patients</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47875" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47875" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> General</h3><div class="NLM_p last">All commercially obtained solvents and reagents were used as received without further purification. All reactions were carried out under an atmosphere of argon. Temperatures are given in degrees Celsius. Solution percentages express a weight to volume relationship, and solution ratios express a volume to volume relationship, unless stated otherwise. NMR spectra were recorded on a Bruker AVANCEII (400 MHz for <sup>1</sup>H NMR) spectrometer and were referenced to either DMSO-<i>d</i><sub>6</sub> (2.50 ppm) or CDCl<sub>3</sub> (7.27 ppm). Data are reported as follows: chemical shift (ppm), multiplicity (s = singlet, d = doublet, t = triplet, br = broad, m = multiplet), coupling constant (<i>J</i>, reported to the nearest 0.5 Hz), and integration. Mass spectra were obtained from a Micromass AutoSpec instrument using FAB as ionization mode with NBA as a matrix support. Purification of crude material was performed either by flash column chromatography or by using a CombiFlash Companion using RediSep Silica or SilicaSep columns according to preprogrammed gradient and flow rate separation conditions in hexane/EtOAc or DCM/MeOH. The final compounds were purified either by column chromatography to yield the neutral compound or by preparative HPLC in a Waters 2767 sample manager with pumps 2525, column fluidics organizer (CFO), PDA detector 2996, and MassLynx 4.1 using either a Whatman Partisil 10-ODS-3 column, 2.2 cm × 50 cm, or a YMC Combi-Prep ODS-AQ column, 50 mm × 20 mm i.d., S, 5 μm, 120 Å, and a linear gradient program from 2% to 100% AcCN/water (0.06% TFA). Fractions were analyzed by analytical HPLC, and the pure fractions were combined, concentrated, frozen, and lyophilized to yield the desired compound as the trifluoroacetate salt. The lyophilized TFA salt was dissolved in water, and either 2 N or 10 N NaOH was added dropwise until a pH of 14 was maintained. The pH was readjusted to 7 with 2 N HCl and the neutral product extracted into EtOAc (3×). The combined extracts were washed with water (2×) and brine (1×), dried over MgSO<sub>4</sub>, filtered, and evaporated to dryness. The obtained solid was dissolved in acetonitrile/water, frozen, and relyophilized to provide the neutral product. The neutral inhibitor HPLC purity was measured by using an Waters Alliance 2695 separation module with a Waters 2487 dual λ absorbance detector. A YMC Combiscreen ODS-AQ HPLC column was used: 50 × 4.6 mm i.d.; S-5 μm, 12 nm (catalog no. CCAQS05-0546WT, AQ-300-CC). Linear gradient at 220 nm was as follows: 5−100% B; solvent A, 0.06% TFA/H<sub>2</sub>O; sovlent B, 0.06% TFA/CH<sub>3</sub>CN. Parameters of the analytical C<sub>18</sub> reversed phase column and the eluting system were as follows: 0.06% TFA in water−0.06% TFA in acetonitrile gradient (20−100% acetonitrile over 30 min). All compounds tested in vitro were determined to be of >95% purity by HPLC.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Enzymatic Assays</h3><div class="NLM_p last">Biochemical assays were carried out as described previously.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> In brief, reactions comprised 0.5 nM genotype 1b NS3-NS4A enzyme,<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> 5 μM fluorogenic depsipeptide substrate anthranilyl-DDIVPAbu[C(O)-O]AMY(3-NO<sub>2</sub>)TW-OH, and inhibitor in a reaction buffer composed of 50 mM Tris-HCl, pH 8.0, 0.25 M sodium citrate, 0.01% <i>n</i>-dodecyl-β-<span class="smallcaps smallerCapital">d</span>-maltoside, 1 mM TCEP, and 5% DMSO. Mixtures were incubated at 23 °C for 60−70 min and terminated by the addition of 1 M MES (pH 5.8). Fluorescence of the N-terminal product anthranilyl-DDIVP-Abu was measured using a PolarStar Galaxy plate reader (BMG). Calculated percent inhibition at each inhibitor concentration was then used to determine the median effective concentration (IC<sub>50</sub>) by the NLIN procedure of SAS (Statistical Software System; SAS Institute Inc., Cary, NC).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> Cell-Based Replicon Assay</h3><div class="NLM_p last">The bicistronic luciferase reporter replicon, encoding the Con1 genotype 1b NS2-NS5B coding region, and the experimental procedures for measuring EC<sub>50</sub> values in the experiments reported above have been described elsewhere<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Compounds were incubated with cells for 72 h, and the relative levels of luciferase present were determined using the Bright-Glo luciferase substrate (Promega) on a Packard Topcount instrument. EC<sub>50</sub> values were determined by the nonlinear regression routine NLIN procedure of SAS (EC<sub>50</sub>).</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Pharmacokinetics</h3><div class="NLM_p last">All protocols involving animal experimentation were reviewed and approved by the local Animal Care and Use Committee. In-life procedures were in compliance with the Guide for the Care and Use of Laboratory Animals from the Canadian Council of Animal Care. All rat PK and distribution studies were performed at Boehringer Ingelheim (Canada) Ltd. Rat pharmacokinetic studies were performed using male Sprague−Dawley rats (275−300 g, Charles River, St-Constant, Quebec, Canada). Animals were fasted overnight with access to 10% dextrose in water. Standard oral PK with individual compounds were performed at an oral dose of 5 mg/kg in a dosing volume of 10 mL/kg of a vehicle consisting of 0.5% Methocel and 0.3% Tween-80. Blood samples were collected from the canulated right carotid at 0, 0.25, 0.5, 1, 1.5, 2, 3, 4, 6, and 8 h postdosing, and plasma samples from three rats were pooled at each time point. Intravenous PK experiments were performed at a dose of 2 mg/kg, with an additional sample collection time at 5 min. For rapid oral PK screening studies, a cassette of four compounds (4 mg/compound) were dosed in two rats and plasma samples collected only at 1 and 2 h postdosing. Extracts for LC−MS analysis were obtained from plasma samples by solid-phase extraction. The temporal profiles of drug concentrations in plasma were analyzed by noncompartmental methods using WinNonlin (version 3.1; Scientific Consulting, Inc., Cary, NC).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> 2-Carbomethoxy-4-hydroxy-7-methoxy-8-methylquinoline (<b>11b</b>)</h3><div class="NLM_p last">Dimethyl acetylenedicarboxylate <b>9</b> (3.6 mL, 29.3 mmol) was added dropwise to a solution of 2-methyl-3-methoxyaniline <b>8b</b> (3.95 g, 28.8 mmol) in MeOH (100 mL) (reaction is exothermic). The mixture was heated at a gentle reflux for 5 h, cooled, and concentrated under vacuum. The crude material was purified by column chromatography (SiO<sub>2</sub>) to provide diester <b>10b</b> (6.5 g, 80.8%). Diester <b>10b</b> (6.5 g, 23.3 mmol) was then dissolved in diphenyl ether (12 mL) and the reaction mixture placed into a preheated sand bath at a bath temperature of 350−400 °C. Once the reaction mixture attained an internal temperature of 240 °C (MeOH evolution observed at 230−240 °C), a count of 6 min was begun before the bath was removed and the reaction mixture allowed to cool to room temperature. When the mixture cooled, the product precipitated. The mixture was diluted with diethyl ether, filtered, and dried to give a tan colored solid (3.48 g crude). The crude material was purified by silica gel chromatography to provide <b>11b</b> (2.1 g, 37%) as a pale yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.81 (s, 1H), 8.25 (d, <i>J</i> = 9.0 Hz, 1H), 7.05 (d, <i>J</i> = 9.0 Hz, 1H), 6.92 (s, 1H), 4.06 (s, 3H), 3.99 (s, 3H), 2.38 (s, 3H). MS (ESI): 246.0 (M − H)<sup>−</sup>, 248.1 (M + H)<sup>+</sup>. HPLC homogeneity: 95%.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 2-Carbomethoxy-8-fluoro-4-hydroxy-7-methoxyquinoline (<b>11c</b>)</h3><div class="NLM_p last">Starting with 2-fluoro-3-methoxyaniline <b>8c</b> and using the procedure described above gave <b>11c</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.96 (s, 1H), 8.10 (dd, <i>J</i> = 9.0, 1.5 Hz, 1H), 7.09 (dd, <i>J</i> = 9.0, 8.4 Hz, 1H), 6.92 (s, 1H), 4.06 (s, 3H), 4.05 (s, 3H). MS (ESI): 249.9 (M − H)<sup>−</sup>, 252.0 (M + H)<sup>+</sup>. HPLC homogeneity: 97%.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 2-Carbomethoxy-8-chloro-4-hydroxy-7-methoxyquinoline (<b>11d</b>)</h3><div class="NLM_p last">Starting with 2-chloro-3-methoxyaniline <b>8d</b> and using the procedure described above gave <b>11d</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.47 (s, 1H), 8.32 (d, <i>J</i> = 8.8 Hz, 1H), 7.18 (s, 1H), 7.12 (d, <i>J</i> = 8.7 Hz, 1H), 4.06 (s, 3H), 4.05 (s, 3H). MS (ESI): 265.9 (M − H)<sup>−</sup>, 267.8 (M + H)<sup>+</sup>. HPLC homogeneity: >99%.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-Carbomethoxy-8-bromo-4-hydroxy-7-methoxyquinoline (<b>11e</b>)</h3><div class="NLM_p last">Starting with 2-bromo-3-methoxyaniline <b>8e</b> and using the procedure described above gave <b>11e</b>. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.37 (s, 1H), 8.33 (d, <i>J</i> = 8.9 Hz, 1H), 7.06 (d, <i>J</i> = 8.9 Hz, 1H), 6.95 (s, 1H), 4.07 (s, 6H). MS (ESI): 310.0, 312.0 (M − H)<sup>−</sup>, 312.0, 314.0 (M + H)<sup>+</sup>. HPLC homogeneity: 98%.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Synthesis of Inhibitors (Compounds from Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>)</h3><div class="NLM_p last">The inhibitors from these tables were synthesized as outlined in the chemistry section of the manuscript. The synthetic sequence leading to the preparation of compound <b>29</b> serves as a representative example for the series.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-<i>tert</i>-leucine (<b>4</b>)</h3><div class="NLM_p last">To a suspension of carbonic acid cyclopentyl ester 2,5-dioxopyrrolidin-1-yl ester (9.00 g; 39.6 mmol) and <i>tert</i>-leucine (6.24 g; 47.5 mmol) in THF (350 mL) were added distilled water (100 mL) and triethylamine (16.6 mL, 119 mmol). The homogeneous solution was allowed to stir at room temperature for 2.5 h. The THF was evaporated and the aqueous residue further diluted with water (100 mL). The mixture was rendered basic by the addition of 1 N NaOH (25 mL, final pH >10) and then extracted with EtOAc (2 × 200 mL). The aqueous phase was then acidified with 1 N HCl (∼70 mL, final pH <2) and the turbid solution extracted with EtOAc (2 × 200 mL). The organic phase was dried (MgSO<sub>4</sub>), filtered, and concentrated to afford carbamate <b>3</b> (8.69 g) as a white solid. <sup>1</sup>H NMR (400 MHz DMSO-<i>d</i><sub>6</sub>): δ 12.46 (s, 1H), 7.11 (d, <i>J</i> = 8.9 Hz, 1H), 4.94 (bs, 1H), 3.78 (d, <i>J</i> = 8.9 Hz, 1H), 1.85−1.72 (m, 2H), 1.70−1.48 (m, 6H), 0.94 (s, 9H). MS (ESI): 241.8 (M − H)<sup>−</sup>, 243.9 (M + H)<sup>+</sup>, 265.9 (M + Na)<sup>+</sup>. HPLC homogeneity: 95%.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>S</i>)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-2-ethenyl-1-(methoxycarbonyl)cyclopropyl]-4-hydroxy-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>6</b>)</h3><div class="NLM_p last">Carbamate <b>4</b> (6.15 g, 22.5 mmol) and TBTU (7.72 g, 24.7 mmol) were suspended in dichloromethane (100 mL) and rapidly stirred before the addition of DIPEA (3.92 mL, 22.5 mmol) at room temperature. After 10 min, a solution of (3<i>S</i>,5<i>S</i>)-5-{[(1<i>R</i>,2<i>S</i>)-2-ethenyl-1-(methoxycarbonyl)cyclopropyl]carbamoyl}pyrrolidin-3-yl 4-nitrobenzoate (<b>5</b>) (10.39 g, 23.6 mmol) in anhydrous dichloromethane (100 mL) containing DIPEA (4.11 mL, 23.62 mmol) was poured into the reaction mixture. The resulting yellow solution was stirred for 14 h before being concentrated in vacuo. The resulting residue was diluted with EtOAc (450 mL) and washed with 0.05 N HCl (2 × 200 mL), saturated Na<sub>2</sub>CO<sub>3</sub> (300 mL), and finally saturated brine (150 mL). The combined extracts were dried over MgSO<sub>4</sub>, filtered, and concentrated to afford tripeptide <b>6</b> as a pale yellow foam (15.68 g, quantitative). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): about 90:10 mixture of cis−trans proline rotamers, major rotamer description; δ 8.27 (d, <i>J</i> = 8.4 Hz, 2H), 8.19 (d, <i>J</i> = 8.4 Hz, 2H), 7.96 (s, 1H), 5.77−5.66 (m, 1H), 5.62−5.56 (m, 1H), 5.29−5.15 (m, 2H), 5.15−5.04 (m, 2H), 4.82 (d, <i>J</i> = 9.0 Hz, 1H), 4.32−4.25 (m, 2H), 3.93 (d, <i>J</i> = 11.8 Hz, 1H), 3.58 (s, 3H), 3.04 (br d, <i>J</i> = 14.4 Hz, 1H), 2.34−2.25 (m, 1H), 2.10−2.01 (m, 1H), 1.96−1.54 (m, 9H), 1.41 (dd, <i>J</i> = 9.4, 5.5 Hz, 1H), 1.07 (s, 9H). MS (ESI): 627.4 (M − H)<sup>−</sup>, 629.4 (M + H)<sup>+</sup>, 652.4 (M + Na)<sup>+</sup>. HPLC homogeneity: 96%.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>S</i>)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-2-ethenyl-1-(methoxycarbonyl)cyclopropyl]-4-hydroxy-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>7</b>)</h3><div class="NLM_p last">Tripeptide <b>6</b> (15.68 g, 24,97 mmol) was dissolved in THF (200 mL) and water (30 mL), and the resulting solution was cooled to 0 °C. A solution of lithium hydroxide monohydrate (1.18 g, 28.12 mmol) was added over 3 min during vigorous stirring. After 3 h at 0 °C, the excess base was neutralized with 1 N HCl (final pH ∼6) before the THF was evaporated. The resulting aqueous suspension (yellow gum) was extracted with EtOAc (2 × 200 mL) and washed with saturated NaHCO<sub>3</sub> (2 × 300 mL). The combined extracts were dried over MgSO<sub>4</sub> and concentrated to give a yellow foam. Silica gel chromatography using EtOAc as an eluent afforded the free alcohol as a white amorphous solid (9.77 g, 91%). The alcohol (9.77 g, 20.85 mmol) was combined with brosyl chloride (11.19 g, 43.79 mmol) and DMAP (254 mg, 2.09 mmol) in dichloromethane (75 mL) at 0 °C before being treated dropwise with triethylamine (10.2 mL, 72.98 mmol). The yellow solution was stirred 1 h at 0 °C and then slowly warmed to room temperature and stirred for 60 h. The reaction mixture was concentrated to dryness, diluted with EtOAc, and washed with saturated NaHCO<sub>3</sub>, water, and saturated brine before being dried (MgSO<sub>4</sub>), filtered, and concentrated to dryness. The crude material was purified by silica gel chromatography with a gradient of EtOAc in hexanes to provide the tripeptide <b>6</b> as a white foam (11.66 g, 74% over three steps). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 84:16 mixture of cis−trans proline rotamers, major rotamer description; δ 8.58 (s, 1H), 7.92 (d, <i>J</i> = 8.6 Hz, 2H), 7.85 (d, <i>J</i> = 8.6 Hz, 2H), 6.94 (d, <i>J</i> = 8.7 Hz, 1H), 5.68−5.56 (m, 1H), 5.23 (dd, <i>J</i> = 17.3, 1.6 Hz, 1H), 5.20−5.12 (m, 1H), 5.09 (dd, <i>J</i> = 10.3, 1.8 Hz, 1H), 4.94−4.89 (m, 1H), 4.36 (dd, <i>J</i> = 9.0, 4.7 Hz, 1H), 4.07−3.95 (m, 2H), 3.59 (dd, <i>J</i> = 11.7, 4.1 Hz, 1H), 3.56 (s, 3H), 2.43−2.27 (m, 1H), 2.09−1.99 (m, 2H), 1.84−1.70 (m, 2H), 1.69−1.46 (m, 7H), 1.25 (dd, <i>J</i> = 9.3, 5.3 Hz, 1H), 0.92 (s, 9H). MS (ESI): 698.1, 699.1 (M − H)<sup>−</sup>, 698.2, 700.2 (M + H)<sup>+</sup>. HPLC homogeneity: 99%.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[8-bromo-7-methoxy-2-(methoxycarbonyl)quinolin-4-yl]oxy}-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-2-ethenyl-1-(methoxycarbonyl)cyclopropyl]-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>12e</b>)</h3><div class="NLM_p last">Tripeptide <b>7</b> (0.5 g, 0.71 mmol), bromoquinoline <b>11e</b> (234 mg, 0.75 mmol), and ground cesium carbonate (56 mg; 0.78 mmol) were dissolved in 1-methyl-2-pyrrolidinone (7.6 mL) before being heated to 70 °C (7 h). The solution was cooled to room temperature and poured into EtOAc before being washed with H<sub>2</sub>O, saturated NaHCO<sub>3</sub>, and brine. The organic phase was dried (MgSO<sub>4</sub>), filtered, and concentrated to dryness before being purification by silica gel chromatography (7:3 EtOAc in hexanes) to afford tripeptide <b>12e</b> (0.429 g, 77%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): about 89:11 mixture of cis−trans proline rotamers, major rotamer description; δ 8.21 (d, <i>J</i> = 9.3 Hz, 1H), 7.58 (s, 1H), 7.51 (s, 1H), 7.30 (d, <i>J</i> = 9.3 Hz, 1H), 5.81−5.70 (m, 1H), 5.42−5.36 (m, 1H), 5.31 (dd, <i>J</i> = 17.3, 1.2 Hz, 1H), 5.25 (d, <i>J</i> = 9.2 Hz, 1H), 5.15 (dd, <i>J</i> = 10.2, 1.2 Hz, 1H), 4.90−4.84 (m, 1H), 4.81 (t, <i>J</i> = 7.6 Hz, 1H), 4.48 (d, <i>J</i> = 12.1 Hz, 1H), 4.36 (d, <i>J</i> = 9.6 Hz, 1H), 4.08 (s, 3H), 4.07 (s, 3H), 3.96 (dd, <i>J</i> = 12.0, 4.4 Hz, 1H), 3.69 (s, 3H), 3.06−2.98 (m, 1H), 2.44 (dd, <i>J</i> = 14.2, 8.2 Hz, 1H), 2.14 (dd, <i>J</i> = 17.2, 8.8 Hz, 1H), 1.88 (dd, <i>J</i> = 8.1, 5.7 Hz, 1H), 1.84−1.49 (m, 8H), 1.44 (dd, <i>J</i> = 9.6, 5.6 Hz, 1H), 1.07 (s, 9H). MS (electrospray): 775.2 (M + 2H)<sup>+</sup>. HPLC homogeneity: 96%.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[8-bromo-2-(bromoacetyl)-7-methoxyquinolin-4-yl]oxy}-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-2-ethenyl-1-(methoxycarbonyl)cyclopropyl]-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>13e</b>)</h3><div class="NLM_p last">Tripeptide <b>12e</b> (4.00 g, 5.17 mmol) in 75 mL of a 4:1 mixture of THF and H<sub>2</sub>O was cooled to 0 °C before the addition of an aqueous solution of 1 N NaOH (5.7 mL). The resulting solution was stirred for 15 min at 0 °C, followed by 1.5 h at room temperature. The mixture was quenched with 1 M HCl, evaporated to near dryness, diluted with water, then frozen and lyophilized to provide the corresponding acid as the sodium salt (3.93 g). The sodium salt was dissolved in THF (65 mL) followed by triethylamine (0.981 mL, 7.04 mmol) before being cooled to 0 °C. Isobutyl chloroformate (0.913 mL, 7.04 mmol) was added dropwise, and the resulting white suspension was stirred at 0 °C for 1 h. This mixture was then treated with a solution of diazomethane (0.67 M in diethyl ether, 45 mL, 30.19 mmol). The reaction mixture was stirred for 15 min at 0 °C and then 1 h at room temperature before being concentrated to a thick suspension. This suspension was dissolved in EtOAc, washed with saturated NaHCO<sub>3</sub> (2×), brine (1×), and then dried (MgSO<sub>4</sub>), filtered, and concentrated to give the corresponding diazoketone (2.91 g). The diazoketone (2.91 g, 3.7 mmol) was dissolved in THF (80 mL) and cooled to 0 °C before the dropwise addition of an HBr solution (48% aq, 2.7 mL) followed by stirring for 1.25 h. The mixture was quenched with a saturated NaHCO<sub>3</sub> solution and the THF evaporated in vacuo. The residue was diluted with EtOAc, washed with a saturated NaHCO<sub>3</sub> and saturated brine before being dried (MgSO<sub>4</sub>), filtered, and concentrated to provide the crude bromoketone <b>13e</b> (2.99 g, 96%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): about 90:10 mixture of cis−trans proline rotamers, major rotamer description; δ 8.19 (d, <i>J</i> = 9.2 Hz, 1H), 7.58 (s, 1H), 7.41 (s, 1H), 7.31 (d, <i>J</i> = 9.3 Hz, 1H), 5.81−5.70 (m, 1H), 5.43−5.35 (m, 1H), 5.31 (d, <i>J</i> = 17.2 Hz, 1H), 5.25−5.10 (m, 4H), 4.86−4.74 (m, 2H), 4.45 (d, <i>J</i> = 12.0 Hz, 1H), 4.32 (d, <i>J</i> = 9.5 Hz, 1H), 4.08 (s, 3H), 3.94 (dd, <i>J</i> = 12.1, 4.1 Hz, 1H), 3.69 (s, 3H), 3.06−2.98 (m, 1H), 2.43 (dd, <i>J</i> = 13.5, 8.4 Hz, 1H), 2.14 (dd, <i>J</i> = 17.2, 8.8 Hz, 1H), 1.91−1.85 (m, 1H), 1.84−1.37 (m, 9H), 1.05 (s, 9H). MS (electrospray): 773.3 (MH + 2)<sup>+</sup> 771.3 (M + H)<sup>+</sup> 769 (M − H)<sup>−</sup>. HPLC homogeneity: 95%.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-[(8-bromo-7-methoxy-2-{2-[(2-methylpropanoyl)amino]-1,3-thiazol-4-yl}quinolin-4-yl)oxy]-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>29</b>)</h3><div class="NLM_p last">A yellow solution of α-bromoketone <b>13e</b> (0.80 g, 0.956 mmol) and isobutyrylthiourea <b>14e</b> (0.159 g, 1.05 mmol) in isopropanol (30 mL) was heated at 75 °C for 1 h. The solution was cooled to room temperature and evaporated to dryness. The crude material was purified by silica gel chromatography to provide the methyl ester of compound <b>29</b> (0.59 g, 70% yield). To a solution of the methyl ester (0.59 g, 0.67 mmol) in a 12 mL mixture of THF/MeOH/H<sub>2</sub>O (2:1:1) was added solid LiOH monohydrate (0.28 g, 6.66 mmol). The resulting mixture was stirred at room temperature overnight and then concentrated. The residue was partitioned between EtOAc (30 mL) and saturated brine (30 mL) before the pH was adjusted to 6.0 with 1 N HCl. The aqueous phase was re-extracted several times with EtOAc. The combined organic extract were washed with water and saturated brine, dried (MgSO<sub>4</sub>), and concentrated to yield compound <b>29</b> as a pale yellow solid (0.57 g, 92% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 86:14 mixture of rotamers, major rotamer description; δ 12.48 (br s, 1H) 12.34 (s, 1H), 8.56 (s, 1H), 8.17 (d, <i>J</i> = 9.2 Hz, 1H), 8.03 (s, 1H), 7.46 (s, 1H), 7.34 (d, <i>J</i> = 9.4 Hz, 1H), 7.02 (d, <i>J</i> = 8.6 Hz, 1H), 5.80−5.65 (m, 1H), 5.48−5.37 (m, 1H), 5.18 (dd, <i>J</i> = 17.0, 1.4 Hz, 1H), 5.05 (dd, <i>J</i> = 10.1, 1.6 Hz, 1H), 4.63−4.55 (m, 1H), 4.43 (t, <i>J</i> = 8.6 Hz, 1H), 4.37 (d, <i>J</i> = 11.7 Hz, 1H), 4.07 (d, <i>J</i> = 8.6 Hz, 1H), 4.01 (s, 3H), 3.94 (br d, <i>J</i> = 9.4 Hz, 1H), 2.85−2.77 (m, 1H), 2.58−2.49 (m, 1H), 2.30−2.20 (m, 1H), 2.06−1.97 (m, 1H), 1.78−1.20 (m, 10H), 1.14 (d, <i>J</i> = 6.7 Hz, 6H), 0.96 (s, 9H). MS (ESI): 869.1, 871.1 (M − H)<sup>−</sup>, 867.1, 869.1 (M + H)<sup>+</sup>. HPLC homogeneity: >99%.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Synthesis of Compounds from Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></h3><div class="NLM_p last">The synthesis was performed using the same procedure as outlined above for compound <b>29</b> but using the appropriate quinoline and thiourea derivatives. The overall reaction sequence was performed on a similar scale and gave comparable yields. The characterization of these compounds is as follows.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-4-({7-methoxy-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>3</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 82:18 mixture of rotamers, major rotamer description; δ 12.50 (br s, 1H), 8.54 (s, 1H), 8.02 (d, <i>J</i> = 9.0 Hz, 1H), 7.70 (d, <i>J</i> = 7.2 Hz, 1H), 7.44 (s, 1H), 7.18 (s, 1H), 7.28 (s, 1H), 7.01 (d, <i>J</i> = 8.6 Hz, 1H), 6.98 (d, <i>J</i> = 9.0 Hz, 1H), 5.43−5.35 (m, 1H), 5.19 (d, <i>J</i> = 16.6 Hz, 1H), 5.06 (d, <i>J</i> = 11.1 Hz, 1H), 4.77−4.70 (m, 1H), 4.43 (t, <i>J</i> = 8.3 Hz, 1H), 4.32 (d, <i>J</i> = 11.3 Hz, 1H), 4.12 (d, <i>J</i> = 8.6 Hz, 1H), 4.00−3.93 (m, 1H), 3.90 (s, 3H), 3.86−3.76 (m, 1H), 2.53−2.45 (m, 1H), 2.08−1.98 (m, 1H), 1.81−1.36 (m, 9H), 1.31−1.25 (m, 1H), 1.25 (d, <i>J</i> = 5.7 Hz, 6H), 0.97 (s, 9H). MS (ESI): 761.4 (M − H)<sup>−</sup>, 763.5 (M + H)<sup>+</sup>. HPLC homogeneity: 99%.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (1<i>R</i>,2<i>S</i>)-2-Ethenyl-1-{[(4<i>R</i>)-1-[(2<i>S</i>)-2-hydroxy-3,3-dimethylbutanoyl]-4-({7-methoxy-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolyl]amino}cyclopropanecarboxylic Acid (<b>15</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 82:18 mixture of rotamers, major rotamer description; δ 10.40 (br s, 1H), 8.60 (s, 1H), 8.18 (br s, 1H), 8.06 (d, <i>J</i> = 9.2 Hz, 1H), 8.02 (d, <i>J</i> = 8.0 Hz, 1H), 7.81 (br s, 1H), 7.71 (s, 1H), 7.39 (br d, <i>J</i> = 8.3 Hz, 1H), 5.79−5.65 (m, 2H), 5.20 (d, <i>J</i> = 16.9 Hz, 1H), 5.07 (d, <i>J</i> = 10.2 Hz, 1H), 4.53 (t, <i>J</i> = 8.6 Hz, 1H), 4.33 (d, <i>J</i> = 12.7 Hz, 1H), 4.21−4.08 (m, 1H), 3.98 (s, 3H), 3.99−3.93 (m, 1H), 3.90 (br s, 1H), 2.57 (dd, <i>J</i> = 12.8, 7.2 Hz, 1H), 2.35−2.27 (m, 1H), 2.08−2.00 (m, 1H), 1.92−1.82 (m, 1H), 1.56 (dd, <i>J</i> = 7.8, 4.9 Hz, 1H), 1.25 (d, <i>J</i> = 6.7 Hz, 6H), 0.90 (s, 9H). MS (ESI): 650.3 (M − H)<sup>−</sup>, 652.3 (M + H)<sup>+</sup>. HPLC homogeneity: 95%.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>-(<i>tert</i>-Butoxycarbonyl)-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-4-({7-methoxy-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>16</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 90:10 mixture of rotamers, major rotamer description; δ 12.52 (br s, 1H), 8.60 (s, 1H), 8.27, (br s, 1H), 8.22 (d, <i>J</i> = 9.2 Hz, 1H), 8.06 (d, <i>J</i> = 7.3 Hz, 1H), 7.86 (s, 1H), 7.75 (s, 1H), 7.26 (d, <i>J</i> = 8.6 Hz, 1H), 6.77 (d, <i>J</i> = 8.0 Hz, 1H), 5.81−5.68 (m, 2H), 5.19 (d, <i>J</i> = 17.2 Hz, 1H), 5.06 (d, <i>J</i> = 10.2 Hz, 1H), 4.54−4.43 (m, 2H), 4.22−4.09 (m, 1H), 4.01 (d, <i>J</i> = 8.3 Hz, 1H), 4.00−3.90 (m, 1H), 3.97 (s, 3H), 2.59 (dd, <i>J</i> = 13.9, 7.8 Hz, 1H), 2.38−2.29 (m, 1H), 2.01 (dd, <i>J</i> = 17.2, 8.9 Hz, 1H), 1.56 (dd, <i>J</i> = 7.7, 5.0 Hz, 1H), 1.31−1.25 (m, 1H), 1.26 (d, <i>J</i> = 6.7 Hz, 6H), 1.19 (s, 9H), 0.97 (s, 9H). MS (ESI): 751.2 (M − H)<sup>−</sup>, 749.2 (M + H)<sup>+</sup>. HPLC homogeneity: H<sub>2</sub>O): 97%.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-[(Cyclobutyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-4-({7-methoxy-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>17</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 87:13 mixture of rotamers, major rotamer description; δ 12.47 (br s, 1H), 8.59 (s, 1H), 8.29−8.20 (br s, 1H), 8.19 (d, <i>J</i> = 9.2 Hz, 1H), 8.04 (br s, 1H), 7.85 (br s, 1H), 7.73 (br s, 1H), 7.32 (br d, <i>J</i> = 8.6 Hz, 1H), 7.17 (d, <i>J</i> = 8.2 Hz, 1H), 5.79−5.67 (m, 2H), 5.20 (dd, <i>J</i> = 17.1, 1.4 Hz, 1H), 5.07 (dd, <i>J</i> = 10.2, 1.8 Hz, 1H), 4.53−4.42 (m, 2H), 4.36−3.96 (m, 3H), 3.98 (s, 3H), 3.93 (dd, <i>J</i> = 12.5, 3.1 Hz, 1H), 2.64−2.54 (m, 1H), 2.38−2.28 (m, 1H), 2.06−1.91 (m, 3H), 1.89−1.74 (m, 2H), 1.70−1.52 (m, 2H), 1.47−1.37 (m, 1H), 1.29−1.26 (m, 1H), 1.26 (d, <i>J</i> = 6.7 Hz, 6H), 0.96 (s, 9H). MS (ESI): 747.4 (M − H)<sup>−</sup>, 749.3 (M + H)<sup>+</sup>. HPLC homogeneity: 97%.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> <i>N</i>-[(Cyclohexyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-4-({7-methoxy-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>18</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 88:12 mixture of rotamers, major rotamer description; δ 12.51 (br s, 1H), 8.62 (s, 1H), 8.26 (br s, 1H), 8.22 (d, <i>J</i> = 8.2 Hz, 1H), 8.05 (br s, 1H), 7.86 (br s, 1H), 7.72 (br s, 1H), 7.24 (br d, <i>J</i> = 7.9 Hz, 1H), 7.11 (d, <i>J</i> = 8.4 Hz, 1H), 5.82−5.61 (m, 2H), 5.21 (d, <i>J</i> = 17.2 Hz, 1H), 5.08 (d, <i>J</i> = 10.2 Hz, 1H), 4.61−4.37 (m, 2H), 4.25−3.86 (m, 4H), 3.98 (s, 3H), 2.64−2.48 (m, 1H), 2.38−2.28 (m, 1H), 2.01 (dd, <i>J</i> = 17.1, 8.8 Hz, 1H), 1.72−1.41 (m, 5H), 1.32−1.05 (m, 7H), 1.28 (d, <i>J</i> = 6.8 Hz, 6H), 0.98 (s, 9H). MS (ESI): 775.4 (M − H)<sup>−</sup>, 777.3 (M + H)<sup>+</sup>. HPLC homogeneity: 98%.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-({2-[2-(acetylamino)-1,3-thiazol-4-yl]-7-methoxyquinolin-4-yl}oxy)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>19</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 86:14 mixture of rotamers, major rotamer description; δ 12.38 (br s, 2H), 8.57 (s, 1H), 8.37 (br s, 1H), 8.18 (d, <i>J</i> = 9.2 Hz, 1H), 7.63 (s, 1H), 7.56 (s, 1H), 7.21 (d, <i>J</i> = 9.0 Hz, 1H), 7.02 (d, <i>J</i> = 7.9 Hz, 1H), 5.77−5.67 (m, 1H), 5.59 (br m, 1H), 5.19 (d, <i>J</i> = 17.2 Hz, 1H), 5.06 (d, <i>J</i> = 10.2 Hz, 1H), 4.61−4.54 (m, 1H), 4.51−4.41 (m, 2H), 4.07 (d, <i>J</i> = 8.6 Hz, 1H), 4.01−3.95 (m, 1H), 3.95 (s, 3H), 2.59 (dd, J=12.9, 7.2 Hz, 1H), 2.35−2.26 (m, 1H), 2.23 (s, 3H), 2.07−1.97 (m, 1H), 1.71−1.31 (m, 9H), 1.27 (dd, <i>J</i> = 9.4, 4.9 Hz, 1H), 0.97 (s, 9H). MS (ESI): 761.1 (M − H)<sup>−</sup>, 763.1 (M + H)<sup>+</sup>. HPLC homogeneity: > 99%.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-4-[(2-{2-[(3,3-dimethylbutanoyl)amino]-1,3-thiazol-4-yl}-7-methoxyquinolin-4-yl)oxy]-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>20</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 85:15 mixture of rotamers, major rotamer description; δ 12.42 (br s, 1H), 12.29 (s, 1H), 8.54 (s, 1H), 8.07 (d, <i>J</i> = 9.2 Hz, 1H), 8.02 (br s, 1H), 7.46 (s, 1H), 7.35 (s, 1H), 7.06 (d, <i>J</i> = 9.2 Hz, 1H), 7.00 (d, <i>J</i> = 8.6 Hz, 1H), 5.79−5.66 (m, 1H), 5.47−5.38 (m, 1H), 5.19 (d, <i>J</i> = 17.2 Hz, 1H), 5.06 (d, <i>J</i> = 10.3 Hz, 1H), 4.78−4.67 (m, 1H), 4.48−4.33 (m, 2H), 4.12 (d, <i>J</i> = 8.4 Hz, 1H), 4.03−3.93 (m, 1H), 3.92 (s, 3H), 2.58−2.49 (m, 1H), 2.43 (s, 2H), 2.31−2.19 (m, 1H), 2.08−1.98 (m, 1H), 1.83−1.15 (m, 10H),), 1.04 (s, 9H),), 0.97 (s, 9H). MS (ESI): 817.4 (M − H)<sup>−</sup>, 819.4 (M + H)<sup>+</sup>. HPLC homogeneity: > 99%.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-4-({7-methoxy-8-methyl-2-[2-(propan-2-ylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>21</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 88:12 mixture of rotamers, major rotamer description; δ 12.55 (br s, 1H), 8.58 (s, 1H), 8.07 (d, <i>J</i> = 7.1 Hz, 1H), 8.06 (br s, 1H), 7.89 (d, <i>J</i> = 9 Hz, 1H), 7.57 (br d, <i>J</i> = 6.9 Hz, 1H), 7.34 (br s, 1H), 7.02 (d, <i>J</i> = 8.6 Hz, 1H), 5.78−5.66 (m, 1H), 5.61−5.49 (br s, 1H), 5.23 (d, <i>J</i> = 17.0 Hz, 1H), 5.07 (d, <i>J</i> = 11.9 Hz, 1H), 4.55 (br s, 1H), 4.46 (t, <i>J</i> = 8.4 Hz, 1H), 4.38 (d, <i>J</i> = 11.2 Hz, 1H), 4.08 (d, <i>J</i> = 8.6 Hz, 1H), 4.03−3.97 (m, 1H), 3.96 (s, 3H), 3.92−3.83 (m, 1H), 2.56 (s, 3H), 2.53−2.47 (m, 1H), 2.38−2.25 (m, 1H), 2.08−1.98 (m, 1H), 1.71−1.35 (m, 9H), 1.35−1.27 (m, 1H), 1.27 (d, <i>J</i> = 6.3 Hz, 6H), 0.96 (s, 9H). MS (ESI): 775.4 (M − H)<sup>−</sup>, 777.5 (M + H)<sup>+</sup>. HPLC homogeneity: 95%.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-({2-[2-(acetylamino)-1,3-thiazol-4-yl]-7-methoxy-8-methylquinolin-4-yl}oxy)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>22</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 85:15 mixture of rotamers, major rotamer description; δ 12.32 (br s, 2H), 8.57 (s, 1H), 8.15−8.03 (m, 1H), 8.04 (d, <i>J</i> = 9.2 Hz, 1H), 7.47−7.37 (m, 1H), 7.29 (d, <i>J</i> = 8.8 Hz, 1H), 7.03 (d, <i>J</i> = 8.6 Hz, 1H), 5.78−5.65 (m, 1H), 5.45−5.38 (m, 1H), 5.19 (d, <i>J</i> = 17.0 Hz, 1H), 5.05 (d, <i>J</i> = 10.7 Hz, 1H), 4.72−4.62 (m, 1H), 4.46−4.32 (m, 2H), 4.16−4.08 (m, 1H), 4.03−3.90 (m, 1H), 3.94 (s, 3H), 2.60 (s, 3H), 2.30−2.19 (m, 1H), 2.20 (s, 3H), 2.06−1.97 (m, 1H), 1.81−1.21 (m, 11H), 0.97 (s, 9H). MS (ESI): 775.4 (M − H)<sup>−</sup>, 777.5 (M + H)<sup>+</sup>. HPLC homogeneity: 99%.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-4-({7-methoxy-8-methyl-2-[2-(propanoylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>23</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 85:15 mixture of rotamers, major rotamer description; δ 12.37 (br s, 1H), 12.33 (br s, 1H), 8.55 (s, 1H), 8.15−8.02 (m, 1H), 8.04 (d, <i>J</i> = 9.0 Hz, 1H), 7.49−7.38 (m, 1H), 7.29 (d, <i>J</i> = 9.2 Hz, 1H), 6.99 (d, <i>J</i> = 8.8 Hz, 1H), 5.78−5.66 (m, 1H), 5.46−5.39 (m, 1H), 5.18 (d, <i>J</i> = 17.0 Hz, 1H), 5.05 (d, <i>J</i> = 10.0 Hz, 1H), 4.71−4.62 (m, 1H), 4.47−4.32 (m, 2H), 4.15−4.09 (m, 1H), 4.03−3.92 (m, 1H), 3.94 (s, 3H), 2.60 (s, 3H), 2.58−2.40 (m, 2H), 2.30−2.20 (m, 1H), 2.07−1.97 (m, 1H), 1.80−1.21 (m, 11H), 1.13 (t, <i>J</i> = 7.5 Hz, 3H), 0.97 (s, 9H). MS (ESI): 789.4 (M − H)<sup>−</sup>, 791.4 (M + H)<sup>+</sup>. HPLC homogeneity: 98%.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-4-({8-fluoro-7-methoxy-2-[2-(propanoylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>24</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 85:15 mixture of rotamers, major rotamer description; δ 12.39 (br s, 1H) 12.35 (s, 1H), 8.54 (s, 1H), 8.03 (s, 1H), 7.92 (d, <i>J</i> = 9.2 Hz, 1H), 7.47 (s, 1H), 7.38 (t, <i>J</i> = 8.3 Hz, 1H), 6.98 (d, <i>J</i> = 8.7 Hz, 1H), 5.78−5.65 (m, 1H), 5.47−5.38 (m, 1H), 5.18 (dd, <i>J</i> = 17.2, 1.4 Hz 1H), 5.05 (dd, <i>J</i> = 10.3, 1.6 Hz, 1H), 4.69−4.60 (m, 1H), 4.48−4.30 (m, 2H), 4.14−3.90 (m, 2H), 3.98 (s, 3H), 2.60−2.39 (m, 3H), 2.30−2.20 (m, 1H), 2.06−1.97 (m, 1H), 1.80−1.37 (m, 8H), 1.37−1.20 (m, 2H), 1.12 (t, <i>J</i> = 7.5 Hz, 3H), 0.96 (s, 9H). MS (ESI): 793.3 (M − H)<sup>−</sup>, 795.3 (M + H)<sup>+</sup>. HPLC homogeneity: 98%.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-4-({8-chloro-7-methoxy-2-[2-(propanoylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>25</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 88:12 mixture of rotamers, major rotamer description; δ 12.49 (br s, 1H) 12.34 (s, 1H), 8.55 (s, 1H), 8.12 (d, <i>J</i> = 9.2 Hz, 1H), 8.05 (s, 1H), 7.48 (s, 1H), 7.39 (d, <i>J</i> = 9.2 Hz, 1H), 6.98 (d, <i>J</i> = 8.6 Hz, 1H), 5.80−5.66 (m, 1H), 5.49−5.37 (m, 1H), 5.19 (d, <i>J</i> = 17.0 Hz, 1H), 5.07 (d, <i>J</i> = 10.4 Hz, 1H), 4.70−4.54 (m, 1H), 4.45 (t, <i>J</i> = 8.6 Hz, 1H), 4.38 (d, <i>J</i> = 11.5 Hz, 1H), 4.09 (d, <i>J</i> = 8.8 Hz, 1H), 4.01 (s, 3H), 3.96 (br d, <i>J</i> = 10.6 Hz, 1H), 2.60−2.43 (m, 3H), 2.32−2.22 (m, 1H), 2.06−1.98 (m, 1H), 1.80−1.41 (m, 8H), 1.39−1.21 (m, 2H), 1.13 (t, <i>J</i> = 7.5 Hz, 3H), 0.96 (s, 9H). MS (ESI): 809.3 (M − H)<sup>−</sup>, 811.3 (M + H)<sup>+</sup>. HPLC homogeneity: 96%.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-({8-bromo-7-methoxy-2-[2-(propanoylamino)-1,3-thiazol-4-yl]quinolin-4-yl}oxy)-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>26</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 85:15 mixture of rotamers, major rotamer description; δ 12.50 (br s, 1H) 12.33 (s, 1H), 8.55 (s, 1H), 8.17 (d, <i>J</i> = 9.2 Hz, 1H), 8.04 (s, 1H), 7.47 (s, 1H), 7.35 (d, <i>J</i> = 9.2 Hz, 1H), 6.98 (d, <i>J</i> = 8.4 Hz, 1H), 5.80−5.66 (m, 1H), 5.47−5.37 (m, 1H), 5.19 (d, <i>J</i> = 17.1 Hz, 1H), 5.07 (d, <i>J</i> = 10.4 Hz, 1H), 4.67−4.55 (m, 1H), 4.45 (t, <i>J</i> = 8.4 Hz, 1H), 4.38 (d, <i>J</i> = 11.7 Hz, 1H), 4.08 (d, <i>J</i> = 8.8 Hz, 1H), 4.01 (s, 3H), 3.95 (br d, <i>J</i> = 8.6 Hz, 1H), 2.60−2.47 (m, 3H), 2.32−2.21 (m, 1H), 2.06−1.98 (m, 1H), 1.77−1.37 (m, 8H), 1.36−1.23 (m, 2H), 1.13 (t, <i>J</i> = 7.6 Hz, 3H), 0.96 (s, 9H). MS (ESI): 855.2, 857.2 (M − H)<sup>−</sup>, 853.1, 855.1 (M + H)<sup>+</sup>. HPLC homogeneity: 97%.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-[(8-bromo-7-methoxy-2-{2-[(methoxycarbonyl)amino]-1,3-thiazol-4-yl}quinolin-4-yl)oxy]-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>27</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 88:12 mixture of rotamers, major rotamer description; δ 12.49 (br s, 1H) 12.06 (s, 1H), 8.55 (s, 1H), 8.16 (d, <i>J</i> = 9.2 Hz, 1H), 8.04 (s, 1H), 7.45 (s, 1H), 7.35 (d, <i>J</i> = 9.4 Hz, 1H), 6.98 (d, <i>J</i> = 8.6 Hz, 1H), 5.80−5.66 (m, 1H), 5.48−5.37 (m, 1H), 5.19 (d, <i>J</i> = 17.1 Hz, 1H), 5.06 (d, <i>J</i> = 10.2 Hz, 1H), 4.65−4.55 (m, 1H), 4.45 (t, <i>J</i> = 8.5 Hz, 1H), 4.37 (d, <i>J</i> = 11.9 Hz, 1H), 4.08 (d, <i>J</i> = 8.8 Hz, 1H), 4.01 (s, 3H), 3.96 (br d, <i>J</i> = 9.4 Hz, 1H), 3.78 (s, 3H), 2.58−2.48 (m, 1H), 2.32−2.21 (m, 1H), 2.06−1.98 (m, 1H), 1.71−1.37 (m, 8H), 1.36−1.26 (m, 2H), 0.96 (s, 9H). MS (ESI): 855.1, 857.1 (M − H)<sup>−</sup>, 857.2, 859.2 (M + H)<sup>+</sup>. HPLC homogeneity: >99%.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> <i>N</i>-[(Cyclopentyloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[8-bromo-7-methoxy-2-(2-{[(propan-2-yloxy)carbonyl]amino}-1,3-thiazol-4-yl)quinolin-4-yl]oxy}-<i>N</i>-[(1<i>R</i>,2<i>S</i>)-1-carboxy-2-ethenylcyclopropyl]-<span class="smallcaps smallerCapital">l</span>-prolinamide (<b>28</b>)</h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): about 85:15 mixture of rotamers, major rotamer description; δ 12.45 (br s, 1H) 11.90 (s, 1H), 8.55 (s, 1H), 8.16 (d, <i>J</i> = 9.2 Hz, 1H), 8.03 (s, 1H), 7.45 (s, 1H), 7.35 (d, <i>J</i> = 9.4 Hz, 1H), 6.98 (d, <i>J</i> = 8.6 Hz, 1H), 5.81−5.66 (m, 1H), 5.48−5.37 (m, 1H), 5.19 (d, <i>J</i> = 17.0 Hz, 1H), 5.07 (d, <i>J</i> = 10.4 Hz, 1H), 4.99 (m, 1H), 4.67−4.55 (m, 1H), 4.45 (t, <i>J</i> = 8.4 Hz, 1H), 4.38 (d, <i>J</i> = 11.9 Hz, 1H), 4.08 (d, <i>J</i> = 8.8 Hz, 1H), 4.01 (s, 3H), 3.96 (br d, <i>J</i> = 9.4 Hz, 1H), 2.58−2.48 (m, 1H), 2.32−2.21 (m, 1H), 2.06−1.98 (m, 1H), 1.71−1.37 (m, 8H), 1.36−1.26 (m, 2H), 1.29 (d, <i>J</i> = 6.3 Hz, 6H), 0.96 (s, 9H). MS (ESI): 883.2, 885.2 (M − H)<sup>−</sup>, 885.3, 887.3 (M + H)<sup>+</sup>. HPLC homogeneity: >99%.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i46"><a href="/doi/suppl/10.1021/jm100690x">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61255" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61255" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Full <sup>1</sup>H and <sup>13</sup>C NMR characterization and assignments provided for <b>29</b>. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100690x/suppl_file/jm100690x_si_001.pdf">jm100690x_si_001.pdf (1.55 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm100690x" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85330" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85330" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Montse Llinàs-Brunet</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#dbb6b4b5afa8bef5b7b7b2b5baa8f6b9a9aeb5beaf9bb9b4beb3a9b2b5bcbea9f6b2b5bcbeb7b3beb2b6f5b8b4b6"><span class="__cf_email__" data-cfemail="234e4c4d5750460d4f4f4a4d42500e4151564d465763414c464b514a4d4446510e4a4d44464f4b464a4e0d404c4e">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Murray D. Bailey</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nathalie Goudreau</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Punit K. Bhardwaj</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Josée Bordeleau</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Bös</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yves Bousquet</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael G. Cordingley</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiamin Duan</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pat Forgione</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michel Garneau</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elise Ghiro</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vida Gorys</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sylvie Goulet</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ted Halmos</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen H. Kawai</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Naud</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marc-André Poupart</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter W. White</span> - <span class="hlFld-Affiliation affiliation">Departments of Medicinal Chemistry, and Biological Sciences, Research and Development, Boehringer Ingelheim (Canada) Ltd., 2100 Cunard Street, Laval, Quebec H7S 2G5, Canada</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77276" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77276" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors thank Dr. Lisette Lagacé, Nathalie Dansereau, Charles Pellerin, Martin Marquis, Lyne Lamarre, Diane Thibeault, Roger Maurice, and Ewald Welchner for EC<sub>50</sub> and IC<sub>50</sub> determinations. The authors also thank the analytical chemistry and bioanalytical departments for technical support. Finally, the authors thank Drs. Paul Anderson, George Kukolj, and Daniel Lamarre for helpful discussions.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86534" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86534" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Lavanchy, D.</span><span> </span><span class="NLM_article-title">The global burden of hepatitis C</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1111%2Fj.1478-3231.2008.01934.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=19207969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A280%3ADC%252BD1M7mvFWqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=74-81&issue=Suppl.+1&author=D.+Lavanchy&title=The+global+burden+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The global burden of hepatitis C</span></div><div class="casAuthors">Lavanchy Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Liver international : official journal of the International Association for the Study of the Liver</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29 Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hepatitis C is of concern both to industrialized and developing countries.  Preliminary unpublished estimates of the global burden of disease (GBD) attributable to HCV-related chronic liver disease seem to be substantial.  Therefore, the reduction of global mortality and morbidity related to chronic hepatitis C should be a concern to public health authorities, and primary, secondary and tertiary prevention activities should be implemented and monitored in each country, with precise targets set to be reached.  In order to decide on national health policies, there is a need to estimate the burden of disease, globally, regionally and nationally.  To evaluate the GBD, three components have to be assessed: 1) The global, regional and national burden of morbidity and mortality associated with HCV infection, based on prevalence, incidence, transmission and economics; 2) The natural history of HCV infection, including 'healthy individuals'; and 3) The areas for which more research is needed.  A working group was created to assist the World Health organization (WHO) in estimating the GBD associated with HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuhPVOhaFqwZQHPYJuLg8TfW6udTcc2ebetfOSo8uEbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7mvFWqtg%253D%253D&md5=c43cb9445029ca7dd4033dc4a2d9a32c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1478-3231.2008.01934.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1478-3231.2008.01934.x%26sid%3Dliteratum%253Aachs%26aulast%3DLavanchy%26aufirst%3DD.%26atitle%3DThe%2520global%2520burden%2520of%2520hepatitis%2520C%26jtitle%3DLiver%2520Int.%26date%3D2009%26volume%3D29%26issue%3DSuppl.%25201%26spage%3D74%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Brown, R. S.</span><span> </span><span class="NLM_article-title">Hepatitis C and liver transplantation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=973-978&author=R.+S.+Brown&title=Hepatitis+C+and+liver+transplantation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BS.%26atitle%3DHepatitis%2520C%2520and%2520liver%2520transplantation%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D973%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Choo, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overby, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1126%2Fscience.2523562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=2523562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=359-362&author=Q.+L.+Chooauthor=G.+Kuoauthor=A.+J.+Weinerauthor=L.+R.+Overbyauthor=D.+W.+Bradleyauthor=M.+Houghton&title=Isolation+of+a+cDNA+clone+derived+from+a+blood-borne+non-A%2C+non-B+viral+hepatitis+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span></div><div class="casAuthors">Choo, Qui Lim; Kuo, George; Weiner, Amy J.; Overby, Lacy R.; Bradley, Daniel W.; Houghton, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4902</span>),
    <span class="NLM_cas:pages">359-62</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A random-primed cDNA library was constructed from plasma contg. the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH.  A cDNA clone was isolated that was shown to encode an antigen assocd. specifically with NANBH infections.  This clone is not derived from host DNA but from an RNA mol. present in NANBH infections that consists of ≥10,000 nucleotides, and that is pos.-stranded with respect to the encoded NANBH antigen.  These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae.  This mol. approach should be of great value in the isolation and characterization of other unidentified infectious agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorpVFx7nEkrVg90H21EOLACvtfcHk0ljHcyGi-gLUIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D&md5=25161cf212790856dd29d3aaf78f20b8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.2523562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2523562%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DQ.%2BL.%26aulast%3DKuo%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DOverby%26aufirst%3DL.%2BR.%26aulast%3DBradley%26aufirst%3DD.%2BW.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520cDNA%2520clone%2520derived%2520from%2520a%2520blood-borne%2520non-A%252C%2520non-B%2520viral%2520hepatitis%2520genome%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D359%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Ghany, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strader, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeff, L. B.</span><span> </span><span class="NLM_article-title">Diagnosis, management, and treatment of hepatitis C: an update</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1335</span><span class="NLM_x">–</span> <span class="NLM_lpage">1374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1002%2Fhep.22759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=19330875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslWjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1335-1374&author=M.+G.+Ghanyauthor=D.+B.+Straderauthor=D.+L.+Thomasauthor=L.+B.+Seeff&title=Diagnosis%2C+management%2C+and+treatment+of+hepatitis+C%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis, management, and treatment of hepatitis C: an update</span></div><div class="casAuthors">Ghany, Marc G.; Strader, Doris B.; Thomas, David L.; Seeff, Leonard B.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1335-1374</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  This document aims to provide clinicians with evidence-based approaches to the prevention, diagnosis, and management of hepatitis C virus (HCV) infection.  Current data on the recommended treatments of patients with chronic HCV infection are included.  The sequential steps recommended for managing and treating persons chronically infected with hepatitis C for whom treatment is considered clearly appropriate are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzNs1N2UX4FrVg90H21EOLACvtfcHk0ljHcyGi-gLUIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslWjs7o%253D&md5=14f112636daff9f246fded6f6b2e23ee</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fhep.22759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22759%26sid%3Dliteratum%253Aachs%26aulast%3DGhany%26aufirst%3DM.%2BG.%26aulast%3DStrader%26aufirst%3DD.%2BB.%26aulast%3DThomas%26aufirst%3DD.%2BL.%26aulast%3DSeeff%26aufirst%3DL.%2BB.%26atitle%3DDiagnosis%252C%2520management%252C%2520and%2520treatment%2520of%2520hepatitis%2520C%253A%2520an%2520update%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3D1335%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Moradpour, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Replication of hepatitis C virus</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1038%2Fnrmicro1645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=17487147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlSqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=453-463&author=D.+Moradpourauthor=F.+Peninauthor=C.+M.+Rice&title=Replication+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of hepatitis C virus</span></div><div class="casAuthors">Moradpour, Darius; Penin, Francois; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">453-463</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Exciting progress has recently been made in understanding the replication of hepatitis C virus, a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide.  The development of complete cell-culture systems should now enable the systematic dissection of the entire viral life-cycle, providing insights into the hitherto difficult-to-study early and late steps.  These efforts have already translated into the identification of novel antiviral targets and the development of new therapeutic strategies, some of which are currently undergoing clin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreB87JperiIrVg90H21EOLACvtfcHk0liQs7oeN9_htA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlSqtb8%253D&md5=be020cc05a67e7256779b1c0ce797089</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1645%26sid%3Dliteratum%253Aachs%26aulast%3DMoradpour%26aufirst%3DD.%26aulast%3DPenin%26aufirst%3DF.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DReplication%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2007%26volume%3D5%26spage%3D453%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Kolykhalov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstone, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">2046</span><span class="NLM_x">–</span> <span class="NLM_lpage">2051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1128%2FJVI.74.4.2046-2051.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=10644379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=2046-2051&author=A.+A.+Kolykhalovauthor=K.+Mihalikauthor=S.+M.+Feinstoneauthor=C.+M.+Rice&title=Hepatitis+C+virus-encoded+enzymatic+activities+and+conserved+RNA+elements+in+the+3%E2%80%B2+nontranslated+region+are+essential+for+virus+replication+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo</span></div><div class="casAuthors">Kolykhalov, Alexander A.; Mihalik, Kathy; Feinstone, Stephen M.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2046-2051</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a widespread major human health concern.  Significant obstacles in the study of this virus include the absence of a reliable tissue culture system and a small-animal model.  Recently, full-length HCV cDNA clones were constructed and HCV infection was successfully initiated in 2 chimpanzees by intrahepatic injection of in vitro-transcribed RNA.  In order to validate potential targets for development of anti-HCV therapeutics, 6 mutant derivs. of this prototype infectious clone were constructed.  Four clones contained point mutations ablating the activity of the NS2-3 protease, the NS3-4A serine protease, the NS3 NTPase/helicase, and the NS5B polymerase.  Two addnl. clones contained deletions encompassing all or part of the highly conserved 98-base sequence at the 3' terminus of the HCV genome RNA.  The RNA transcript from each of the 6 clones was injected intrahepatically into a chimpanzee.  No signs of HCV infection were detected in the 8 mo following the injection.  Inoculation of the same animal with nonmutant RNA transcripts resulted in productive HCV infection, as evidenced by viremia, elevated serum alanine aminotransferase, and HCV-specific seroconversion.  These data suggest that these 4 HCV-encoded enzymic activities and the conserved 3' terminal RNA element are essential for productive replication in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcxsUWOuM9sLVg90H21EOLACvtfcHk0liQs7oeN9_htA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D&md5=69facc6778408ae96f31373f78c06600</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1128%2FJVI.74.4.2046-2051.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.74.4.2046-2051.2000%26sid%3Dliteratum%253Aachs%26aulast%3DKolykhalov%26aufirst%3DA.%2BA.%26aulast%3DMihalik%26aufirst%3DK.%26aulast%3DFeinstone%26aufirst%3DS.%2BM.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DHepatitis%2520C%2520virus-encoded%2520enzymatic%2520activities%2520and%2520conserved%2520RNA%2520elements%2520in%2520the%25203%25E2%2580%25B2%2520nontranslated%2520region%2520are%2520essential%2520for%2520virus%2520replication%2520in%2520vivo%26jtitle%3DJ.%2520Virol.%26date%3D2000%26volume%3D74%26spage%3D2046%26epage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">A review of HCV protease inhibitors</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=821-837&author=K.+X.+Chenauthor=F.+G.+Njoroge&title=A+review+of+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DA%2520review%2520of%2520HCV%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D821%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.,  St</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+Bosauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.+M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagaceauthor=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.+A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=R.+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.+L.+Yongauthor=M.+Llinas-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0lg9N388ZbFAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.%2BM.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.%2BA.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DGeorge%26aufirst%3DR.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Hinrichsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forns, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronlein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaves, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G. G.</span><span> </span><span class="NLM_article-title">Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=1347-1355&author=H.+Hinrichsenauthor=Y.+Benhamouauthor=H.+Wedemeyerauthor=M.+Reiserauthor=R.+E.+Sentjensauthor=J.+L.+Callejaauthor=X.+Fornsauthor=A.+Erhardtauthor=J.+Cronleinauthor=R.+L.+Chavesauthor=C.+L.+Yongauthor=G.+Nehmizauthor=G.+G.+Steinmann&title=Short-term+antiviral+efficacy+of+BILN+2061%2C+a+hepatitis+C+virus+serine+protease+inhibitor%2C+in+hepatitis+C+genotype+1+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHinrichsen%26aufirst%3DH.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DReiser%26aufirst%3DM.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DForns%26aufirst%3DX.%26aulast%3DErhardt%26aufirst%3DA.%26aulast%3DCronlein%26aufirst%3DJ.%26aulast%3DChaves%26aufirst%3DR.%2BL.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DNehmiz%26aufirst%3DG.%26aulast%3DSteinmann%26aufirst%3DG.%2BG.%26atitle%3DShort-term%2520antiviral%2520efficacy%2520of%2520BILN%25202061%252C%2520a%2520hepatitis%2520C%2520virus%2520serine%2520protease%2520inhibitor%252C%2520in%2520hepatitis%2520C%2520genotype%25201%2520patients%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3D1347%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.+P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.%2BP.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Malcolm, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span> <span class="citation_source-journal">Antimicrobial Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1128%2FAAC.50.3.1013-1020.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=16495264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFamtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1013-1020&author=B.+A.+Malcolmauthor=R.+Liuauthor=F.+Lahserauthor=S.+Agrawalauthor=B.+Belangerauthor=N.+Butkiewiczauthor=R.+Chaseauthor=F.+Gheyasauthor=A.+Hartauthor=D.+Heskauthor=P.+Ingravalloauthor=C.+Jiangauthor=R.+Kongauthor=J.+Luauthor=J.+Pichardoauthor=A.+Prongayauthor=A.+Skeltonauthor=X.+Tongauthor=S.+Venkatramanauthor=E.+Xiaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=SCH+503034%2C+a+mechanism-based+inhibitor+of+hepatitis+C+virus+NS3+protease%2C+suppresses+polyprotein+maturation+and+enhances+the+antiviral+activity+of+alpha+interferon+in+replicon+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span></div><div class="casAuthors">Malcolm, B. A.; Liu, R.; Lahser, F.; Agrawal, S.; Belanger, B.; Butkiewicz, N.; Chase, R.; Gheyas, F.; Hart, A.; Hesk, D.; Ingravallo, P.; Jiang, C.; Kong, R.; Lu, J.; Pichardo, J.; Prongay, A.; Skelton, A.; Tong, X.; Venkatraman, S.; Xia, E.; Girijavallabhan, V.; Njoroge, F. G.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1013-1020</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Cleavage of the hepatitis C virus (HCV) polyprotein by the viral NS3 protease releases functional viral proteins essential for viral replication.  Recent studies by Foy and coworkers strongly suggest that NS3-mediated cleavage of host factors may abrogate cellular response to alpha interferon (IFN-α).  Blockage of NS3 protease activity therefore is expected to inhibit HCV replication by both direct suppression of viral protein prodn. as well as by restoring host responsiveness to IFN.  Using structure-assisted design, a ketoamide inhibitor, SCH 503034, was generated which demonstrated potent (overall inhibition const., 14 nM) time-dependent inhibition of the NS3 protease in cell-free enzyme assays as well as robust in vitro activity in the HCV replicon system, as monitored by immunofluorescence and real-time PCR anal.  Continuous exposure of replicon-bearing cell lines to six times the 90% effective concn. of SCH 503034 for 15 days resulted in a greater than 4-log redn. in replicon RNA.  The combination of SCH 503034 with IFN was more effective in suppressing replicon synthesis than either compd. alone, supporting the suggestion of Foy and coworkers that combinations of IFN with protease inhibitors would lead to enhanced therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpEpdwyo4a_bVg90H21EOLACvtfcHk0lg9N388ZbFAvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFamtLY%253D&md5=c21551e6d306f85039888211b1d07479</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.3.1013-1020.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.3.1013-1020.2006%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DB.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DSCH%2520503034%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%252C%2520suppresses%2520polyprotein%2520maturation%2520and%2520enhances%2520the%2520antiviral%2520activity%2520of%2520alpha%2520interferon%2520in%2520replicon%2520cells%26jtitle%3DAntimicrobial%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Chen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, S. L.</span><span> </span><span class="NLM_article-title">Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2317</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.2174%2F0929867054864769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=16181135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWks7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2317-2342&author=S.+H.+Chenauthor=S.+L.+Tan&title=Discovery+of+small-molecule+inhibitors+of+HCV+NS3-4A+protease+as+potential+therapeutic+agents+against+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection</span></div><div class="casAuthors">Chen, Shu-Hui; Tan, Seng-Lai</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2317-2342</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic infection with hepatitis C virus (HCV) is assocd. with liver cirrhosis that often leads to hepatic failure and hepatocellular carcinoma (HCC).  HCV infection has become a global health threat and the main cause of adult liver transplants in developed nations.  Current approved anti-HCV therapies (interferon and pegylated interferon alone or in combination with ribavirin) are not effective in eliminating the viral infection in a significant population of patients (e.g., those infected with HCV genotype 1).  Furthermore, these therapies are plagued with many undesirable side effects.  Therefore, the HCV epidemic represents a huge unmet medical need that has triggered intensive research efforts towards the development of more effective drugs.  Given its essential role in the process of HCV replication, the viral NS3/4A serine protease is arguably the most thoroughly characterized HCV enzyme and the most intensively pursued anti-HCV target for drug development.  This is further fueled by the successful use of small-mol. inhibitors of the human immunodeficiency virus (HIV) viral protease, which have had an impressive effect on HIV-related morbidity and mortality, offering hope that analogous drugs might also have a similar impact against HCV.  Here, we review the recent progress and development of small-mol. inhibitors of the HCV NS3/4A protease.  In particular, we focus on the discovery of VX-950, the latest HCV NS3-4A protease inhibitor to be advanced to clin. studies.  While the challenges of designing potent inhibitors of the viral protease have been solved, as highlighted by BILN 2061 and VX-950, it is still too early to det. whether these efforts will eventually yield promising drug candidates.  For the emerging small-mol. HCV inhibitors, viral resistance will likely be a big problem.  Thus, combination therapy of different drugs with different targets/mechanisms will be necessary to effectively inhibit HCV replication.  It is also hoped that a detail characterization of how the resistance mutations that affect NS3 inhibitor binding may provide useful information for the design of inhibitors with the potential to treat resistant viruses that may arise during chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPS11RNEtD9LVg90H21EOLACvtfcHk0li4DnRyP_XEVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWks7jN&md5=5c255f47a40c7db2fa951f8727c5a21c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F0929867054864769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867054864769%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%2520small-molecule%2520inhibitors%2520of%2520HCV%2520NS3-4A%2520protease%2520as%2520potential%2520therapeutic%2520agents%2520against%2520HCV%2520infection%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2317%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Prongay, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosise, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taremi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarosh-Tomaine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senior, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span> </span><span class="NLM_article-title">Discovery of the HCV NS3/4A protease inhibitor (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (Sch 503034) II. Key steps in structure-based optimization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2310</span><span class="NLM_x">–</span> <span class="NLM_lpage">2318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060173k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2310-2318&author=A.+J.+Prongayauthor=Z.+Guoauthor=N.+Yaoauthor=J.+Pichardoauthor=T.+Fischmannauthor=C.+Stricklandauthor=J.+Myersauthor=P.+C.+Weberauthor=B.+M.+Beyerauthor=R.+Ingramauthor=Z.+Hongauthor=W.+W.+Prosiseauthor=L.+Ramanathanauthor=S.+S.+Taremiauthor=T.+Yarosh-Tomaineauthor=R.+Zhangauthor=M.+Seniorauthor=R.+S.+Yangauthor=B.+Malcolmauthor=A.+Arasappanauthor=F.+Bennettauthor=S.+L.+Bogenauthor=K.+Chenauthor=E.+Jaoauthor=Y.+T.+Liuauthor=R.+G.+Loveyauthor=A.+K.+Saksenaauthor=S.+Venkatramanauthor=V.+Girijavallabhanauthor=F.+G.+Njorogeauthor=V.+Madison&title=Discovery+of+the+HCV+NS3%2F4A+protease+inhibitor+%281R%2C5S%29-N-%5B3-amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28Sch+503034%29+II.+Key+steps+in+structure-based+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm060173k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060173k%26sid%3Dliteratum%253Aachs%26aulast%3DProngay%26aufirst%3DA.%2BJ.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DFischmann%26aufirst%3DT.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DProsise%26aufirst%3DW.%2BW.%26aulast%3DRamanathan%26aufirst%3DL.%26aulast%3DTaremi%26aufirst%3DS.%2BS.%26aulast%3DYarosh-Tomaine%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSenior%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DR.%2BS.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.%2BT.%26aulast%3DLovey%26aufirst%3DR.%2BG.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520the%2520HCV%2520NS3%252F4A%2520protease%2520inhibitor%2520%25281R%252C5S%2529-N-%255B3-amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528Sch%2520503034%2529%2520II.%2520Key%2520steps%2520in%2520structure-based%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2310%26epage%3D2318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laplante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Peptide-based inhibitors of the hepatitis C virus serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1713</span><span class="NLM_x">–</span> <span class="NLM_lpage">1718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=1713-1718&author=M.+Llinas-Brunetauthor=M.+Baileyauthor=G.+Fazalauthor=S.+Gouletauthor=T.+Halmosauthor=S.+Laplanteauthor=R.+Mauriceauthor=M.+Poirierauthor=M.+A.+Poupartauthor=D.+Thibeaultauthor=D.+Wernicauthor=D.+Lamarre&title=Peptide-based+inhibitors+of+the+hepatitis+C+virus+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLaplante%26aufirst%3DS.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.%2BA.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DPeptide-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D1713%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Steinkuhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biasiol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span> </span><span class="NLM_article-title">Product inhibition of the hepatitis C virus NS3 protease</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">8899</span><span class="NLM_x">–</span> <span class="NLM_lpage">8905</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi980313v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=8899-8905&author=C.+Steinkuhlerauthor=G.+Biasiolauthor=M.+Brunettiauthor=A.+Urbaniauthor=U.+Kochauthor=R.+Corteseauthor=A.+Pessiauthor=R.+De+Francesco&title=Product+inhibition+of+the+hepatitis+C+virus+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbi980313v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980313v%26sid%3Dliteratum%253Aachs%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DBiasiol%26aufirst%3DG.%26aulast%3DBrunetti%26aufirst%3DM.%26aulast%3DUrbani%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DPessi%26aufirst%3DA.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26atitle%3DProduct%2520inhibition%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D8899%26epage%3D8905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deziel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=2719-2724&author=M.+Llinas-Brunetauthor=M.+Baileyauthor=R.+Dezielauthor=G.+Fazalauthor=V.+Gorysauthor=S.+Gouletauthor=T.+Halmosauthor=R.+Mauriceauthor=M.+Poirierauthor=M.+A.+Poupartauthor=J.+Rancourtauthor=D.+Thibeaultauthor=D.+Wernicauthor=D.+Lamarre&title=Studies+on+the+C-terminal+of+hexapeptide+inhibitors+of+the+hepatitis+C+virus+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DDeziel%26aufirst%3DR.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.%2BA.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStudies%2520on%2520the%2520C-terminal%2520of%2520hexapeptide%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D2719%26epage%3D2724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1356</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1002%2Fanie.200390347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlygsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1356-1360&author=Y.+S.+Tsantrizosauthor=G.+Bolgerauthor=P.+Bonneauauthor=D.+R.+Cameronauthor=N.+Goudreauauthor=G.+Kukoljauthor=S.+R.+LaPlanteauthor=M.+Llinas-Brunetauthor=H.+Narauthor=D.+Lamarre&title=Macrocyclic+inhibitors+of+the+NS3+protease+as+potential+therapeutic+agents+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span></div><div class="casAuthors">Tsantrizos, Youla S.; Bolger, Gordon; Bonneau, Pierre; Cameron, Dale R.; Goudreau, Nathalie; Kukolj, George; LaPlante, Steven R.; Llinas-Brunet, Montse; Nar, Herbert; Lamarre, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1356-1360</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A novel class of selective inhibitors of the hepatitis C virus NS3 protease, an enzyme which is essential for viral replication in vivo, was developed.  The inhibitors are based on the structure-activity relationship between a substrate-based peptidomimetic ligand and the HCV NS3 serine protease.  The designed HCV inhibitor and its satd. analogs are the first inhibitors of the NS3 protease which inhibit HCV RNA replication in the cell-based replicon assay.  In addn., they are orally absorbed and stable to metabolic breakdown.  Thus, these compds. show many of the desirable properties of a druglike archetype and could lead t a clin. useful antiviral agent for the treatment of hepatitis C viral infections in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCij3shP5tmLVg90H21EOLACvtfcHk0lhZ8AaDhdw73Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlygsrc%253D&md5=e0a3c98ee0096bfc3d058bf0b92b81c3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fanie.200390347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200390347%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520the%2520NS3%2520protease%2520as%2520potential%2520therapeutic%2520agents%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D1356%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand-Maitre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre-Paquette, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Structure−activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1608</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0342414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1605-1608&author=M.+Llinas-Brunetauthor=M.+D.+Baileyauthor=G.+Bolgerauthor=C.+Brochuauthor=A.+M.+Faucherauthor=J.+M.+Ferlandauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=C.+Grand-Maitreauthor=T.+Halmosauthor=N.+Lapeyre-Paquetteauthor=F.+Liardauthor=M.+Poirierauthor=M.+Rheaumeauthor=Y.+S.+Tsantrizosauthor=D.+Lamarre&title=Structure%E2%88%92activity+study+on+a+novel+series+of+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3+protease+leading+to+the+discovery+of+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0342414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0342414%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DFaucher%26aufirst%3DA.%2BM.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGrand-Maitre%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLapeyre-Paquette%26aufirst%3DN.%26aulast%3DLiard%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRheaume%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStructure%25E2%2588%2592activity%2520study%2520on%2520a%2520novel%2520series%2520of%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520BILN%25202061%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1605%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">Peptide-based inhibitors of the hepatitis C virus NS3 protease: structure−activity relationship at the C-terminal position</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2511</span><span class="NLM_x">–</span> <span class="NLM_lpage">2522</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030573x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2511-2522&author=J.+Rancourtauthor=D.+R.+Cameronauthor=V.+Gorysauthor=D.+Lamarreauthor=M.+Poirierauthor=D.+Thibeaultauthor=M.+Llinas-Brunet&title=Peptide-based+inhibitors+of+the+hepatitis+C+virus+NS3+protease%3A+structure%E2%88%92activity+relationship+at+the+C-terminal+position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm030573x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030573x%26sid%3Dliteratum%253Aachs%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DPeptide-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%253A%2520structure%25E2%2588%2592activity%2520relationship%2520at%2520the%2520C-terminal%2520position%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2511%26epage%3D2522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Schechter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span> </span><span class="NLM_article-title">On the size of the active site in proteases. I. Papain</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1016%2FS0006-291X%2867%2980055-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=6035483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1967&pages=157-162&author=I.+Schechterauthor=A.+Berger&title=On+the+size+of+the+active+site+in+proteases.+I.+Papain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">On the size of the active site in proteases.  I.  Papain</span></div><div class="casAuthors">Schechter, Israel; Berger, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-62</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The action of papain on 40 diastereoisomeric peptides of alanine, ranging in length from Ala2 to Ala6, was studied to investigate the size of the active site.  The variations observed in the rates of hydrolysis lead to the conclusion that papain has a large active site which extends over ∼25 A. and can be divided into 7 "subsites," each accommodating 1 amino acid residue of the peptide substrate.  The subsites are located on both sides of the catalytic site, 4 on the one side and 3 on the other.  It is postulated that a long "groove" analogous to that found by x-ray analysis in lysozyme is present.  The substrate is believed to fit into the groove, binding to several subsites of specific geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_kZeRVAOVyrVg90H21EOLACvtfcHk0lgxoggYY-m53A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D&md5=a58ceccdbb5cc5c021af06912835f77c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2867%2980055-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252867%252980055-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DOn%2520the%2520size%2520of%2520the%2520active%2520site%2520in%2520proteases.%2520I.%2520Papain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1967%26volume%3D27%26spage%3D157%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Stoltz, J. H.; Stern, J. O.; Huang, Q.; Seidler, R. W.; Pack, F. D.; Knight, B. L.</span><span> </span><span class="NLM_article-title">A 28-day mechanistic time course study in the rhesus monkey with hepatitis C virus protease inhibitor BILN 2061</span>.  <span class="citation_source-journal">Toxicol. Pathol.</span>, submitted 2010.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Stoltz%2C+J.+H.%3B+Stern%2C+J.+O.%3B+Huang%2C+Q.%3B+Seidler%2C+R.+W.%3B+Pack%2C+F.+D.%3B+Knight%2C+B.+L.+A+28-day+mechanistic+time+course+study+in+the+rhesus+monkey+with+hepatitis+C+virus+protease+inhibitor+BILN+2061.+Toxicol.+Pathol.%2C+submitted+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStoltz%26aufirst%3DJ.%2BH.%26atitle%3DA%252028-day%2520mechanistic%2520time%2520course%2520study%2520in%2520the%2520rhesus%2520monkey%2520with%2520hepatitis%2520C%2520virus%2520protease%2520inhibitor%2520BILN%25202061%26jtitle%3DToxicol.%2520Pathol." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Macrocyclic inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1277</span><span class="NLM_x">–</span> <span class="NLM_lpage">1303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1517%2F13543770903044994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=19563268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1277-1303&author=S.+Venkatramanauthor=F.+G.+Njoroge&title=Macrocyclic+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of HCV NS3 protease</span></div><div class="casAuthors">Venkatraman, Srikanth; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1277-1303</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  HCV NS3 is a serine protease that plays a pivotal role in catalyzing the cleavage of the single polyprotein encoded by HCV after infection of hepatocytes.  Anal. of the X-ray crystal structure of the enzyme reveals a shallow catalytic site located on the surface of the protein, which has made development of inhibitors a formidable task.  Attempts to discover leads by a traditional approach of screening of compd. libraries have proved futile and, therefore, researchers have adopted a structure-based drug design.  Anal. of the X-ray structure of NS3 protease reveals close proximity of S1-S3 and S2-S4 pockets.  Various novel approaches have been used to design preorganized, depeptidized macrocyclic inhibitors linking the P2-P4 groups and P1-P3 residues.  The article summarizes efforts by various groups to develop inhibitors that bind to the active site and inhibit viral replication.  Review of recent patents and scientific literature.  Macrocyclization has proved to be an effective tool for depeptidization of peptidic inhibitors with improved binding and pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbzHliWVL17Vg90H21EOLACvtfcHk0lgxoggYY-m53A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FI&md5=4081e78be8e92b762d50501ca8fcb97c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F13543770903044994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903044994%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D1277%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+characteristics+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520characteristics%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Lin, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbinnen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholliers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeiren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1377-1385&author=T.+I.+Linauthor=O.+Lenzauthor=G.+Fanningauthor=T.+Verbinnenauthor=F.+Delouvroyauthor=A.+Scholliersauthor=K.+Vermeirenauthor=A.+Rosenquistauthor=M.+Edlundauthor=B.+Samuelssonauthor=L.+Vrangauthor=H.+de+Kockauthor=P.+Wigerinckauthor=P.+Raboissonauthor=K.+Simmen&title=In+vitro+activity+and+preclinical+profile+of+TMC435350%2C+a+potent+hepatitis+C+virus+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.%2BI.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DFanning%26aufirst%3DG.%26aulast%3DVerbinnen%26aufirst%3DT.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DScholliers%26aufirst%3DA.%26aulast%3DVermeiren%26aufirst%3DK.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DIn%2520vitro%2520activity%2520and%2520preclinical%2520profile%2520of%2520TMC435350%252C%2520a%2520potent%2520hepatitis%2520C%2520virus%2520protease%2520inhibitor%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D1377%26epage%3D1385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=305-311&author=N.+J.+Livertonauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=D.+J.+Grahamauthor=D.+Hazudaauthor=M.+K.+Hollowayauthor=S.+W.+Ludmererauthor=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=D.+B.+Olsenauthor=M.+T.+Ruddauthor=M.+Stahlhutauthor=J.+P.+Vacca&title=MK-7009%2C+a+potent+and+selective+inhibitor+of+hepatitis+C+virus+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMK-7009%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D305%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span> </span><span class="NLM_article-title">A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: discovery of potent and specific tripeptide inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6584</span><span class="NLM_x">–</span> <span class="NLM_lpage">6594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0494523" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6584-6594&author=M.+Llinas-Brunetauthor=M.+D.+Baileyauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=M.+Poirierauthor=J.+Rancourtauthor=N.+Goudreau&title=A+systematic+approach+to+the+optimization+of+substrate-based+inhibitors+of+the+hepatitis+C+virus+NS3+protease%3A+discovery+of+potent+and+specific+tripeptide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0494523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0494523%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DGoudreau%26aufirst%3DN.%26atitle%3DA%2520systematic%2520approach%2520to%2520the%2520optimization%2520of%2520substrate-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%253A%2520discovery%2520of%2520potent%2520and%2520specific%2520tripeptide%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6584%26epage%3D6594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Faucher, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duceppe, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humans</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2901</span><span class="NLM_x">–</span> <span class="NLM_lpage">2904</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0489907" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVSkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=2901-2904&author=A.+M.+Faucherauthor=M.+D.+Baileyauthor=P.+L.+Beaulieuauthor=C.+Brochuauthor=J.+S.+Duceppeauthor=J.+M.+Ferlandauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=S.+H.+Kawaiauthor=M.+Poirierauthor=B.+Simoneauauthor=Y.+S.+Tsantrizosauthor=M.+Llinas-Brunet&title=Synthesis+of+BILN+2061%2C+an+HCV+NS3+protease+inhibitor+with+proven+antiviral+effect+in+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans</span></div><div class="casAuthors">Faucher, Anne-Marie; Bailey, Murray D.; Beaulieu, Pierre L.; Brochu, Christian; Duceppe, Jean-Simon; Ferland, Jean-Marie; Ghiro, Elise; Gorys, Vida; Halmos, Ted; Kawai, Stephen H.; Poirier, Martin; Simoneau, Bruno; Tsantrizos, Youla S.; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2901-2904</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of BILN 2061 (I), a hepatitis C virus (HCV) NS3 protease inhibitor with proven antiviral effect in humans, was accomplished in a convergent manner from four building blocks.  The procedure described here was suitable for the prepn. of multigram quantities of BILN 2061 for preclin. pharmacol. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3e_dv4CxKirVg90H21EOLACvtfcHk0lgfnbjTRzyflQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVSkur0%253D&md5=cfc1b877b24dc5df86fe3ea7f8996f9c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fol0489907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0489907%26sid%3Dliteratum%253Aachs%26aulast%3DFaucher%26aufirst%3DA.%2BM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DDuceppe%26aufirst%3DJ.%2BS.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520BILN%25202061%252C%2520an%2520HCV%2520NS3%2520protease%2520inhibitor%2520with%2520proven%2520antiviral%2520effect%2520in%2520humans%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D2901%26epage%3D2904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duceppe, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grozinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houpis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimroth, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnaubelt, J.</span><span> </span><span class="NLM_article-title">Synthesis of (1<i>R</i>,2<i>S</i>)-1-amino-2-vinylcyclopropanecarboxylic acid vinyl-ACCA) derivatives: key intermediates for the preparation of inhibitors of the hepatitis C virus NS3 protease</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">5869</span><span class="NLM_x">–</span> <span class="NLM_lpage">5879</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo050468q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt12nur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=5869-5879&author=P.+L.+Beaulieuauthor=J.+Gillardauthor=M.+D.+Baileyauthor=C.+Boucherauthor=J.+S.+Duceppeauthor=B.+Simoneauauthor=X.+J.+Wangauthor=L.+Zhangauthor=K.+Grozingerauthor=I.+Houpisauthor=V.+Farinaauthor=H.+Heimrothauthor=T.+Kruegerauthor=J.+Schnaubelt&title=Synthesis+of+%281R%2C2S%29-1-amino-2-vinylcyclopropanecarboxylic+acid+vinyl-ACCA%29+derivatives%3A+key+intermediates+for+the+preparation+of+inhibitors+of+the+hepatitis+C+virus+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of (1R,2S)-1-Amino-2-vinylcyclopropanecarboxylic Acid Vinyl-ACCA) Derivatives: Key Intermediates for the Preparation of Inhibitors of the Hepatitis C Virus NS3 Protease</span></div><div class="casAuthors">Beaulieu, Pierre L.; Gillard, James; Bailey, Murray D.; Boucher, Colette; Duceppe, Jean-Simon; Simoneau, Bruno; Wang, Xiao-Jun; Zhang, Li; Grozinger, Karl; Houpis, Ioannis; Farina, Vittorio; Heimroth, Heidi; Krueger, Thomas; Schnaubelt, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5869-5879</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(1R,2S)-1-Amino-2-vinylcyclopropanecarboxylic acid (vinyl-ACCA) is a key building block in the synthesis of BILN 2061, a potent inhibitor of hepatitis C virus NS3 and was recently shown to dramatically reduce viral load after administration to patients infected with HCV genotype 1.  The authors developed a scalable process that delivered derivs. of (1R,2S)-vinyl-ACCA in >99% enantiomeric excess.  The strategy included dialkylation of a glycine Schiff base using (E)-1,4-dibromo-2-butene as an electrophile to produce racemic vinyl-ACCA, which was subsequently resolved using a readily available, inexpensive esterase enzyme (Alcalase 2.4L).  Factors that affect diastereoselection in the initial dialkylation steps were examd. and the conditions were optimized to deliver the desired diastereomer selectively.  Product inhibition, which was encountered during the enzymic resoln. step, initially resulted in prolonged cycle times.  Enrichment of racemic vinyl-ACCA through a chem. resoln. via diastereomeric salt formation or the use of forcing conditions in the enzymic reaction both led to improvements in throughput and the development of a viable process.  Thus, multi-kilogram quantities of (1R,2S)-vinyl-ACCA were produced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMTSBIrZEPk7Vg90H21EOLACvtfcHk0lgfnbjTRzyflQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt12nur4%253D&md5=2165443a83201467dc3f8404758425cf</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo050468q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo050468q%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DDuceppe%26aufirst%3DJ.%2BS.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGrozinger%26aufirst%3DK.%26aulast%3DHoupis%26aufirst%3DI.%26aulast%3DFarina%26aufirst%3DV.%26aulast%3DHeimroth%26aufirst%3DH.%26aulast%3DKrueger%26aufirst%3DT.%26aulast%3DSchnaubelt%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520%25281R%252C2S%2529-1-amino-2-vinylcyclopropanecarboxylic%2520acid%2520vinyl-ACCA%2529%2520derivatives%253A%2520key%2520intermediates%2520for%2520the%2520preparation%2520of%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D5869%26epage%3D5879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Unangst, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, D. T.</span><span> </span><span class="NLM_article-title">Synthesis and transformations of 2,6-bis(1,1-dimethylethyl)-4-[2-(thiazolyl)ethenyl]phenols</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1992&pages=1097-1100&author=P.+C.+Unangstauthor=D.+T.+Connor&title=Synthesis+and+transformations+of+2%2C6-bis%281%2C1-dimethylethyl%29-4-%5B2-%28thiazolyl%29ethenyl%5Dphenols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUnangst%26aufirst%3DP.%2BC.%26aulast%3DConnor%26aufirst%3DD.%2BT.%26atitle%3DSynthesis%2520and%2520transformations%2520of%25202%252C6-bis%25281%252C1-dimethylethyl%2529-4-%255B2-%2528thiazolyl%2529ethenyl%255Dphenols%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1992%26volume%3D29%26spage%3D1097%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Manns, M. P.; Bourlière, M.; Benhamou, Y.; Pol, S.; Bonacini, M.; Trepo, C.; Wright, D.; Berg, T.; Calleja, J. L.; White, P. W.; Stern, J. O.; Steinmann, G.; Yong, C. L.; Kukolj, G.; Scherer, J.; Boecher, W. O.</span><span> </span><span class="NLM_article-title">Potency, safety and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection</span>.  <span class="citation_source-journal">J. Hepatol.</span>, submitted 2010.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Manns%2C+M.+P.%3B+Bourli%C3%A8re%2C+M.%3B+Benhamou%2C+Y.%3B+Pol%2C+S.%3B+Bonacini%2C+M.%3B+Trepo%2C+C.%3B+Wright%2C+D.%3B+Berg%2C+T.%3B+Calleja%2C+J.+L.%3B+White%2C+P.+W.%3B+Stern%2C+J.+O.%3B+Steinmann%2C+G.%3B+Yong%2C+C.+L.%3B+Kukolj%2C+G.%3B+Scherer%2C+J.%3B+Boecher%2C+W.+O.+Potency%2C+safety+and+pharmacokinetics+of+the+NS3%2F4A+protease+inhibitor+BI201335+in+patients+with+chronic+HCV+genotype-1+infection.+J.+Hepatol.%2C+submitted+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26atitle%3DPotency%252C%2520safety%2520and%2520pharmacokinetics%2520of%2520the%2520NS3%252F4A%2520protease%2520inhibitor%2520BI201335%2520in%2520patients%2520with%2520chronic%2520HCV%2520genotype-1%2520infection%26jtitle%3DJ.%2520Hepatol." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Massariol, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span> </span><span class="NLM_article-title">Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">697</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2010&pages=692-697&author=M.+J.+Massariolauthor=S.+Zhaoauthor=M.+Marquisauthor=D.+Thibeaultauthor=P.+W.+White&title=Protease+and+helicase+activities+of+hepatitis+C+virus+genotype+4%2C+5%2C+and+6+NS3-NS4A+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMassariol%26aufirst%3DM.%2BJ.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26atitle%3DProtease%2520and%2520helicase%2520activities%2520of%2520hepatitis%2520C%2520virus%2520genotype%25204%252C%25205%252C%2520and%25206%2520NS3-NS4A%2520proteins%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2010%26volume%3D391%26spage%3D692%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingras, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor BILN 2061</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">7352</span><span class="NLM_x">–</span> <span class="NLM_lpage">7359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1128%2FJVI.78.14.7352-7359.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=15220408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFShtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2004&pages=7352-7359&author=D.+Thibeaultauthor=C.+Bousquetauthor=R.+Gingrasauthor=L.+Lagaceauthor=R.+Mauriceauthor=P.+W.+Whiteauthor=D.+Lamarre&title=Sensitivity+of+NS3+serine+proteases+from+hepatitis+C+virus+genotypes+2+and+3+to+the+inhibitor+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor BILN 2061</span></div><div class="casAuthors">Thibeault, Diane; Bousquet, Christiane; Gingras, Rock; Lagace, Lisette; Maurice, Roger; White, Peter W.; Lamarre, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7352-7359</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) displays a high degree of genetic variability.  Six genotypes and more than 50 subtypes have been identified to date.  In this report, kinetic profiles were detd. for NS3 proteases of genotypes 1a, 1b, 2ac, 2b, and 3a, revealing no major differences in activity.  In vitro sensitivity studies with BILN 2061 showed a decrease in affinity for proteases of genotypes 2 and 3 (Ki, 80 to 90 nM) compared to genotype 1 enzymes (Ki, 1.5 nM).  To understand the reduced sensitivity of genotypes 2 and 3 to BILN 2061, active-site residues in the proximity of the inhibitor binding site were replaced in the genotype-1b enzyme with the corresponding genotype-2b or -3a residues.  The replacement of five residues at positions 78, 79, 80, 122, and 132 accounted for most of the reduced sensitivity of genotype 2b, while replacement of residue 168 alone could account for the reduced sensitivity of genotype 3a.  BILN 2061 remains a potent inhibitor of these non-genotype-1 NS3-NS4A proteins, with Ki values below 100 nM.  This in vitro potency, in conjunction with the good pharmacokinetic data reported for humans, suggests that there is potential for BILN 2061 as an antiviral agent for individuals infected with non-genotype-1 HCV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-UbNAzXUCMLVg90H21EOLACvtfcHk0lgqwqjUzA8-Cg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFShtLg%253D&md5=fa11f0c178a5559fb3fbaa03c827391a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FJVI.78.14.7352-7359.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.78.14.7352-7359.2004%26sid%3Dliteratum%253Aachs%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DBousquet%26aufirst%3DC.%26aulast%3DGingras%26aufirst%3DR.%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DSensitivity%2520of%2520NS3%2520serine%2520proteases%2520from%2520hepatitis%2520C%2520virus%2520genotypes%25202%2520and%25203%2520to%2520the%2520inhibitor%2520BILN%25202061%26jtitle%3DJ.%2520Virol.%26date%3D2004%26volume%3D78%26spage%3D7352%26epage%3D7359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Vaillancourt, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilote, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liuzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=5-10&author=F.+H.+Vaillancourtauthor=L.+Piloteauthor=M.+Cartierauthor=J.+Lippensauthor=M.+Liuzziauthor=R.+C.+Bethellauthor=M.+G.+Cordingleyauthor=G.+Kukolj&title=Identification+of+a+lipid+kinase+as+a+host+factor+involved+in+hepatitis+C+virus+RNA+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVaillancourt%26aufirst%3DF.%2BH.%26aulast%3DPilote%26aufirst%3DL.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DLippens%26aufirst%3DJ.%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DBethell%26aufirst%3DR.%2BC.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520lipid%2520kinase%2520as%2520a%2520host%2520factor%2520involved%2520in%2520hepatitis%2520C%2520virus%2520RNA%2520replication%26jtitle%3DVirology%26date%3D2009%26volume%3D387%26spage%3D5%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 74 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Nitinchandra D. Patel, Xudong Wei, Denis Byrne, Bikshandarkoil A. Narayanan, Scott Pennino, Max Sarvestani, Anjan Saha, Nizar Haddad, Suresh Kapadia, Jon C. Lorenz, Philomen DeCroos, Andrew Ye, Heewon Lee, Nelu Grinberg, Azad Hossain, Carl A. Busacca, Nathan K. Yee, <span class="NLM_string-name hlFld-ContribAuthor">Chris H. Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">Sulfone-Mediated SNAr Reaction as a Powerful Tool for the Synthesis of 4-Quinolinyl Ethers and More—Application to the Synthesis of HCV NS3/4a Protease Inhibitor BI 201420. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (13)
                                     , 8339-8351. <a href="https://doi.org/10.1021/acs.joc.0c00554" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00554%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSulfone-Mediated%252BSNAr%252BReaction%252Bas%252Ba%252BPowerful%252BTool%252Bfor%252Bthe%252BSynthesis%252Bof%252B4-Quinolinyl%252BEthers%252Band%252BMore%2525E2%252580%252594Application%252Bto%252Bthe%252BSynthesis%252Bof%252BHCV%252BNS3%25252F4a%252BProtease%252BInhibitor%252BBI%252B201420%26aulast%3DPatel%26aufirst%3DNitinchandra%2BD.%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D02032020%26date%3D19062020%26date%3D28052020%26volume%3D85%26issue%3D13%26spage%3D8339%26epage%3D8351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michal H.  Kolář</span> and <span class="hlFld-ContribAuthor ">Oriana  Tabarrini</span>  . </span><span class="cited-content_cbyCitation_article-title">Halogen Bonding in Nucleic Acid Complexes. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (21)
                                     , 8681-8690. <a href="https://doi.org/10.1021/acs.jmedchem.7b00329" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00329</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00329&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00329%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHalogen%252BBonding%252Bin%252BNucleic%252BAcid%252BComplexes%26aulast%3DKol%25C3%25A1%25C5%2599%26aufirst%3DMichal%2BH.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D01032017%26date%3D23062017%26date%3D09112017%26date%3D12062017%26volume%3D60%26issue%3D21%26spage%3D8681%26epage%3D8690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A. T.  Blaskovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Unusual Amino Acids in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (24)
                                     , 10807-10836. <a href="https://doi.org/10.1021/acs.jmedchem.6b00319" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00319%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUnusual%252BAmino%252BAcids%252Bin%252BMedicinal%252BChemistry%26aulast%3DBlaskovich%26aufirst%3DMark%2BA.%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02032016%26date%3D30092016%26date%3D22122016%26date%3D02092016%26volume%3D59%26issue%3D24%26spage%3D10807%26epage%3D10836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Eric  Mull</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Stanley  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Richard  Rampulla</span>, <span class="hlFld-ContribAuthor ">Bang-Chi  Chen</span>, <span class="hlFld-ContribAuthor ">Theerthagiri  Palani</span>, <span class="hlFld-ContribAuthor ">Sivakumar  Ganesan</span>, <span class="hlFld-ContribAuthor ">Pirama Nayagam  Arunachalam</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Steven  Levine</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Richard  Schartman</span>, <span class="hlFld-ContribAuthor ">Maria  Donoso</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Tredup</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Alicia  Ng</span>, <span class="hlFld-ContribAuthor ">Luciano  Mueller</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Stephen  Adams</span>, <span class="hlFld-ContribAuthor ">James  Loy</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Huabin  Sun</span>, <span class="hlFld-ContribAuthor ">Hong  Shi</span>, <span class="hlFld-ContribAuthor ">Lucy  Sun</span>, <span class="hlFld-ContribAuthor ">William  Warner</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Hua  Fang</span>, <span class="hlFld-ContribAuthor ">Mark I.  Cockett</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, and <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 8042-8060. <a href="https://doi.org/10.1021/acs.jmedchem.6b00821" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00821%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BAcyclic%25252C%252BTripeptidic%25252C%252BAcyl%252BSulfonamide%252BInhibitor%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%252BProtease%252Bas%252Ba%252BBack-up%252Bto%252BAsunaprevir%252Bwith%252Bthe%252BPotential%252Bfor%252BOnce-Daily%252BDosing%26aulast%3DSun%26aufirst%3DLi-Qiang%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01062016%26date%3D26082016%26date%3D08092016%26volume%3D59%26issue%3D17%26spage%3D8042%26epage%3D8060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michal H.  Kolář</span> and <span class="hlFld-ContribAuthor ">Pavel  Hobza</span>  . </span><span class="cited-content_cbyCitation_article-title">Computer Modeling of Halogen Bonds and Other σ-Hole Interactions. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2016,</strong> <em>116 </em>
                                    (9)
                                     , 5155-5187. <a href="https://doi.org/10.1021/acs.chemrev.5b00560" title="DOI URL">https://doi.org/10.1021/acs.chemrev.5b00560</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.5b00560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.5b00560%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DComputer%252BModeling%252Bof%252BHalogen%252BBonds%252Band%252BOther%252B%2525CF%252583-Hole%252BInteractions%26aulast%3DKol%25C3%25A1%25C5%2599%26aufirst%3DMichal%2BH.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D22092015%26date%3D03022016%26date%3D11052016%26volume%3D116%26issue%3D9%26spage%3D5155%26epage%3D5187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lydia C.  Gilday</span>, <span class="hlFld-ContribAuthor ">Sean W.  Robinson</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Barendt</span>, <span class="hlFld-ContribAuthor ">Matthew J.  Langton</span>, <span class="hlFld-ContribAuthor ">Benjamin R.  Mullaney</span>, and <span class="hlFld-ContribAuthor ">Paul D.  Beer</span>  . </span><span class="cited-content_cbyCitation_article-title">Halogen Bonding in Supramolecular Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2015,</strong> <em>115 </em>
                                    (15)
                                     , 7118-7195. <a href="https://doi.org/10.1021/cr500674c" title="DOI URL">https://doi.org/10.1021/cr500674c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr500674c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr500674c%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DHalogen%252BBonding%252Bin%252BSupramolecular%252BChemistry%26aulast%3DGilday%26aufirst%3DLydia%2BC.%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D28112014%26date%3D13072015%26date%3D12082015%26volume%3D115%26issue%3D15%26spage%3D7118%26epage%3D7195" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>, <span class="hlFld-ContribAuthor ">Paul C.  Anderson</span>, <span class="hlFld-ContribAuthor ">Richard  Bethell</span>, <span class="hlFld-ContribAuthor ">Michael  Bös</span>, <span class="hlFld-ContribAuthor ">Yves  Bousquet</span>, <span class="hlFld-ContribAuthor ">Christian  Brochu</span>, <span class="hlFld-ContribAuthor ">Michael G.  Cordingley</span>, <span class="hlFld-ContribAuthor ">Gulrez  Fazal</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">James R.  Gillard</span>, <span class="hlFld-ContribAuthor ">Stephen  Kawai</span>, <span class="hlFld-ContribAuthor ">Martin  Marquis</span>, <span class="hlFld-ContribAuthor ">Ginette  McKercher</span>, <span class="hlFld-ContribAuthor ">Marc-André  Poupart</span>, <span class="hlFld-ContribAuthor ">Timothy  Stammers</span>, <span class="hlFld-ContribAuthor ">Bounkham  Thavonekham</span>, <span class="hlFld-ContribAuthor ">Dominik  Wernic</span>, <span class="hlFld-ContribAuthor ">Jianmin  Duan</span>, and <span class="hlFld-ContribAuthor ">George  Kukolj</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of BI 207524, an Indole Diamide NS5B Thumb Pocket 1 Inhibitor with Improved Potency for the Potential Treatment of Chronic Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 10130-10143. <a href="https://doi.org/10.1021/jm501532z" title="DOI URL">https://doi.org/10.1021/jm501532z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501532z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501532z%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BBI%252B207524%25252C%252Ban%252BIndole%252BDiamide%252BNS5B%252BThumb%252BPocket%252B1%252BInhibitor%252Bwith%252BImproved%252BPotency%252Bfor%252Bthe%252BPotential%252BTreatment%252Bof%252BChronic%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DBeaulieu%26aufirst%3DPierre%2BL.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D05102014%26date%3D25112014%26date%3D11122014%26date%3D13112014%26volume%3D57%26issue%3D23%26spage%3D10130%26epage%3D10143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Ren</span>, <span class="hlFld-ContribAuthor ">Yang  He</span>, <span class="hlFld-ContribAuthor ">Wuyan  Chen</span>, <span class="hlFld-ContribAuthor ">Tiantian  Chen</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Zhijian  Xu</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Luo</span>, <span class="hlFld-ContribAuthor ">Weiliang  Zhu</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Jingshan  Shen</span>, and <span class="hlFld-ContribAuthor ">Yechun  Xu</span>  . </span><span class="cited-content_cbyCitation_article-title">Thermodynamic and Structural Characterization of Halogen Bonding in Protein–Ligand Interactions: A Case Study of PDE5 and Its Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (8)
                                     , 3588-3593. <a href="https://doi.org/10.1021/jm5002315" title="DOI URL">https://doi.org/10.1021/jm5002315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm5002315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm5002315%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThermodynamic%252Band%252BStructural%252BCharacterization%252Bof%252BHalogen%252BBonding%252Bin%252BProtein%2525E2%252580%252593Ligand%252BInteractions%25253A%252BA%252BCase%252BStudy%252Bof%252BPDE5%252Band%252BIts%252BInhibitors%26aulast%3DRen%26aufirst%3DJing%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D12022014%26date%3D15042014%26date%3D24042014%26date%3D05042014%26volume%3D57%26issue%3D8%26spage%3D3588%26epage%3D3593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oliver  Hucke</span>, <span class="hlFld-ContribAuthor ">René  Coulombe</span>, <span class="hlFld-ContribAuthor ">Pierre  Bonneau</span>, <span class="hlFld-ContribAuthor ">Mégan  Bertrand-Laperle</span>, <span class="hlFld-ContribAuthor ">Christian  Brochu</span>, <span class="hlFld-ContribAuthor ">James  Gillard</span>, <span class="hlFld-ContribAuthor ">Marc-André  Joly</span>, <span class="hlFld-ContribAuthor ">Serge  Landry</span>, <span class="hlFld-ContribAuthor ">Olivier  Lepage</span>, <span class="hlFld-ContribAuthor ">Montse  Llinàs-Brunet</span>, <span class="hlFld-ContribAuthor ">Marc  Pesant</span>, <span class="hlFld-ContribAuthor ">Martin  Poirier</span>, <span class="hlFld-ContribAuthor ">Maude  Poirier</span>, <span class="hlFld-ContribAuthor ">Ginette  McKercher</span>, <span class="hlFld-ContribAuthor ">Martin  Marquis</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>, <span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>, and <span class="hlFld-ContribAuthor ">Timothy A.  Stammers</span>  . </span><span class="cited-content_cbyCitation_article-title">Molecular Dynamics Simulations and Structure-Based Rational Design Lead to Allosteric HCV NS5B Polymerase Thumb Pocket 2 Inhibitor with Picomolar Cellular Replicon Potency. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1932-1943. <a href="https://doi.org/10.1021/jm4004522" title="DOI URL">https://doi.org/10.1021/jm4004522</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm4004522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm4004522%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMolecular%252BDynamics%252BSimulations%252Band%252BStructure-Based%252BRational%252BDesign%252BLead%252Bto%252BAllosteric%252BHCV%252BNS5B%252BPolymerase%252BThumb%252BPocket%252B2%252BInhibitor%252Bwith%252BPicomolar%252BCellular%252BReplicon%252BPotency%26aulast%3DHucke%26aufirst%3DOliver%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D28032013%26date%3D12072013%26date%3D13032014%26date%3D17062013%26volume%3D57%26issue%3D5%26spage%3D1932%26epage%3D1943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven R.  LaPlante</span>, <span class="hlFld-ContribAuthor ">Herbert  Nar</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Lemke</span>, <span class="hlFld-ContribAuthor ">Araz  Jakalian</span>, <span class="hlFld-ContribAuthor ">Norman  Aubry</span>, and <span class="hlFld-ContribAuthor ">Stephen H.  Kawai</span>  . </span><span class="cited-content_cbyCitation_article-title">Ligand Bioactive Conformation Plays a Critical Role in the Design of Drugs That Target the Hepatitis C Virus NS3 Protease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1777-1789. <a href="https://doi.org/10.1021/jm401338c" title="DOI URL">https://doi.org/10.1021/jm401338c</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401338c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401338c%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLigand%252BBioactive%252BConformation%252BPlays%252Ba%252BCritical%252BRole%252Bin%252Bthe%252BDesign%252Bof%252BDrugs%252BThat%252BTarget%252Bthe%252BHepatitis%252BC%252BVirus%252BNS3%252BProtease%26aulast%3DLaPlante%26aufirst%3DSteven%2BR.%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D30082013%26date%3D08112013%26date%3D13032014%26date%3D21102013%26volume%3D57%26issue%3D5%26spage%3D1777%26epage%3D1789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael T.  Rudd</span>, <span class="hlFld-ContribAuthor ">John A.  McCauley</span>, <span class="hlFld-ContribAuthor ">John W.  Butcher</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Romano</span>, <span class="hlFld-ContribAuthor ">Charles J.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Kevin T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Kimberly J.  Bush</span>, <span class="hlFld-ContribAuthor ">M. Katharine  Holloway</span>, <span class="hlFld-ContribAuthor ">John  Swestock</span>, <span class="hlFld-ContribAuthor ">Bang-Lin  Wan</span>, <span class="hlFld-ContribAuthor ">Steven S.  Carroll</span>, <span class="hlFld-ContribAuthor ">Jillian M.  DiMuzio</span>, <span class="hlFld-ContribAuthor ">Donald J.  Graham</span>, <span class="hlFld-ContribAuthor ">Steven W.  Ludmerer</span>, <span class="hlFld-ContribAuthor ">Mark W.  Stahlhut</span>, <span class="hlFld-ContribAuthor ">Christine M.  Fandozzi</span>, <span class="hlFld-ContribAuthor ">Nicole  Trainor</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Vacca</span>, and <span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of  MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (3)
                                     , 207-212. <a href="https://doi.org/10.1021/ml1002426" title="DOI URL">https://doi.org/10.1021/ml1002426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml1002426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml1002426%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BMK-1220%25253A%252BA%252BMacrocyclic%252BInhibitor%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%25252F4A%252BProtease%252Bwith%252BImproved%252BPreclinical%252BPlasma%252BExposure%26aulast%3DRudd%26aufirst%3DMichael%2BT.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D08102010%26date%3D24122010%26date%3D12012011%26date%3D10032011%26volume%3D2%26issue%3D3%26spage%3D207%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Salahinejad</span>, <span class="hlFld-ContribAuthor ">Sodeh  Sadjadi</span>, <span class="hlFld-ContribAuthor ">Majid  Abdouss</span>. </span><span class="cited-content_cbyCitation_article-title">Investigating fluorescence quenching of cysteine-functionalized carbon quantum dots by heavy metal ions: Experimental and QSPR studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Liquids</span><span> <strong>2021,</strong> <em>334 </em>, 116067. <a href="https://doi.org/10.1016/j.molliq.2021.116067" title="DOI URL">https://doi.org/10.1016/j.molliq.2021.116067</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molliq.2021.116067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molliq.2021.116067%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Liquids%26atitle%3DInvestigating%252Bfluorescence%252Bquenching%252Bof%252Bcysteine-functionalized%252Bcarbon%252Bquantum%252Bdots%252Bby%252Bheavy%252Bmetal%252Bions%25253A%252BExperimental%252Band%252BQSPR%252Bstudies%26aulast%3DSalahinejad%26aufirst%3DMaryam%26date%3D2021%26volume%3D334%26spage%3D116067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Ghiasi</span>, <span class="hlFld-ContribAuthor ">S.  Ahmadi</span>, <span class="hlFld-ContribAuthor ">E.  Ahmadi</span>, <span class="hlFld-ContribAuthor ">M.R.  Talei Bavil Olyai</span>, <span class="hlFld-ContribAuthor ">Z.  Khodadadi</span>. </span><span class="cited-content_cbyCitation_article-title">The index of ideality of correlation: QSAR studies of hepatitis C virus NS3/4A protease inhibitors using SMILES descriptors. </span><span class="cited-content_cbyCitation_journal-name">SAR and QSAR in Environmental Research</span><span> <strong>2021,</strong> <em>32 </em>
                                    (6)
                                     , 495-520. <a href="https://doi.org/10.1080/1062936X.2021.1925344" title="DOI URL">https://doi.org/10.1080/1062936X.2021.1925344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/1062936X.2021.1925344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F1062936X.2021.1925344%26sid%3Dliteratum%253Aachs%26jtitle%3DSAR%2520and%2520QSAR%2520in%2520Environmental%2520Research%26atitle%3DThe%252Bindex%252Bof%252Bideality%252Bof%252Bcorrelation%25253A%252BQSAR%252Bstudies%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS3%25252F4A%252Bprotease%252Binhibitors%252Busing%252BSMILES%252Bdescriptors%26aulast%3DGhiasi%26aufirst%3DT.%26date%3D2021%26date%3D2021%26volume%3D32%26issue%3D6%26spage%3D495%26epage%3D520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark S.  Taylor</span>. </span><span class="cited-content_cbyCitation_article-title">Thermodynamics of Halogen Bonding in Solution. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 43-82. <a href="https://doi.org/10.1002/9783527825738.ch2" title="DOI URL">https://doi.org/10.1002/9783527825738.ch2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527825738.ch2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527825738.ch2%26sid%3Dliteratum%253Aachs%26atitle%3DThermodynamics%252Bof%252BHalogen%252BBonding%252Bin%252BSolution%26aulast%3DTaylor%26aufirst%3DMark%2BS.%26date%3D2021%26date%3D2021%26spage%3D43%26epage%3D82%26pub%3DWiley%26atitle%3DHalogen%252BBonding%252Bin%252BSolution%26aulast%3DHuber%26aufirst%3DStefan%26date%3D2021%26date%3D2021%26volume%3D476" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">G. F.  Vafina</span>, <span class="hlFld-ContribAuthor ">M. D.  Khanova</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Cyclopropylmethyl Esters of Maleopimaric Acid and Diketocage Derivatives of Quinopimaric Acid by a Catalytic Reaction of the Corresponding Allyl Esters with Diazomethane. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>56 </em>
                                    (2)
                                     , 346-349. <a href="https://doi.org/10.1134/S1070428020020293" title="DOI URL">https://doi.org/10.1134/S1070428020020293</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428020020293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428020020293%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BCyclopropylmethyl%252BEsters%252Bof%252BMaleopimaric%252BAcid%252Band%252BDiketocage%252BDerivatives%252Bof%252BQuinopimaric%252BAcid%252Bby%252Ba%252BCatalytic%252BReaction%252Bof%252Bthe%252BCorresponding%252BAllyl%252BEsters%252Bwith%252BDiazomethane%26aulast%3DVafina%26aufirst%3DG.%2BF.%26date%3D2020%26date%3D2020%26volume%3D56%26issue%3D2%26spage%3D346%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rishitha  Gundala</span>, <span class="hlFld-ContribAuthor ">Himani  Balutia</span>, <span class="hlFld-ContribAuthor ">R.  Lavanya</span>, <span class="hlFld-ContribAuthor ">Ravichandiran  Velayutham</span>, <span class="hlFld-ContribAuthor ">Kuldeep K.  Roy</span>. </span><span class="cited-content_cbyCitation_article-title">HCV NS3 serine protease as a drug target for the development of drugs against hepatocellular carcinoma (liver cancer). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 243-263. <a href="https://doi.org/10.1016/B978-0-12-818168-3.00009-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-818168-3.00009-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818168-3.00009-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818168-3.00009-7%26sid%3Dliteratum%253Aachs%26atitle%3DHCV%252BNS3%252Bserine%252Bprotease%252Bas%252Ba%252Bdrug%252Btarget%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bdrugs%252Bagainst%252Bhepatocellular%252Bcarcinoma%252B%252528liver%252Bcancer%252529%26aulast%3DGundala%26aufirst%3DRishitha%26date%3D2020%26spage%3D243%26epage%3D263%26pub%3DElsevier%26atitle%3DCancer-Leading%252BProteases%26date%3D2020%26volume%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Haibo  Mei</span>, <span class="hlFld-ContribAuthor ">Jianlin  Han</span>, <span class="hlFld-ContribAuthor ">Karel D.  Klika</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, <span class="hlFld-ContribAuthor ">Tatsunori  Sato</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>. </span><span class="cited-content_cbyCitation_article-title">Applications of fluorine-containing amino acids for drug design. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>186 </em>, 111826. <a href="https://doi.org/10.1016/j.ejmech.2019.111826" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.111826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.111826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.111826%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplications%252Bof%252Bfluorine-containing%252Bamino%252Bacids%252Bfor%252Bdrug%252Bdesign%26aulast%3DMei%26aufirst%3DHaibo%26date%3D2020%26volume%3D186%26spage%3D111826" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Usman  Ashraf</span>, <span class="hlFld-ContribAuthor ">Kanzal  Iman</span>, <span class="hlFld-ContribAuthor ">Muhammad Farhan  Khalid</span>, <span class="hlFld-ContribAuthor ">Hafiz Muhammad  Salman</span>, <span class="hlFld-ContribAuthor ">Talha  Shafi</span>, <span class="hlFld-ContribAuthor ">Momal  Rafi</span>, <span class="hlFld-ContribAuthor ">Nida  Javaid</span>, <span class="hlFld-ContribAuthor ">Rashid  Hussain</span>, <span class="hlFld-ContribAuthor ">Fayyaz  Ahmad</span>, <span class="hlFld-ContribAuthor ">Syed  Shahzad‐Ul‐Hussan</span>, <span class="hlFld-ContribAuthor ">Shaper  Mirza</span>, <span class="hlFld-ContribAuthor ">Muhammad  Shafiq</span>, <span class="hlFld-ContribAuthor ">Samia  Afzal</span>, <span class="hlFld-ContribAuthor ">Sadia  Hamera</span>, <span class="hlFld-ContribAuthor ">Saima  Anwar</span>, <span class="hlFld-ContribAuthor ">Romena  Qazi</span>, <span class="hlFld-ContribAuthor ">Muhammad  Idrees</span>, <span class="hlFld-ContribAuthor ">Sohail A.  Qureshi</span>, <span class="hlFld-ContribAuthor ">Safee Ullah  Chaudhary</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of efficacious pangenotypic hepatitis C virus therapies. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (3)
                                     , 1091-1136. <a href="https://doi.org/10.1002/med.21554" title="DOI URL">https://doi.org/10.1002/med.21554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21554%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DEvolution%252Bof%252Befficacious%252Bpangenotypic%252Bhepatitis%252BC%252Bvirus%252Btherapies%26aulast%3DAshraf%26aufirst%3DMuhammad%2BUsman%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D3%26spage%3D1091%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harry A.  Klein</span>, <span class="hlFld-ContribAuthor ">Paul D.  Beer</span>. </span><span class="cited-content_cbyCitation_article-title">Iodide Discrimination by Tetra‐Iodotriazole Halogen Bonding Interlocked Hosts. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2019,</strong> <em>28 </em><a href="https://doi.org/10.1002/chem.201806093" title="DOI URL">https://doi.org/10.1002/chem.201806093</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201806093&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201806093%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DIodide%252BDiscrimination%252Bby%252BTetra%2525E2%252580%252590Iodotriazole%252BHalogen%252BBonding%252BInterlocked%252BHosts%26aulast%3DKlein%26aufirst%3DHarry%2BA.%26date%3D2019%26date%3D2019%26volume%3D28" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayşegül  Özen</span>, <span class="hlFld-ContribAuthor ">Kristina  Prachanronarong</span>, <span class="hlFld-ContribAuthor ">Ashley N.  Matthew</span>, <span class="hlFld-ContribAuthor ">Djade I.  Soumana</span>, <span class="hlFld-ContribAuthor ">Celia A.  Schiffer</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Biochemistry and Molecular Biology</span><span> <strong>2019,</strong> <em>54 </em>
                                    (1)
                                     , 11-26. <a href="https://doi.org/10.1080/10409238.2019.1568962" title="DOI URL">https://doi.org/10.1080/10409238.2019.1568962</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10409238.2019.1568962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10409238.2019.1568962%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DResistance%252Boutside%252Bthe%252Bsubstrate%252Benvelope%25253A%252Bhepatitis%252BC%252BNS3%25252F4A%252Bprotease%252Binhibitors%26aulast%3D%25C3%2596zen%26aufirst%3DAy%25C5%259Feg%25C3%25BCl%26date%3D2019%26date%3D2019%26volume%3D54%26issue%3D1%26spage%3D11%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of HCV NS3/4a Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 231-259. <a href="https://doi.org/10.1007/7355_2018_39" title="DOI URL">https://doi.org/10.1007/7355_2018_39</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_39%26sid%3Dliteratum%253Aachs%26atitle%3DEvolution%252Bof%252BHCV%252BNS3%25252F4a%252BProtease%252BInhibitors%26aulast%3DLiverton%26aufirst%3DNigel%2BJ.%26date%3D2019%26date%3D2019%26spage%3D231%26epage%3D259%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N. V.  Yashin</span>. </span><span class="cited-content_cbyCitation_article-title">Methods for the preparation of 1-Aminocyclopropanecarboxylic Acids. </span><span class="cited-content_cbyCitation_journal-name">Review Journal of Chemistry</span><span> <strong>2018,</strong> <em>8 </em>
                                    (4)
                                     , 373-401. <a href="https://doi.org/10.1134/S2079978018040040" title="DOI URL">https://doi.org/10.1134/S2079978018040040</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S2079978018040040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS2079978018040040%26sid%3Dliteratum%253Aachs%26jtitle%3DReview%2520Journal%2520of%2520Chemistry%26atitle%3DMethods%252Bfor%252Bthe%252Bpreparation%252Bof%252B1-Aminocyclopropanecarboxylic%252BAcids%26aulast%3DYashin%26aufirst%3DN.%2BV.%26date%3D2018%26date%3D2018%26volume%3D8%26issue%3D4%26spage%3D373%26epage%3D401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayodeji A.  Agbowuro</span>, <span class="hlFld-ContribAuthor ">Wilhelmina M.  Huston</span>, <span class="hlFld-ContribAuthor ">Allan B.  Gamble</span>, <span class="hlFld-ContribAuthor ">Joel D. A.  Tyndall</span>. </span><span class="cited-content_cbyCitation_article-title">Proteases and protease inhibitors in infectious diseases. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (4)
                                     , 1295-1331. <a href="https://doi.org/10.1002/med.21475" title="DOI URL">https://doi.org/10.1002/med.21475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21475%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DProteases%252Band%252Bprotease%252Binhibitors%252Bin%252Binfectious%252Bdiseases%26aulast%3DAgbowuro%26aufirst%3DAyodeji%2BA.%26date%3D2018%26date%3D2017%26volume%3D38%26issue%3D4%26spage%3D1295%26epage%3D1331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zijian  Qin</span>, <span class="hlFld-ContribAuthor ">Maolin  Wang</span>, <span class="hlFld-ContribAuthor ">Aixia  Yan</span>. </span><span class="cited-content_cbyCitation_article-title">QSAR studies of the bioactivity of hepatitis C virus (HCV) NS3/4A protease inhibitors by multiple linear regression (MLR) and support vector machine (SVM). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (13)
                                     , 2931-2938. <a href="https://doi.org/10.1016/j.bmcl.2017.05.001" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.05.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.05.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.05.001%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DQSAR%252Bstudies%252Bof%252Bthe%252Bbioactivity%252Bof%252Bhepatitis%252BC%252Bvirus%252B%252528HCV%252529%252BNS3%25252F4A%252Bprotease%252Binhibitors%252Bby%252Bmultiple%252Blinear%252Bregression%252B%252528MLR%252529%252Band%252Bsupport%252Bvector%252Bmachine%252B%252528SVM%252529%26aulast%3DQin%26aufirst%3DZijian%26date%3D2017%26volume%3D27%26issue%3D13%26spage%3D2931%26epage%3D2938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satya  P Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">HCV NS3/4A Protease and its Emerging Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Analytical & Pharmaceutical Research</span><span> <strong>2017,</strong> <em>4 </em>
                                    (4)
                                     <a href="https://doi.org/10.15406/japlr.2017.04.00108" title="DOI URL">https://doi.org/10.15406/japlr.2017.04.00108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15406/japlr.2017.04.00108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15406%2Fjaplr.2017.04.00108%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Analytical%2520%2526%2520Pharmaceutical%2520Research%26atitle%3DHCV%252BNS3%25252F4A%252BProtease%252Band%252Bits%252BEmerging%252BInhibitors%26aulast%3DP%2BGupta%26aufirst%3DSatya%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 553-627. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12406-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12406-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12406-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12406-0%26sid%3Dliteratum%253Aachs%26atitle%3DDirect-Acting%252BAntiviral%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DMeanwell%26aufirst%3DN.A.%26date%3D2017%26spage%3D553%26epage%3D627%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nina C.  Gonnella</span>, <span class="hlFld-ContribAuthor ">Shirley A.  Rodriguez</span>, <span class="hlFld-ContribAuthor ">Scott  Pennino</span>, <span class="hlFld-ContribAuthor ">Daniel  Norwood</span>. </span><span class="cited-content_cbyCitation_article-title">Structure Elucidation of a Complex Faldaprevir-(±)-α-Tocopherol Addition Product Reveals Reactivity of Common Excipient Vitamin E-TPGS. </span><span class="cited-content_cbyCitation_journal-name">Journal of Heterocyclic Chemistry</span><span> <strong>2016,</strong> <em>53 </em>
                                    (6)
                                     , 1878-1891. <a href="https://doi.org/10.1002/jhet.2502" title="DOI URL">https://doi.org/10.1002/jhet.2502</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jhet.2502&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjhet.2502%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Heterocyclic%2520Chemistry%26atitle%3DStructure%252BElucidation%252Bof%252Ba%252BComplex%252BFaldaprevir-%252528%2525C2%2525B1%252529-%2525CE%2525B1-Tocopherol%252BAddition%252BProduct%252BReveals%252BReactivity%252Bof%252BCommon%252BExcipient%252BVitamin%252BE-TPGS%26aulast%3DGonnella%26aufirst%3DNina%2BC.%26date%3D2016%26date%3D2015%26volume%3D53%26issue%3D6%26spage%3D1878%26epage%3D1891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John A  McCauley</span>, <span class="hlFld-ContribAuthor ">Michael T  Rudd</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis C virus NS3/4a protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2016,</strong> <em>30 </em>, 84-92. <a href="https://doi.org/10.1016/j.coph.2016.07.015" title="DOI URL">https://doi.org/10.1016/j.coph.2016.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2016.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2016.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DHepatitis%252BC%252Bvirus%252BNS3%25252F4a%252Bprotease%252Binhibitors%26aulast%3DMcCauley%26aufirst%3DJohn%2BA%26date%3D2016%26volume%3D30%26spage%3D84%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tatsunori  Sato</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>. </span><span class="cited-content_cbyCitation_article-title">Tailor-Made α-Amino Acids in the Pharmaceutical Industry: Synthetic Approaches to (1R,2S)-1-Amino-2-vinylcyclopropane-1-carboxylic Acid (Vinyl-ACCA). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Organic Chemistry</span><span> <strong>2016,</strong> <em>2016 </em>
                                    (16)
                                     , 2757-2774. <a href="https://doi.org/10.1002/ejoc.201600112" title="DOI URL">https://doi.org/10.1002/ejoc.201600112</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ejoc.201600112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fejoc.201600112%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DTailor-Made%252B%2525CE%2525B1-Amino%252BAcids%252Bin%252Bthe%252BPharmaceutical%252BIndustry%25253A%252BSynthetic%252BApproaches%252Bto%252B%2525281R%25252C2S%252529-1-Amino-2-vinylcyclopropane-1-carboxylic%252BAcid%252B%252528Vinyl-ACCA%252529%26aulast%3DSato%26aufirst%3DTatsunori%26date%3D2016%26date%3D2016%26volume%3D2016%26issue%3D16%26spage%3D2757%26epage%3D2774" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aki  Kawashima</span>, <span class="hlFld-ContribAuthor ">Shuangjie  Shu</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Takeda</span>, <span class="hlFld-ContribAuthor ">Akie  Kawamura</span>, <span class="hlFld-ContribAuthor ">Tatsunori  Sato</span>, <span class="hlFld-ContribAuthor ">Hiroki  Moriwaki</span>, <span class="hlFld-ContribAuthor ">Jiang  Wang</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>, <span class="hlFld-ContribAuthor ">Hong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Advanced asymmetric synthesis of (1R,2S)-1-amino-2-vinylcyclopropanecarboxylic acid by alkylation/cyclization of newly designed axially chiral Ni(II) complex of glycine Schiff base. </span><span class="cited-content_cbyCitation_journal-name">Amino Acids</span><span> <strong>2016,</strong> <em>48 </em>
                                    (4)
                                     , 973-986. <a href="https://doi.org/10.1007/s00726-015-2138-3" title="DOI URL">https://doi.org/10.1007/s00726-015-2138-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00726-015-2138-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00726-015-2138-3%26sid%3Dliteratum%253Aachs%26jtitle%3DAmino%2520Acids%26atitle%3DAdvanced%252Basymmetric%252Bsynthesis%252Bof%252B%2525281R%25252C2S%252529-1-amino-2-vinylcyclopropanecarboxylic%252Bacid%252Bby%252Balkylation%25252Fcyclization%252Bof%252Bnewly%252Bdesigned%252Baxially%252Bchiral%252BNi%252528II%252529%252Bcomplex%252Bof%252Bglycine%252BSchiff%252Bbase%26aulast%3DKawashima%26aufirst%3DAki%26date%3D2016%26date%3D2015%26volume%3D48%26issue%3D4%26spage%3D973%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Ferenci</span>, <span class="hlFld-ContribAuthor ">Tarik  Asselah</span>, <span class="hlFld-ContribAuthor ">Graham R.  Foster</span>, <span class="hlFld-ContribAuthor ">Stefan  Zeuzem</span>, <span class="hlFld-ContribAuthor ">Christoph  Sarrazin</span>, <span class="hlFld-ContribAuthor ">Christophe  Moreno</span>, <span class="hlFld-ContribAuthor ">Denis  Ouzan</span>, <span class="hlFld-ContribAuthor ">Marina  Maevskaya</span>, <span class="hlFld-ContribAuthor ">Filipe  Calinas</span>, <span class="hlFld-ContribAuthor ">Luis E.  Morano</span>, <span class="hlFld-ContribAuthor ">Javier  Crespo</span>, <span class="hlFld-ContribAuthor ">Jean-François  Dufour</span>, <span class="hlFld-ContribAuthor ">Marc  Bourlière</span>, <span class="hlFld-ContribAuthor ">Kosh  Agarwal</span>, <span class="hlFld-ContribAuthor ">Daniel  Forton</span>, <span class="hlFld-ContribAuthor ">Marcus  Schuchmann</span>, <span class="hlFld-ContribAuthor ">Elmar  Zehnter</span>, <span class="hlFld-ContribAuthor ">Shuhei  Nishiguchi</span>, <span class="hlFld-ContribAuthor ">Masao  Omata</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>, <span class="hlFld-ContribAuthor ">Yakov  Datsenko</span>, <span class="hlFld-ContribAuthor ">Miguel  Garcia</span>, <span class="hlFld-ContribAuthor ">Joseph  Scherer</span>, <span class="hlFld-ContribAuthor ">Anne-Marie  Quinson</span>, <span class="hlFld-ContribAuthor ">Jerry O.  Stern</span>. </span><span class="cited-content_cbyCitation_article-title">STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hepatology</span><span> <strong>2015,</strong> <em>62 </em>
                                    (6)
                                     , 1246-1255. <a href="https://doi.org/10.1016/j.jhep.2014.12.024" title="DOI URL">https://doi.org/10.1016/j.jhep.2014.12.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jhep.2014.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jhep.2014.12.024%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hepatology%26atitle%3DSTARTVerso1%25253A%252BA%252Brandomized%252Btrial%252Bof%252Bfaldaprevir%252Bplus%252Bpegylated%252Binterferon%25252Fribavirin%252Bfor%252Bchronic%252BHCV%252Bgenotype-1%252Binfection%26aulast%3DFerenci%26aufirst%3DPeter%26date%3D2015%26volume%3D62%26issue%3D6%26spage%3D1246%26epage%3D1255" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianjian  Fu</span>, <span class="hlFld-ContribAuthor ">Jing  Wei</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics study on drug resistance mechanism of HCV NS3/4A protease inhibitor: BI201335. </span><span class="cited-content_cbyCitation_journal-name">Molecular Simulation</span><span> <strong>2015,</strong> <em>41 </em>
                                    (8)
                                     , 674-682. <a href="https://doi.org/10.1080/08927022.2014.917298" title="DOI URL">https://doi.org/10.1080/08927022.2014.917298</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/08927022.2014.917298&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F08927022.2014.917298%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Simulation%26atitle%3DMolecular%252Bdynamics%252Bstudy%252Bon%252Bdrug%252Bresistance%252Bmechanism%252Bof%252BHCV%252BNS3%25252F4A%252Bprotease%252Binhibitor%25253A%252BBI201335%26aulast%3DFu%26aufirst%3DJianjian%26date%3D2015%26date%3D2014%26volume%3D41%26issue%3D8%26spage%3D674%26epage%3D682" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aki  Kawashima</span>, <span class="hlFld-ContribAuthor ">Chen  Xie</span>, <span class="hlFld-ContribAuthor ">Haibo  Mei</span>, <span class="hlFld-ContribAuthor ">Ryosuke  Takeda</span>, <span class="hlFld-ContribAuthor ">Akie  Kawamura</span>, <span class="hlFld-ContribAuthor ">Tatsunori  Sato</span>, <span class="hlFld-ContribAuthor ">Hiroki  Moriwaki</span>, <span class="hlFld-ContribAuthor ">Kunisuke  Izawa</span>, <span class="hlFld-ContribAuthor ">Jianlin  Han</span>, <span class="hlFld-ContribAuthor ">José Luis  Aceña</span>, <span class="hlFld-ContribAuthor ">Vadim A.  Soloshonok</span>. </span><span class="cited-content_cbyCitation_article-title">Asymmetric synthesis of (1R,2S)-1-amino-2-vinylcyclopropanecarboxylic acid by sequential S
              N
              2–S
              N
              2′ dialkylation of (R)-N-(benzyl)proline-derived glycine Schiff base Ni(
              ii
              ) complex. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (2)
                                     , 1051-1058. <a href="https://doi.org/10.1039/C4RA12658K" title="DOI URL">https://doi.org/10.1039/C4RA12658K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4RA12658K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4RA12658K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DAsymmetric%252Bsynthesis%252Bof%252B%2525281R%25252C2S%252529-1-amino-2-vinylcyclopropanecarboxylic%252Bacid%252Bby%252Bsequential%252BS%252BN%252B2%2525E2%252580%252593S%252BN%252B2%2525E2%252580%2525B2%252Bdialkylation%252Bof%252B%252528R%252529-N-%252528benzyl%252529proline-derived%252Bglycine%252BSchiff%252Bbase%252BNi%252528%252Bii%252B%252529%252Bcomplex%26aulast%3DKawashima%26aufirst%3DAki%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D2%26spage%3D1051%26epage%3D1058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Stevenazzi</span>, <span class="hlFld-ContribAuthor ">Mattia  Marchini</span>, <span class="hlFld-ContribAuthor ">Giovanni  Sandrone</span>, <span class="hlFld-ContribAuthor ">Barbara  Vergani</span>, <span class="hlFld-ContribAuthor ">Maria  Lattanzio</span>. </span><span class="cited-content_cbyCitation_article-title">Amino acidic scaffolds bearing unnatural side chains: An old idea generates new and versatile tools for the life sciences. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2014,</strong> <em>24 </em>
                                    (23)
                                     , 5349-5356. <a href="https://doi.org/10.1016/j.bmcl.2014.10.016" title="DOI URL">https://doi.org/10.1016/j.bmcl.2014.10.016</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2014.10.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2014.10.016%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAmino%252Bacidic%252Bscaffolds%252Bbearing%252Bunnatural%252Bside%252Bchains%25253A%252BAn%252Bold%252Bidea%252Bgenerates%252Bnew%252Band%252Bversatile%252Btools%252Bfor%252Bthe%252Blife%252Bsciences%26aulast%3DStevenazzi%26aufirst%3DAndrea%26date%3D2014%26volume%3D24%26issue%3D23%26spage%3D5349%26epage%3D5356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Linzhi  Chen</span>, <span class="hlFld-ContribAuthor ">Roger St.  George</span>, <span class="hlFld-ContribAuthor ">Stephen H.  Norris</span>, <span class="hlFld-ContribAuthor ">Yanping  Mao</span>, <span class="hlFld-ContribAuthor ">Elsy  Philip</span>, <span class="hlFld-ContribAuthor ">Li-Quan  Wang</span>, <span class="hlFld-ContribAuthor ">Diana  Wu</span>, <span class="hlFld-ContribAuthor ">Michael J.  Potchoiba</span>. </span><span class="cited-content_cbyCitation_article-title">Biotransformation and mass balance of faldaprevir, a hepatitis C NS3/NS4 protease inhibitor in rats. </span><span class="cited-content_cbyCitation_journal-name">Xenobiotica</span><span> <strong>2014,</strong> <em>44 </em>
                                    (11)
                                     , 1014-1025. <a href="https://doi.org/10.3109/00498254.2014.920116" title="DOI URL">https://doi.org/10.3109/00498254.2014.920116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/00498254.2014.920116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F00498254.2014.920116%26sid%3Dliteratum%253Aachs%26jtitle%3DXenobiotica%26atitle%3DBiotransformation%252Band%252Bmass%252Bbalance%252Bof%252Bfaldaprevir%25252C%252Ba%252Bhepatitis%252BC%252BNS3%25252FNS4%252Bprotease%252Binhibitor%252Bin%252Brats%26aulast%3DChen%26aufirst%3DLinzhi%26date%3D2014%26date%3D2014%26volume%3D44%26issue%3D11%26spage%3D1014%26epage%3D1025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">William L.  Irving</span>, <span class="hlFld-ContribAuthor ">Daniel  Rupp</span>, <span class="hlFld-ContribAuthor ">C. Patrick  McClure</span>, <span class="hlFld-ContribAuthor ">Lwin Mar  Than</span>, <span class="hlFld-ContribAuthor ">Andrew  Titman</span>, <span class="hlFld-ContribAuthor ">Jonathan K.  Ball</span>, <span class="hlFld-ContribAuthor ">Eike  Steinmann</span>, <span class="hlFld-ContribAuthor ">Ralf  Bartenschlager</span>, <span class="hlFld-ContribAuthor ">Thomas  Pietschmann</span>, <span class="hlFld-ContribAuthor ">Richard J.P.  Brown</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a high-throughput pyrosequencing assay for monitoring temporal evolution and resistance associated variant emergence in the Hepatitis C virus protease coding-region. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2014,</strong> <em>110 </em>, 52-59. <a href="https://doi.org/10.1016/j.antiviral.2014.07.009" title="DOI URL">https://doi.org/10.1016/j.antiviral.2014.07.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2014.07.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2014.07.009%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DDevelopment%252Bof%252Ba%252Bhigh-throughput%252Bpyrosequencing%252Bassay%252Bfor%252Bmonitoring%252Btemporal%252Bevolution%252Band%252Bresistance%252Bassociated%252Bvariant%252Bemergence%252Bin%252Bthe%252BHepatitis%252BC%252Bvirus%252Bprotease%252Bcoding-region%26aulast%3DIrving%26aufirst%3DWilliam%2BL.%26date%3D2014%26volume%3D110%26spage%3D52%26epage%3D59" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaihana  Abdulrahman Almatrrouk</span>, <span class="hlFld-ContribAuthor ">Anthony W  Oliver</span>, <span class="hlFld-ContribAuthor ">Lynne  Hampson</span>, <span class="hlFld-ContribAuthor ">Ian N  Hampson</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting gap junction intercellular communication as a potential therapy for HCV-related carcinogenesis. </span><span class="cited-content_cbyCitation_journal-name">Future Virology</span><span> <strong>2014,</strong> <em>9 </em>
                                    (7)
                                     , 679-692. <a href="https://doi.org/10.2217/fvl.14.50" title="DOI URL">https://doi.org/10.2217/fvl.14.50</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fvl.14.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffvl.14.50%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Virology%26atitle%3DTargeting%252Bgap%252Bjunction%252Bintercellular%252Bcommunication%252Bas%252Ba%252Bpotential%252Btherapy%252Bfor%252BHCV-related%252Bcarcinogenesis%26aulast%3DAbdulrahman%2BAlmatrrouk%26aufirst%3DShaihana%26date%3D2014%26volume%3D9%26issue%3D7%26spage%3D679%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bachir  Latli</span>, <span class="hlFld-ContribAuthor ">Matt  Hrapchak</span>, <span class="hlFld-ContribAuthor ">Vida  Gorys</span>, <span class="hlFld-ContribAuthor ">Montse  Llinàs-Brunet</span>, <span class="hlFld-ContribAuthor ">Scot S.  Campbell</span>, <span class="hlFld-ContribAuthor ">Jinhua  Song</span>, <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis C virus serine protease: synthesis of radioactive and stable isotope-labeled potent inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Labelled Compounds and Radiopharmaceuticals</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 350-357. <a href="https://doi.org/10.1002/jlcr.3187" title="DOI URL">https://doi.org/10.1002/jlcr.3187</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/jlcr.3187&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fjlcr.3187%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Labelled%2520Compounds%2520and%2520Radiopharmaceuticals%26atitle%3DHepatitis%252BC%252Bvirus%252Bserine%252Bprotease%25253A%252Bsynthesis%252Bof%252Bradioactive%252Band%252Bstable%252Bisotope-labeled%252Bpotent%252Binhibitors%26aulast%3DLatli%26aufirst%3DBachir%26date%3D2014%26date%3D2014%26volume%3D57%26issue%3D5%26spage%3D350%26epage%3D357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad  Imran</span>, <span class="hlFld-ContribAuthor ">Sobia  Manzoor</span>, <span class="hlFld-ContribAuthor ">Nasir Mahmood  Khattak</span>, <span class="hlFld-ContribAuthor ">Madiha  Khalid</span>, <span class="hlFld-ContribAuthor ">Qazi Laeeque  Ahmed</span>, <span class="hlFld-ContribAuthor ">Fahed  Parvaiz</span>, <span class="hlFld-ContribAuthor ">Muqddas  Tariq</span>, <span class="hlFld-ContribAuthor ">Javed  Ashraf</span>, <span class="hlFld-ContribAuthor ">Waseem  Ashraf</span>, <span class="hlFld-ContribAuthor ">Sikandar  Azam</span>, <span class="hlFld-ContribAuthor ">Muhammad  Ashraf</span>. </span><span class="cited-content_cbyCitation_article-title">Current and future therapies for hepatitis C virus infection: from viral proteins to host targets. </span><span class="cited-content_cbyCitation_journal-name">Archives of Virology</span><span> <strong>2014,</strong> <em>159 </em>
                                    (5)
                                     , 831-846. <a href="https://doi.org/10.1007/s00705-013-1803-7" title="DOI URL">https://doi.org/10.1007/s00705-013-1803-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00705-013-1803-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00705-013-1803-7%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Virology%26atitle%3DCurrent%252Band%252Bfuture%252Btherapies%252Bfor%252Bhepatitis%252BC%252Bvirus%252Binfection%25253A%252Bfrom%252Bviral%252Bproteins%252Bto%252Bhost%252Btargets%26aulast%3DImran%26aufirst%3DMuhammad%26date%3D2014%26date%3D2013%26volume%3D159%26issue%3D5%26spage%3D831%26epage%3D846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean–Michel  Pawlotsky</span>. </span><span class="cited-content_cbyCitation_article-title">New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges. </span><span class="cited-content_cbyCitation_journal-name">Gastroenterology</span><span> <strong>2014,</strong> <em>146 </em>
                                    (5)
                                     , 1176-1192. <a href="https://doi.org/10.1053/j.gastro.2014.03.003" title="DOI URL">https://doi.org/10.1053/j.gastro.2014.03.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.gastro.2014.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.gastro.2014.03.003%26sid%3Dliteratum%253Aachs%26jtitle%3DGastroenterology%26atitle%3DNew%252BHepatitis%252BC%252BTherapies%25253A%252BThe%252BToolbox%25252C%252BStrategies%25252C%252Band%252BChallenges%26aulast%3DPawlotsky%26aufirst%3DJean%25E2%2580%2593Michel%26date%3D2014%26volume%3D146%26issue%3D5%26spage%3D1176%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A.  Hill</span>, <span class="hlFld-ContribAuthor ">S.  Khoo</span>, <span class="hlFld-ContribAuthor ">J.  Fortunak</span>, <span class="hlFld-ContribAuthor ">B.  Simmons</span>, <span class="hlFld-ContribAuthor ">N.  Ford</span>. </span><span class="cited-content_cbyCitation_article-title">Minimum Costs for Producing Hepatitis C Direct-Acting Antivirals for Use in Large-Scale Treatment Access Programs in Developing Countries. </span><span class="cited-content_cbyCitation_journal-name">Clinical Infectious Diseases</span><span> <strong>2014,</strong> <em>58 </em>
                                    (7)
                                     , 928-936. <a href="https://doi.org/10.1093/cid/ciu012" title="DOI URL">https://doi.org/10.1093/cid/ciu012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/cid/ciu012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fcid%2Fciu012%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Infectious%2520Diseases%26atitle%3DMinimum%252BCosts%252Bfor%252BProducing%252BHepatitis%252BC%252BDirect-Acting%252BAntivirals%252Bfor%252BUse%252Bin%252BLarge-Scale%252BTreatment%252BAccess%252BPrograms%252Bin%252BDeveloping%252BCountries%26aulast%3DHill%26aufirst%3DA.%26date%3D2014%26date%3D2014%26volume%3D58%26issue%3D7%26spage%3D928%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin-Zhi  Chen</span>, <span class="hlFld-ContribAuthor ">Peter  Rose</span>, <span class="hlFld-ContribAuthor ">Yanping  Mao</span>, <span class="hlFld-ContribAuthor ">Chan-Loi  Yong</span>, <span class="hlFld-ContribAuthor ">Roger  St. George</span>, <span class="hlFld-ContribAuthor ">Fenglei  Huang</span>, <span class="hlFld-ContribAuthor ">Bachir  Latli</span>, <span class="hlFld-ContribAuthor ">Debra  Mandarino</span>, <span class="hlFld-ContribAuthor ">Yongmei  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Mass Balance and Metabolite Profiling of Steady-State Faldaprevir, a Hepatitis C Virus NS3/4 Protease Inhibitor, in Healthy Male Subjects. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2014,</strong> <em>58 </em>
                                    (4)
                                     , 2369-2376. <a href="https://doi.org/10.1128/AAC.02156-13" title="DOI URL">https://doi.org/10.1128/AAC.02156-13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.02156-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.02156-13%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DMass%252BBalance%252Band%252BMetabolite%252BProfiling%252Bof%252BSteady-State%252BFaldaprevir%25252C%252Ba%252BHepatitis%252BC%252BVirus%252BNS3%25252F4%252BProtease%252BInhibitor%25252C%252Bin%252BHealthy%252BMale%252BSubjects%26aulast%3DChen%26aufirst%3DLin-Zhi%26date%3D2014%26date%3D2014%26volume%3D58%26issue%3D4%26spage%3D2369%26epage%3D2376" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Natalia Lorna  Laufer</span>, <span class="hlFld-ContribAuthor ">Jürgen Kurt  Rockstroh</span>. </span><span class="cited-content_cbyCitation_article-title">Faldaprevir (BI 201335) for the treatment of hepatitis C in patients co-infected with HIV. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Anti-infective Therapy</span><span> <strong>2014,</strong> <em>12 </em>
                                    (2)
                                     , 157-164. <a href="https://doi.org/10.1586/14787210.2014.868774" title="DOI URL">https://doi.org/10.1586/14787210.2014.868774</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/14787210.2014.868774&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F14787210.2014.868774%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Anti-infective%2520Therapy%26atitle%3DFaldaprevir%252B%252528BI%252B201335%252529%252Bfor%252Bthe%252Btreatment%252Bof%252Bhepatitis%252BC%252Bin%252Bpatients%252Bco-infected%252Bwith%252BHIV%26aulast%3DLaufer%26aufirst%3DNatalia%2BLorna%26date%3D2014%26date%3D2013%26volume%3D12%26issue%3D2%26spage%3D157%26epage%3D164" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexander  Draganov</span>, <span class="hlFld-ContribAuthor ">Danzhu  Wang</span>, <span class="hlFld-ContribAuthor ">Binghe  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">The Future of Boron in Medicinal Chemistry: Therapeutic and Diagnostic Applications. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 1-27. <a href="https://doi.org/10.1007/7355_2014_65" title="DOI URL">https://doi.org/10.1007/7355_2014_65</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_65&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_65%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BFuture%252Bof%252BBoron%252Bin%252BMedicinal%252BChemistry%25253A%252BTherapeutic%252Band%252BDiagnostic%252BApplications%26aulast%3DDraganov%26aufirst%3DAlexander%26date%3D2014%26date%3D2014%26spage%3D1%26epage%3D27%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DAtypical%252BElements%252Bin%252BDrug%252BDesign%26aulast%3DSchwarz%26aufirst%3DJacob%26date%3D2016%26volume%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">David A.  Chaplin</span>, <span class="hlFld-ContribAuthor ">Martin E.  Fox</span>, <span class="hlFld-ContribAuthor ">Sebastian H. B.  Kroll</span>. </span><span class="cited-content_cbyCitation_article-title">Dynamic kinetic resolution of dehydrocoronamic acid. </span><span class="cited-content_cbyCitation_journal-name">Chem. Commun.</span><span> <strong>2014,</strong> <em>50 </em>
                                    (44)
                                     , 5858-5860. <a href="https://doi.org/10.1039/C4CC01125B" title="DOI URL">https://doi.org/10.1039/C4CC01125B</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4CC01125B&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4CC01125B%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Commun.%26atitle%3DDynamic%252Bkinetic%252Bresolution%252Bof%252Bdehydrocoronamic%252Bacid%26aulast%3DChaplin%26aufirst%3DDavid%2BA.%26date%3D2014%26date%3D2014%26volume%3D50%26issue%3D44%26spage%3D5858%26epage%3D5860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuhei  Nishiguchi</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Sakai</span>, <span class="hlFld-ContribAuthor ">Makoto  Kuboki</span>, <span class="hlFld-ContribAuthor ">Satoshi  Tsunematsu</span>, <span class="hlFld-ContribAuthor ">Yasuhisa  Urano</span>, <span class="hlFld-ContribAuthor ">Wataru  Sakamoto</span>, <span class="hlFld-ContribAuthor ">Yasuhiro  Tsuda</span>, <span class="hlFld-ContribAuthor ">Gerhard  Steinmann</span>, <span class="hlFld-ContribAuthor ">Masao  Omata</span>. </span><span class="cited-content_cbyCitation_article-title">Safety and efficacy of faldaprevir with pegylated interferon alfa-2a and ribavirin in Japanese patients with chronic genotype-1 hepatitis C infection. </span><span class="cited-content_cbyCitation_journal-name">Liver International</span><span> <strong>2014,</strong> <em>34 </em>
                                    (1)
                                     , 78-88. <a href="https://doi.org/10.1111/liv.12254" title="DOI URL">https://doi.org/10.1111/liv.12254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/liv.12254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fliv.12254%26sid%3Dliteratum%253Aachs%26jtitle%3DLiver%2520International%26atitle%3DSafety%252Band%252Befficacy%252Bof%252Bfaldaprevir%252Bwith%252Bpegylated%252Binterferon%252Balfa-2a%252Band%252Bribavirin%252Bin%252BJapanese%252Bpatients%252Bwith%252Bchronic%252Bgenotype-1%252Bhepatitis%252BC%252Binfection%26aulast%3DNishiguchi%26aufirst%3DShuhei%26date%3D2014%26date%3D2013%26volume%3D34%26issue%3D1%26spage%3D78%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy A.  Stammers</span>, <span class="hlFld-ContribAuthor ">René  Coulombe</span>, <span class="hlFld-ContribAuthor ">Martin  Duplessis</span>, <span class="hlFld-ContribAuthor ">Gulrez  Fazal</span>, <span class="hlFld-ContribAuthor ">Alexandre  Gagnon</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Sylvie  Goulet</span>, <span class="hlFld-ContribAuthor ">Araz  Jakalian</span>, <span class="hlFld-ContribAuthor ">Steven  LaPlante</span>, <span class="hlFld-ContribAuthor ">Jean  Rancourt</span>, <span class="hlFld-ContribAuthor ">Bounkham  Thavonekham</span>, <span class="hlFld-ContribAuthor ">Dominik  Wernic</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>, <span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>. </span><span class="cited-content_cbyCitation_article-title">Anthranilic acid-based Thumb Pocket 2 HCV NS5B polymerase inhibitors with sub-micromolar potency in the cell-based replicon assay. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (24)
                                     , 6879-6885. <a href="https://doi.org/10.1016/j.bmcl.2013.09.102" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.09.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.09.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.09.102%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DAnthranilic%252Bacid-based%252BThumb%252BPocket%252B2%252BHCV%252BNS5B%252Bpolymerase%252Binhibitors%252Bwith%252Bsub-micromolar%252Bpotency%252Bin%252Bthe%252Bcell-based%252Breplicon%252Bassay%26aulast%3DStammers%26aufirst%3DTimothy%2BA.%26date%3D2013%26volume%3D23%26issue%3D24%26spage%3D6879%26epage%3D6885" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jing  Li</span>, <span class="hlFld-ContribAuthor ">Xian  Liu</span>, <span class="hlFld-ContribAuthor ">Shanshan  Li</span>, <span class="hlFld-ContribAuthor ">Yulan  Wang</span>, <span class="hlFld-ContribAuthor ">Nannan  Zhou</span>, <span class="hlFld-ContribAuthor ">Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Xiaomin  Luo</span>, <span class="hlFld-ContribAuthor ">Mingyue  Zheng</span>, <span class="hlFld-ContribAuthor ">Hualiang  Jiang</span>, <span class="hlFld-ContribAuthor ">Kaixian  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Novel Small Molecules as Inhibitors of  Hepatitis C Virus by Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2013,</strong> <em>14 </em>
                                    (11)
                                     , 22845-22856. <a href="https://doi.org/10.3390/ijms141122845" title="DOI URL">https://doi.org/10.3390/ijms141122845</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms141122845&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms141122845%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DIdentification%252Bof%252BNovel%252BSmall%252BMolecules%252Bas%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252Bby%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DLi%26aufirst%3DJing%26date%3D2013%26date%3D2013%26volume%3D14%26issue%3D11%26spage%3D22845%26epage%3D22856" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Murray D.  Bailey</span>, <span class="hlFld-ContribAuthor ">Josée  Bordeleau</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Mélissa  Leblanc</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Lemke</span>, <span class="hlFld-ContribAuthor ">Jeff  O’Meara</span>, <span class="hlFld-ContribAuthor ">Peter W.  White</span>, <span class="hlFld-ContribAuthor ">Montse  Llinàs-Brunet</span>. </span><span class="cited-content_cbyCitation_article-title">Peptide backbone replacement of hepatitis C virus NS3 serine protease C-terminal cleavage product analogs: Discovery of potent succinamide inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (15)
                                     , 4447-4452. <a href="https://doi.org/10.1016/j.bmcl.2013.05.045" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.05.045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.05.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.05.045%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DPeptide%252Bbackbone%252Breplacement%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS3%252Bserine%252Bprotease%252BC-terminal%252Bcleavage%252Bproduct%252Banalogs%25253A%252BDiscovery%252Bof%252Bpotent%252Bsuccinamide%252Binhibitors%26aulast%3DBailey%26aufirst%3DMurray%2BD.%26date%3D2013%26volume%3D23%26issue%3D15%26spage%3D4447%26epage%3D4452" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Murray D.  Bailey</span>, <span class="hlFld-ContribAuthor ">Teddy  Halmos</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Lemke</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel P2 substituted 4-biaryl proline inhibitors of hepatitis C virus NS3 serine protease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (15)
                                     , 4436-4440. <a href="https://doi.org/10.1016/j.bmcl.2013.05.046" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.05.046</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.05.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.05.046%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bnovel%252BP2%252Bsubstituted%252B4-biaryl%252Bproline%252Binhibitors%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS3%252Bserine%252Bprotease%26aulast%3DBailey%26aufirst%3DMurray%2BD.%26date%3D2013%26volume%3D23%26issue%3D15%26spage%3D4436%26epage%3D4440" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Esperance  Schaefer</span>, <span class="hlFld-ContribAuthor ">Raymond T.  Chung</span>. </span><span class="cited-content_cbyCitation_article-title">Development of Anti-HCV Drugs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 377-391. <a href="https://doi.org/10.1002/9781118637272.ch26" title="DOI URL">https://doi.org/10.1002/9781118637272.ch26</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118637272.ch26&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118637272.ch26%26sid%3Dliteratum%253Aachs%26atitle%3DDevelopment%252Bof%252BAnti-HCV%252BDrugs%26aulast%3DSchaefer%26aufirst%3DEsperance%26date%3D2013%26date%3D2013%26spage%3D377%26epage%3D391%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Ltd%26atitle%3DViral%252BHepatitis%26aulast%3DThomas%26aufirst%3DHoward%2BC.%26date%3D2013%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">François  Bilodeau</span>, <span class="hlFld-ContribAuthor ">Murray D.  Bailey</span>, <span class="hlFld-ContribAuthor ">Punit K.  Bhardwaj</span>, <span class="hlFld-ContribAuthor ">Josée  Bordeleau</span>, <span class="hlFld-ContribAuthor ">Pat  Forgione</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Elise  Ghiro</span>, <span class="hlFld-ContribAuthor ">Vida  Gorys</span>, <span class="hlFld-ContribAuthor ">Ted  Halmos</span>, <span class="hlFld-ContribAuthor ">Eric S.  Jolicoeur</span>, <span class="hlFld-ContribAuthor ">Mélissa  Leblanc</span>, <span class="hlFld-ContribAuthor ">Christopher T.  Lemke</span>, <span class="hlFld-ContribAuthor ">Julie  Naud</span>, <span class="hlFld-ContribAuthor ">Jeff  O’Meara</span>, <span class="hlFld-ContribAuthor ">Peter W.  White</span>, <span class="hlFld-ContribAuthor ">Montse  Llinàs-Brunet</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and optimization of a novel series of HCV NS3 protease inhibitors: 4-Arylproline analogs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (14)
                                     , 4267-4271. <a href="https://doi.org/10.1016/j.bmcl.2013.03.043" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.043%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Boptimization%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252BHCV%252BNS3%252Bprotease%252Binhibitors%25253A%252B4-Arylproline%252Banalogs%26aulast%3DBilodeau%26aufirst%3DFran%25C3%25A7ois%26date%3D2013%26volume%3D23%26issue%3D14%26spage%3D4267%26epage%3D4271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>, <span class="hlFld-ContribAuthor ">René  Coulombe</span>, <span class="hlFld-ContribAuthor ">Jianmin  Duan</span>, <span class="hlFld-ContribAuthor ">Gulrez  Fazal</span>, <span class="hlFld-ContribAuthor ">Cédrickx  Godbout</span>, <span class="hlFld-ContribAuthor ">Oliver  Hucke</span>, <span class="hlFld-ContribAuthor ">Araz  Jakalian</span>, <span class="hlFld-ContribAuthor ">Marc-André  Joly</span>, <span class="hlFld-ContribAuthor ">Olivier  Lepage</span>, <span class="hlFld-ContribAuthor ">Montse  Llinàs-Brunet</span>, <span class="hlFld-ContribAuthor ">Julie  Naud</span>, <span class="hlFld-ContribAuthor ">Martin  Poirier</span>, <span class="hlFld-ContribAuthor ">Nathalie  Rioux</span>, <span class="hlFld-ContribAuthor ">Bounkham  Thavonekham</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Stammers</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design of novel HCV NS5B thumb pocket 2 allosteric inhibitors with submicromolar gt1 replicon potency: Discovery of a quinazolinone chemotype. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (14)
                                     , 4132-4140. <a href="https://doi.org/10.1016/j.bmcl.2013.05.037" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.05.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.05.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.05.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%252Bof%252Bnovel%252BHCV%252BNS5B%252Bthumb%252Bpocket%252B2%252Ballosteric%252Binhibitors%252Bwith%252Bsubmicromolar%252Bgt1%252Breplicon%252Bpotency%25253A%252BDiscovery%252Bof%252Ba%252Bquinazolinone%252Bchemotype%26aulast%3DBeaulieu%26aufirst%3DPierre%2BL.%26date%3D2013%26volume%3D23%26issue%3D14%26spage%3D4132%26epage%3D4140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Deena S.  Lasheen</span>, <span class="hlFld-ContribAuthor ">Mohamed A.H.  Ismail</span>, <span class="hlFld-ContribAuthor ">Dalal A.  Abou El Ella</span>, <span class="hlFld-ContribAuthor ">Nasser S.M.  Ismail</span>, <span class="hlFld-ContribAuthor ">Sameh  Eid</span>, <span class="hlFld-ContribAuthor ">Susan  Vleck</span>, <span class="hlFld-ContribAuthor ">Jeffrey S.  Glenn</span>, <span class="hlFld-ContribAuthor ">Andrew G.  Watts</span>, <span class="hlFld-ContribAuthor ">Khaled A.M.  Abouzid</span>. </span><span class="cited-content_cbyCitation_article-title">Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2013,</strong> <em>21 </em>
                                    (10)
                                     , 2742-2755. <a href="https://doi.org/10.1016/j.bmc.2013.03.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2013.03.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2013.03.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2013.03.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DAnalogs%252Bdesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bpeptidomimetics%252Bwith%252Bpotential%252Banti-HCV%252Bactivity%26aulast%3DLasheen%26aufirst%3DDeena%2BS.%26date%3D2013%26volume%3D21%26issue%3D10%26spage%3D2742%26epage%3D2755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy A.  Stammers</span>, <span class="hlFld-ContribAuthor ">René  Coulombe</span>, <span class="hlFld-ContribAuthor ">Jean  Rancourt</span>, <span class="hlFld-ContribAuthor ">Bounkham  Thavonekham</span>, <span class="hlFld-ContribAuthor ">Gulrez  Fazal</span>, <span class="hlFld-ContribAuthor ">Sylvie  Goulet</span>, <span class="hlFld-ContribAuthor ">Araz  Jakalian</span>, <span class="hlFld-ContribAuthor ">Dominic  Wernic</span>, <span class="hlFld-ContribAuthor ">Youla  Tsantrizos</span>, <span class="hlFld-ContribAuthor ">Marc-André  Poupart</span>, <span class="hlFld-ContribAuthor ">Michael  Bös</span>, <span class="hlFld-ContribAuthor ">Ginette  McKercher</span>, <span class="hlFld-ContribAuthor ">Louise  Thauvette</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>, <span class="hlFld-ContribAuthor ">Pierre L.  Beaulieu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a novel series of non-nucleoside thumb pocket 2 HCV NS5B polymerase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (9)
                                     , 2585-2589. <a href="https://doi.org/10.1016/j.bmcl.2013.02.110" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.02.110</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.02.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.02.110%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252Bnon-nucleoside%252Bthumb%252Bpocket%252B2%252BHCV%252BNS5B%252Bpolymerase%252Binhibitors%26aulast%3DStammers%26aufirst%3DTimothy%2BA.%26date%3D2013%26volume%3D23%26issue%3D9%26spage%3D2585%26epage%3D2589" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Stanley V.  D'Andrea</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Cianci</span>, <span class="hlFld-ContribAuthor ">Ira B.  Dicker</span>, <span class="hlFld-ContribAuthor ">Kap-Sun  Yeung</span>, <span class="hlFld-ContribAuthor ">Makonen  Belema</span>, <span class="hlFld-ContribAuthor ">Mark  Krystal</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 439-515. <a href="https://doi.org/10.1002/9781118354483.ch11" title="DOI URL">https://doi.org/10.1002/9781118354483.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118354483.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118354483.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DAntiviral%252BDrug%252BDiscovery%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2013%26date%3D2013%26spage%3D439%26epage%3D515%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DDrug%252BDiscovery%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2013%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vaishali M.  Patil</span>, <span class="hlFld-ContribAuthor ">Neeraj  Masand</span>, <span class="hlFld-ContribAuthor ">Satya Prakash  Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Proteases in the Management of Hepatitis C Virus. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 335-360. <a href="https://doi.org/10.1007/978-1-4614-9233-7_20" title="DOI URL">https://doi.org/10.1007/978-1-4614-9233-7_20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-9233-7_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-9233-7_20%26sid%3Dliteratum%253Aachs%26atitle%3DRole%252Bof%252BProteases%252Bin%252Bthe%252BManagement%252Bof%252BHepatitis%252BC%252BVirus%26aulast%3DPatil%26aufirst%3DVaishali%2BM.%26date%3D2013%26date%3D2013%26spage%3D335%26epage%3D360%26pub%3DSpringer%2520New%2520York%26atitle%3DProteases%252Bin%252BHealth%252Band%252BDisease%26aulast%3DChakraborti%26aufirst%3DSajal%26date%3D2013%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Steinkühler</span>. </span><span class="cited-content_cbyCitation_article-title">Hepacivirin. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 3120-3130. <a href="https://doi.org/10.1016/B978-0-12-382219-2.00688-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-382219-2.00688-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-382219-2.00688-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-382219-2.00688-8%26sid%3Dliteratum%253Aachs%26atitle%3DHepacivirin%26aulast%3DSteink%25C3%25BChler%26aufirst%3DChristian%26date%3D2013%26spage%3D3120%26epage%3D3130%26pub%3DElsevier%26atitle%3DHandbook%252Bof%252BProteolytic%252BEnzymes%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas M.  Beale</span>, <span class="hlFld-ContribAuthor ">Michael G.  Chudzinski</span>, <span class="hlFld-ContribAuthor ">Mohammed G.  Sarwar</span>, <span class="hlFld-ContribAuthor ">Mark S.  Taylor</span>. </span><span class="cited-content_cbyCitation_article-title">Halogen bonding in solution: thermodynamics and applications. </span><span class="cited-content_cbyCitation_journal-name">Chem. Soc. Rev.</span><span> <strong>2013,</strong> <em>42 </em>
                                    (4)
                                     , 1667-1680. <a href="https://doi.org/10.1039/C2CS35213C" title="DOI URL">https://doi.org/10.1039/C2CS35213C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C2CS35213C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC2CS35213C%26sid%3Dliteratum%253Aachs%26jtitle%3DChem.%2520Soc.%2520Rev.%26atitle%3DHalogen%252Bbonding%252Bin%252Bsolution%25253A%252Bthermodynamics%252Band%252Bapplications%26aulast%3DBeale%26aufirst%3DThomas%2BM.%26date%3D2013%26date%3D2013%26volume%3D42%26issue%3D4%26spage%3D1667%26epage%3D1680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xianfeng  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Yong-Kang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jacob J.  Plattner</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Baker</span>, <span class="hlFld-ContribAuthor ">Wei  Bu</span>, <span class="hlFld-ContribAuthor ">Liang  Liu</span>, <span class="hlFld-ContribAuthor ">Yasheen  Zhou</span>, <span class="hlFld-ContribAuthor ">Charles Z.  Ding</span>, <span class="hlFld-ContribAuthor ">Suoming  Zhang</span>, <span class="hlFld-ContribAuthor ">Wieslaw M.  Kazmierski</span>, <span class="hlFld-ContribAuthor ">Robert  Hamatake</span>, <span class="hlFld-ContribAuthor ">Maosheng  Duan</span>, <span class="hlFld-ContribAuthor ">Lois L.  Wright</span>, <span class="hlFld-ContribAuthor ">Gary K.  Smith</span>, <span class="hlFld-ContribAuthor ">Richard L.  Jarvest</span>, <span class="hlFld-ContribAuthor ">Jing-Jing  Ji</span>, <span class="hlFld-ContribAuthor ">Joel P.  Cooper</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Tallant</span>, <span class="hlFld-ContribAuthor ">Renae M.  Crosby</span>, <span class="hlFld-ContribAuthor ">Katrina  Creech</span>, <span class="hlFld-ContribAuthor ">Amy  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (24)
                                     , 7351-7356. <a href="https://doi.org/10.1016/j.bmcl.2012.10.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.10.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.10.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.10.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bantiviral%252Bactivity%252Bof%252Bnovel%252BHCV%252BNS3%252Bprotease%252Binhibitors%252Bwith%252BP4%252Bcapping%252Bgroups%26aulast%3DLi%26aufirst%3DXianfeng%26date%3D2012%26volume%3D22%26issue%3D24%26spage%3D7351%26epage%3D7356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik  De Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">The race for interferon-free HCV therapies: a snapshot by the spring of 2012. </span><span class="cited-content_cbyCitation_journal-name">Reviews in Medical Virology</span><span> <strong>2012,</strong> <em>22 </em>
                                    (6)
                                     , 392-411. <a href="https://doi.org/10.1002/rmv.1727" title="DOI URL">https://doi.org/10.1002/rmv.1727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/rmv.1727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Frmv.1727%26sid%3Dliteratum%253Aachs%26jtitle%3DReviews%2520in%2520Medical%2520Virology%26atitle%3DThe%252Brace%252Bfor%252Binterferon-free%252BHCV%252Btherapies%25253A%252Ba%252Bsnapshot%252Bby%252Bthe%252Bspring%252Bof%252B2012%26aulast%3DDe%2BClercq%26aufirst%3DErik%26date%3D2012%26date%3D2012%26volume%3D22%26issue%3D6%26spage%3D392%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carl A.  Busacca</span>, <span class="hlFld-ContribAuthor ">Xudong  Wei</span>, <span class="hlFld-ContribAuthor ">Nizar  Haddad</span>, <span class="hlFld-ContribAuthor ">Suresh  Kapadia</span>, <span class="hlFld-ContribAuthor ">Jon. C.  Lorenz</span>, <span class="hlFld-ContribAuthor ">Anjan K.  Saha</span>, <span class="hlFld-ContribAuthor ">Richard J.  Varsolona</span>, <span class="hlFld-ContribAuthor ">Thilo  Berkenbusch</span>, <span class="hlFld-ContribAuthor ">Scot C.  Campbell</span>, <span class="hlFld-ContribAuthor ">Vittorio  Farina</span>, <span class="hlFld-ContribAuthor ">XuWu  Feng</span>, <span class="hlFld-ContribAuthor ">Nina C.  Gonnella</span>, <span class="hlFld-ContribAuthor ">Nelu  Grinberg</span>, <span class="hlFld-ContribAuthor ">Paul-James  Jones</span>, <span class="hlFld-ContribAuthor ">Heewon  Lee</span>, <span class="hlFld-ContribAuthor ">Zhibin  Li</span>, <span class="hlFld-ContribAuthor ">Oliver  Niemeier</span>, <span class="hlFld-ContribAuthor ">Wendelin  Samstag</span>, <span class="hlFld-ContribAuthor ">Max  Sarvestani</span>, <span class="hlFld-ContribAuthor ">Juergen  Schroeder</span>, <span class="hlFld-ContribAuthor ">John  Smoliga</span>, <span class="hlFld-ContribAuthor ">Earl M.  Spinelli</span>, <span class="hlFld-ContribAuthor ">Jana  Vitous</span>, <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">Practical Large-Scale Synthesis of the Hepatitis C Virus Protease Inhibitor BI 201335. </span><span class="cited-content_cbyCitation_journal-name">Asian Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>1 </em>
                                    (1)
                                     , 80-89. <a href="https://doi.org/10.1002/ajoc.201200014" title="DOI URL">https://doi.org/10.1002/ajoc.201200014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ajoc.201200014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fajoc.201200014%26sid%3Dliteratum%253Aachs%26jtitle%3DAsian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DPractical%252BLarge-Scale%252BSynthesis%252Bof%252Bthe%252BHepatitis%2525E2%252580%252585C%252BVirus%252BProtease%252BInhibitor%252BBI%2525E2%252580%252585201335%26aulast%3DBusacca%26aufirst%3DCarl%2BA.%26date%3D2012%26date%3D2012%26volume%3D1%26issue%3D1%26spage%3D80%26epage%3D89" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Boceprevir and Narlaprevir: The First and Second Generation of HCV NS3 Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 296-335. <a href="https://doi.org/10.1002/9781118219683.ch12" title="DOI URL">https://doi.org/10.1002/9781118219683.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118219683.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118219683.ch12%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252BBoceprevir%252Band%252BNarlaprevir%25253A%252BThe%252BFirst%252Band%252BSecond%252BGeneration%252Bof%252BHCV%252BNS3%252BProtease%252BInhibitors%26aulast%3DChen%26aufirst%3DKevin%2BX.%26date%3D2012%26date%3D2012%26spage%3D296%26epage%3D335%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DCase%252BStudies%252Bin%252BModern%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DHuang%26aufirst%3DXianhai%26date%3D2012%26volume%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jianmin  Duan</span>, <span class="hlFld-ContribAuthor ">Chan-Loi  Yong</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Ma’an  Amad</span>, <span class="hlFld-ContribAuthor ">Gordon  Bolger</span>, <span class="hlFld-ContribAuthor ">Josie  De Marte</span>, <span class="hlFld-ContribAuthor ">Hélène  Montpetit</span>, <span class="hlFld-ContribAuthor ">Francois  Otis</span>, <span class="hlFld-ContribAuthor ">Martin  Jutras</span>, <span class="hlFld-ContribAuthor ">Manon  Rhéaume</span>, <span class="hlFld-ContribAuthor ">Peter W.  White</span>, <span class="hlFld-ContribAuthor ">Montse  Llinàs-Brunet</span>, <span class="hlFld-ContribAuthor ">Richard C.  Bethell</span>, <span class="hlFld-ContribAuthor ">Michael G.  Cordingley</span>. </span><span class="cited-content_cbyCitation_article-title">Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Xenobiotica</span><span> <strong>2012,</strong> <em>42 </em>
                                    (2)
                                     , 164-172. <a href="https://doi.org/10.3109/00498254.2011.611546" title="DOI URL">https://doi.org/10.3109/00498254.2011.611546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3109/00498254.2011.611546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3109%2F00498254.2011.611546%26sid%3Dliteratum%253Aachs%26jtitle%3DXenobiotica%26atitle%3DCross-species%252Babsorption%25252C%252Bmetabolism%25252C%252Bdistribution%252Band%252Bpharmacokinetics%252Bof%252BBI%252B201335%25252C%252Ba%252Bpotent%252BHCV%252Bgenotype%252B1%252BNS3%25252F4A%252Bprotease%252Binhibitor%26aulast%3DDuan%26aufirst%3DJianmin%26date%3D2012%26date%3D2011%26volume%3D42%26issue%3D2%26spage%3D164%26epage%3D172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.K.  Yee</span>, <span class="hlFld-ContribAuthor ">X.  Wei</span>, <span class="hlFld-ContribAuthor ">C.A.  Busacca</span>, <span class="hlFld-ContribAuthor ">X.  Zeng</span>, <span class="hlFld-ContribAuthor ">D.R.  Fandrick</span>, <span class="hlFld-ContribAuthor ">J.J.  Song</span>, <span class="hlFld-ContribAuthor ">C.H.  Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">9.19 Synthesis of the Leading HCV Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 483-506. <a href="https://doi.org/10.1016/B978-0-08-095167-6.00934-4" title="DOI URL">https://doi.org/10.1016/B978-0-08-095167-6.00934-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-095167-6.00934-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-095167-6.00934-4%26sid%3Dliteratum%253Aachs%26atitle%3D9.19%252BSynthesis%252Bof%252Bthe%252BLeading%252BHCV%252BProtease%252BInhibitors%26aulast%3DYee%26aufirst%3DN.K.%26date%3D2012%26spage%3D483%26epage%3D506%26pub%3DElsevier%26atitle%3DComprehensive%252BChirality%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gregory T.  Notte</span>. </span><span class="cited-content_cbyCitation_article-title">New Chemical Entities Entering Phase III Trials in 2011. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 477-498. <a href="https://doi.org/10.1016/B978-0-12-396492-2.00030-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-396492-2.00030-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-396492-2.00030-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-396492-2.00030-8%26sid%3Dliteratum%253Aachs%26atitle%3DNew%252BChemical%252BEntities%252BEntering%252BPhase%252BIII%252BTrials%252Bin%252B2011%26aulast%3DNotte%26aufirst%3DGregory%2BT.%26date%3D2012%26spage%3D477%26epage%3D498%26pub%3DElsevier%26atitle%3DAnnual%252BReports%252Bin%252BMedicinal%252BChemistry%252BVolume%252B47%26date%3D2012%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lisette  Lagacé</span>, <span class="hlFld-ContribAuthor ">Peter W.  White</span>, <span class="hlFld-ContribAuthor ">Christiane  Bousquet</span>, <span class="hlFld-ContribAuthor ">Nathalie  Dansereau</span>, <span class="hlFld-ContribAuthor ">Florence  Dô</span>, <span class="hlFld-ContribAuthor ">Montse  Llinas-Brunet</span>, <span class="hlFld-ContribAuthor ">Martin  Marquis</span>, <span class="hlFld-ContribAuthor ">Marie-Josée  Massariol</span>, <span class="hlFld-ContribAuthor ">Roger  Maurice</span>, <span class="hlFld-ContribAuthor ">Catherine  Spickler</span>, <span class="hlFld-ContribAuthor ">Diane  Thibeault</span>, <span class="hlFld-ContribAuthor ">Ibtissem  Triki</span>, <span class="hlFld-ContribAuthor ">Songping  Zhao</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>. </span><span class="cited-content_cbyCitation_article-title">In Vitro
              Resistance Profile of the Hepatitis C Virus NS3 Protease Inhibitor BI 201335. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2012,</strong> <em>56 </em>
                                    (1)
                                     , 569-572. <a href="https://doi.org/10.1128/AAC.05166-11" title="DOI URL">https://doi.org/10.1128/AAC.05166-11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.05166-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.05166-11%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DIn%252BVitro%252BResistance%252BProfile%252Bof%252Bthe%252BHepatitis%252BC%252BVirus%252BNS3%252BProtease%252BInhibitor%252BBI%252B201335%26aulast%3DLagac%25C3%25A9%26aufirst%3DLisette%26date%3D2012%26date%3D2011%26volume%3D56%26issue%3D1%26spage%3D569%26epage%3D572" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul J.  Edwards</span>, <span class="hlFld-ContribAuthor ">Steven R.  LaPlante</span>. </span><span class="cited-content_cbyCitation_article-title">Peptides as Leads for Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 1-55. <a href="https://doi.org/10.1002/9783527636730.ch1" title="DOI URL">https://doi.org/10.1002/9783527636730.ch1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527636730.ch1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527636730.ch1%26sid%3Dliteratum%253Aachs%26atitle%3DPeptides%252Bas%252BLeads%252Bfor%252BDrug%252BDiscovery%26aulast%3DEdwards%26aufirst%3DPaul%2BJ.%26date%3D2011%26date%3D2011%26spage%3D1%26epage%3D55%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DPeptide%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DCastanho%26aufirst%3DMiguel%26date%3D2011%26volume%3D41" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carl A.  Busacca</span>, <span class="hlFld-ContribAuthor ">Daniel R.  Fandrick</span>, <span class="hlFld-ContribAuthor ">Jinhua J.  Song</span>, <span class="hlFld-ContribAuthor ">Chris H.  Senanayake</span>. </span><span class="cited-content_cbyCitation_article-title">The Growing Impact of Catalysis in the Pharmaceutical Industry. </span><span class="cited-content_cbyCitation_journal-name">Advanced Synthesis & Catalysis</span><span> <strong>2011,</strong> <em>353 </em>
                                    (11-12)
                                     , 1825-1864. <a href="https://doi.org/10.1002/adsc.201100488" title="DOI URL">https://doi.org/10.1002/adsc.201100488</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adsc.201100488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadsc.201100488%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Synthesis%2520%2526%2520Catalysis%26atitle%3DThe%252BGrowing%252BImpact%252Bof%252BCatalysis%252Bin%252Bthe%252BPharmaceutical%252BIndustry%26aulast%3DBusacca%26aufirst%3DCarl%2BA.%26date%3D2011%26date%3D2011%26volume%3D353%26issue%3D11-12%26spage%3D1825%26epage%3D1864" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nagraj  Mani</span>, <span class="hlFld-ContribAuthor ">Bhisetti G.  Rao</span>, <span class="hlFld-ContribAuthor ">Tara L.  Kieffer</span>, <span class="hlFld-ContribAuthor ">Ann D.  Kwong</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Progress in the Development of HCV Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 307-328. <a href="https://doi.org/10.1002/9783527635955.ch12" title="DOI URL">https://doi.org/10.1002/9783527635955.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527635955.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527635955.ch12%26sid%3Dliteratum%253Aachs%26atitle%3DRecent%252BProgress%252Bin%252Bthe%252BDevelopment%252Bof%252BHCV%252BProtease%252BInhibitors%26aulast%3DMani%26aufirst%3DNagraj%26date%3D2011%26date%3D2011%26spage%3D307%26epage%3D328%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DAntiviral%252BDrug%252BStrategies%26aulast%3DDe%2BClercq%26aufirst%3DErik%26date%3D2011%26volume%3D14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xianfeng  Li</span>, <span class="hlFld-ContribAuthor ">Suoming  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong-Kang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Charles Z.  Ding</span>, <span class="hlFld-ContribAuthor ">Yasheen  Zhou</span>, <span class="hlFld-ContribAuthor ">Jacob J.  Plattner</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Baker</span>, <span class="hlFld-ContribAuthor ">Wei  Bu</span>, <span class="hlFld-ContribAuthor ">Liang  Liu</span>, <span class="hlFld-ContribAuthor ">Wieslaw M.  Kazmierski</span>, <span class="hlFld-ContribAuthor ">Maosheng  Duan</span>, <span class="hlFld-ContribAuthor ">Richard M.  Grimes</span>, <span class="hlFld-ContribAuthor ">Lois L.  Wright</span>, <span class="hlFld-ContribAuthor ">Gary K.  Smith</span>, <span class="hlFld-ContribAuthor ">Richard L.  Jarvest</span>, <span class="hlFld-ContribAuthor ">Jing-Jing  Ji</span>, <span class="hlFld-ContribAuthor ">Joel P.  Cooper</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Tallant</span>, <span class="hlFld-ContribAuthor ">Renae M.  Crosby</span>, <span class="hlFld-ContribAuthor ">Katrina  Creech</span>, <span class="hlFld-ContribAuthor ">Zhi-Jie  Ni</span>, <span class="hlFld-ContribAuthor ">Wuxin  Zou</span>, <span class="hlFld-ContribAuthor ">Jon  Wright</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and SAR of acyclic HCV NS3 protease inhibitors with novel P4-benzoxaborole moieties. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>21 </em>
                                    (7)
                                     , 2048-2054. <a href="https://doi.org/10.1016/j.bmcl.2011.02.006" title="DOI URL">https://doi.org/10.1016/j.bmcl.2011.02.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2011.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2011.02.006%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252BSAR%252Bof%252Bacyclic%252BHCV%252BNS3%252Bprotease%252Binhibitors%252Bwith%252Bnovel%252BP4-benzoxaborole%252Bmoieties%26aulast%3DLi%26aufirst%3DXianfeng%26date%3D2011%26volume%3D21%26issue%3D7%26spage%3D2048%26epage%3D2054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher T.  Lemke</span>, <span class="hlFld-ContribAuthor ">Nathalie  Goudreau</span>, <span class="hlFld-ContribAuthor ">Songping  Zhao</span>, <span class="hlFld-ContribAuthor ">Oliver  Hucke</span>, <span class="hlFld-ContribAuthor ">Diane  Thibeault</span>, <span class="hlFld-ContribAuthor ">Montse  Llinàs-Brunet</span>, <span class="hlFld-ContribAuthor ">Peter W.  White</span>. </span><span class="cited-content_cbyCitation_article-title">Combined X-ray, NMR, and Kinetic Analyses Reveal Uncommon Binding Characteristics of the Hepatitis C Virus NS3-NS4A Protease Inhibitor BI 201335. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biological Chemistry</span><span> <strong>2011,</strong> <em>286 </em>
                                    (13)
                                     , 11434-11443. <a href="https://doi.org/10.1074/jbc.M110.211417" title="DOI URL">https://doi.org/10.1074/jbc.M110.211417</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1074/jbc.M110.211417&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1074%2Fjbc.M110.211417%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biological%2520Chemistry%26atitle%3DCombined%252BX-ray%25252C%252BNMR%25252C%252Band%252BKinetic%252BAnalyses%252BReveal%252BUncommon%252BBinding%252BCharacteristics%252Bof%252Bthe%252BHepatitis%252BC%252BVirus%252BNS3-NS4A%252BProtease%252BInhibitor%252BBI%252B201335%26aulast%3DLemke%26aufirst%3DChristopher%2BT.%26date%3D2011%26volume%3D286%26issue%3D13%26spage%3D11434%26epage%3D11443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Jin  Wu</span>, <span class="hlFld-ContribAuthor ">Bingwei V.  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Five-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2011,</strong>,, 267-291. <a href="https://doi.org/10.1016/B978-0-08-096805-6.00009-7" title="DOI URL">https://doi.org/10.1016/B978-0-08-096805-6.00009-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-096805-6.00009-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-096805-6.00009-7%26sid%3Dliteratum%253Aachs%26atitle%3DFive-Membered%252BRing%252BSystems%26aulast%3DWu%26aufirst%3DYong-Jin%26date%3D2011%26spage%3D267%26epage%3D291%26pub%3DElsevier%26date%3D2011%26volume%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter W.  White</span>, <span class="hlFld-ContribAuthor ">Montse  Llinàs-Brunet</span>, <span class="hlFld-ContribAuthor ">Ma'an  Amad</span>, <span class="hlFld-ContribAuthor ">Richard C.  Bethell</span>, <span class="hlFld-ContribAuthor ">Gordon  Bolger</span>, <span class="hlFld-ContribAuthor ">Michael G.  Cordingley</span>, <span class="hlFld-ContribAuthor ">Jianmin  Duan</span>, <span class="hlFld-ContribAuthor ">Michel  Garneau</span>, <span class="hlFld-ContribAuthor ">Lisette  Lagacé</span>, <span class="hlFld-ContribAuthor ">Diane  Thibeault</span>, <span class="hlFld-ContribAuthor ">George  Kukolj</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Characterization of BI 201335, a C-Terminal Carboxylic Acid Inhibitor of the Hepatitis C Virus NS3-NS4A Protease. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2010,</strong> <em>54 </em>
                                    (11)
                                     , 4611-4618. <a href="https://doi.org/10.1128/AAC.00787-10" title="DOI URL">https://doi.org/10.1128/AAC.00787-10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00787-10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00787-10%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DPreclinical%252BCharacterization%252Bof%252BBI%252B201335%25252C%252Ba%252BC-Terminal%252BCarboxylic%252BAcid%252BInhibitor%252Bof%252Bthe%252BHepatitis%252BC%252BVirus%252BNS3-NS4A%252BProtease%26aulast%3DWhite%26aufirst%3DPeter%2BW.%26date%3D2010%26volume%3D54%26issue%3D11%26spage%3D4611%26epage%3D4618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/medium/jm-2010-00690x_0005.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/large/jm-2010-00690x_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100690x&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/medium/jm-2010-00690x_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/large/jm-2010-00690x_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. General Synthetic Route for Inhibitors of Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a> and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/large/jm-2010-00690x_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100690x&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) TBTU, DIPEA, DCM, room temp, 14 h; (b) 1 equiv of LiOH, H<sub>2</sub>O/THF, 0 °C, 3 h; (c) brosyl chloride, DMAP, DCM, 0 °C to room temp; (d) <b>11a</b>−<b>11c</b>, Cs<sub>2</sub>CO<sub>3</sub>, NMP, 70 °C, 7 h; (e) 1.1 equiv of 1 N NaOH, H<sub>2</sub>O−THF, 0 °C to room temp; (f) IBCF, TEA, THF, 0 °C to room temp; (g) CH<sub>2</sub>N<sub>2</sub>, Et<sub>2</sub>O, 0 °C to room temp; (h) HBr (48% aq), THF; (i) <b>14a</b>−<b>g</b>, <i>i</i>-PrOH, 50 °C, 1 h; (j) LiOH, H<sub>2</sub>O−MeOH−THF.</p></p></figure><figure data-id="sch2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/medium/jm-2010-00690x_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/large/jm-2010-00690x_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of the Different 8-Substituted 2-Carbomethoxy-4-hydroxy-7-methoxyquinoline Derivatives<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-17/jm100690x/production/images/large/jm-2010-00690x_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm100690x&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>8a</b>−<b>e</b>, MeOH, 70 °C, 5 h; (b) Ph<sub>2</sub>O, 240 °C, 6−8 min.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i47">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65186" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65186" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Lavanchy, D.</span><span> </span><span class="NLM_article-title">The global burden of hepatitis C</span> <span class="citation_source-journal">Liver Int.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">Suppl. 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">74</span><span class="NLM_x">–</span> <span class="NLM_lpage">81</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1111%2Fj.1478-3231.2008.01934.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=19207969" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A280%3ADC%252BD1M7mvFWqtg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2009&pages=74-81&issue=Suppl.+1&author=D.+Lavanchy&title=The+global+burden+of+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The global burden of hepatitis C</span></div><div class="casAuthors">Lavanchy Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Liver international : official journal of the International Association for the Study of the Liver</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">29 Suppl 1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Hepatitis C is of concern both to industrialized and developing countries.  Preliminary unpublished estimates of the global burden of disease (GBD) attributable to HCV-related chronic liver disease seem to be substantial.  Therefore, the reduction of global mortality and morbidity related to chronic hepatitis C should be a concern to public health authorities, and primary, secondary and tertiary prevention activities should be implemented and monitored in each country, with precise targets set to be reached.  In order to decide on national health policies, there is a need to estimate the burden of disease, globally, regionally and nationally.  To evaluate the GBD, three components have to be assessed: 1) The global, regional and national burden of morbidity and mortality associated with HCV infection, based on prevalence, incidence, transmission and economics; 2) The natural history of HCV infection, including 'healthy individuals'; and 3) The areas for which more research is needed.  A working group was created to assist the World Health organization (WHO) in estimating the GBD associated with HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuhPVOhaFqwZQHPYJuLg8TfW6udTcc2eZegVqq6AaQCLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M7mvFWqtg%253D%253D&md5=c43cb9445029ca7dd4033dc4a2d9a32c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1111%2Fj.1478-3231.2008.01934.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1478-3231.2008.01934.x%26sid%3Dliteratum%253Aachs%26aulast%3DLavanchy%26aufirst%3DD.%26atitle%3DThe%2520global%2520burden%2520of%2520hepatitis%2520C%26jtitle%3DLiver%2520Int.%26date%3D2009%26volume%3D29%26issue%3DSuppl.%25201%26spage%3D74%26epage%3D81" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Brown, R. S.</span><span> </span><span class="NLM_article-title">Hepatitis C and liver transplantation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=973-978&author=R.+S.+Brown&title=Hepatitis+C+and+liver+transplantation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BS.%26atitle%3DHepatitis%2520C%2520and%2520liver%2520transplantation%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D973%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Choo, Q. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuo, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weiner, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Overby, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houghton, M.</span><span> </span><span class="NLM_article-title">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">244</span><span class="NLM_x">, </span> <span class="NLM_fpage">359</span><span class="NLM_x">–</span> <span class="NLM_lpage">362</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1126%2Fscience.2523562" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=2523562" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=1989&pages=359-362&author=Q.+L.+Chooauthor=G.+Kuoauthor=A.+J.+Weinerauthor=L.+R.+Overbyauthor=D.+W.+Bradleyauthor=M.+Houghton&title=Isolation+of+a+cDNA+clone+derived+from+a+blood-borne+non-A%2C+non-B+viral+hepatitis+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome</span></div><div class="casAuthors">Choo, Qui Lim; Kuo, George; Weiner, Amy J.; Overby, Lacy R.; Bradley, Daniel W.; Houghton, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">4902</span>),
    <span class="NLM_cas:pages">359-62</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    </div><div class="casAbstract">A random-primed cDNA library was constructed from plasma contg. the uncharacterized non-A, non-B hepatitis (NANBH) agent and screened with serum from a patient diagnosed with NANBH.  A cDNA clone was isolated that was shown to encode an antigen assocd. specifically with NANBH infections.  This clone is not derived from host DNA but from an RNA mol. present in NANBH infections that consists of ≥10,000 nucleotides, and that is pos.-stranded with respect to the encoded NANBH antigen.  These data indicate that this clone is derived from the genome of the NANBH agent and are consistent with the agent being similar to the togaviridae or flaviviridae.  This mol. approach should be of great value in the isolation and characterization of other unidentified infectious agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqorpVFx7nEkrVg90H21EOLACvtfcHk0lgB3D4mjzwYPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXit1Khtrk%253D&md5=25161cf212790856dd29d3aaf78f20b8</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1126%2Fscience.2523562&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.2523562%26sid%3Dliteratum%253Aachs%26aulast%3DChoo%26aufirst%3DQ.%2BL.%26aulast%3DKuo%26aufirst%3DG.%26aulast%3DWeiner%26aufirst%3DA.%2BJ.%26aulast%3DOverby%26aufirst%3DL.%2BR.%26aulast%3DBradley%26aufirst%3DD.%2BW.%26aulast%3DHoughton%26aufirst%3DM.%26atitle%3DIsolation%2520of%2520a%2520cDNA%2520clone%2520derived%2520from%2520a%2520blood-borne%2520non-A%252C%2520non-B%2520viral%2520hepatitis%2520genome%26jtitle%3DScience%26date%3D1989%26volume%3D244%26spage%3D359%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Ghany, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strader, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomas, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seeff, L. B.</span><span> </span><span class="NLM_article-title">Diagnosis, management, and treatment of hepatitis C: an update</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">1335</span><span class="NLM_x">–</span> <span class="NLM_lpage">1374</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1002%2Fhep.22759" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=19330875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXkslWjs7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2009&pages=1335-1374&author=M.+G.+Ghanyauthor=D.+B.+Straderauthor=D.+L.+Thomasauthor=L.+B.+Seeff&title=Diagnosis%2C+management%2C+and+treatment+of+hepatitis+C%3A+an+update"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Diagnosis, management, and treatment of hepatitis C: an update</span></div><div class="casAuthors">Ghany, Marc G.; Strader, Doris B.; Thomas, David L.; Seeff, Leonard B.</div><div class="citationInfo"><span class="NLM_cas:title">Hepatology (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1335-1374</span>CODEN:
                <span class="NLM_cas:coden">HPTLD9</span>;
        ISSN:<span class="NLM_cas:issn">0270-9139</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  This document aims to provide clinicians with evidence-based approaches to the prevention, diagnosis, and management of hepatitis C virus (HCV) infection.  Current data on the recommended treatments of patients with chronic HCV infection are included.  The sequential steps recommended for managing and treating persons chronically infected with hepatitis C for whom treatment is considered clearly appropriate are summarized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzNs1N2UX4FrVg90H21EOLACvtfcHk0lgB3D4mjzwYPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXkslWjs7o%253D&md5=14f112636daff9f246fded6f6b2e23ee</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Fhep.22759&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fhep.22759%26sid%3Dliteratum%253Aachs%26aulast%3DGhany%26aufirst%3DM.%2BG.%26aulast%3DStrader%26aufirst%3DD.%2BB.%26aulast%3DThomas%26aufirst%3DD.%2BL.%26aulast%3DSeeff%26aufirst%3DL.%2BB.%26atitle%3DDiagnosis%252C%2520management%252C%2520and%2520treatment%2520of%2520hepatitis%2520C%253A%2520an%2520update%26jtitle%3DHepatology%26date%3D2009%26volume%3D49%26spage%3D1335%26epage%3D1374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Moradpour, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penin, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Replication of hepatitis C virus</span> <span class="citation_source-journal">Nat. Rev. Microbiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">453</span><span class="NLM_x">–</span> <span class="NLM_lpage">463</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1038%2Fnrmicro1645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=17487147" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD2sXltlSqtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2007&pages=453-463&author=D.+Moradpourauthor=F.+Peninauthor=C.+M.+Rice&title=Replication+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of hepatitis C virus</span></div><div class="casAuthors">Moradpour, Darius; Penin, Francois; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Microbiology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">453-463</span>CODEN:
                <span class="NLM_cas:coden">NRMACK</span>;
        ISSN:<span class="NLM_cas:issn">1740-1526</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Exciting progress has recently been made in understanding the replication of hepatitis C virus, a major cause of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma worldwide.  The development of complete cell-culture systems should now enable the systematic dissection of the entire viral life-cycle, providing insights into the hitherto difficult-to-study early and late steps.  These efforts have already translated into the identification of novel antiviral targets and the development of new therapeutic strategies, some of which are currently undergoing clin. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreB87JperiIrVg90H21EOLACvtfcHk0lgB3D4mjzwYPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXltlSqtb8%253D&md5=be020cc05a67e7256779b1c0ce797089</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrmicro1645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrmicro1645%26sid%3Dliteratum%253Aachs%26aulast%3DMoradpour%26aufirst%3DD.%26aulast%3DPenin%26aufirst%3DF.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DReplication%2520of%2520hepatitis%2520C%2520virus%26jtitle%3DNat.%2520Rev.%2520Microbiol.%26date%3D2007%26volume%3D5%26spage%3D453%26epage%3D463" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Kolykhalov, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mihalik, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feinstone, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, C. M.</span><span> </span><span class="NLM_article-title">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3′ nontranslated region are essential for virus replication in vivo</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">2046</span><span class="NLM_x">–</span> <span class="NLM_lpage">2051</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1128%2FJVI.74.4.2046-2051.2000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=10644379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2000&pages=2046-2051&author=A.+A.+Kolykhalovauthor=K.+Mihalikauthor=S.+M.+Feinstoneauthor=C.+M.+Rice&title=Hepatitis+C+virus-encoded+enzymatic+activities+and+conserved+RNA+elements+in+the+3%E2%80%B2+nontranslated+region+are+essential+for+virus+replication+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Hepatitis C virus-encoded enzymatic activities and conserved RNA elements in the 3' nontranslated region are essential for virus replication in vivo</span></div><div class="casAuthors">Kolykhalov, Alexander A.; Mihalik, Kathy; Feinstone, Stephen M.; Rice, Charles M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">74</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2046-2051</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a widespread major human health concern.  Significant obstacles in the study of this virus include the absence of a reliable tissue culture system and a small-animal model.  Recently, full-length HCV cDNA clones were constructed and HCV infection was successfully initiated in 2 chimpanzees by intrahepatic injection of in vitro-transcribed RNA.  In order to validate potential targets for development of anti-HCV therapeutics, 6 mutant derivs. of this prototype infectious clone were constructed.  Four clones contained point mutations ablating the activity of the NS2-3 protease, the NS3-4A serine protease, the NS3 NTPase/helicase, and the NS5B polymerase.  Two addnl. clones contained deletions encompassing all or part of the highly conserved 98-base sequence at the 3' terminus of the HCV genome RNA.  The RNA transcript from each of the 6 clones was injected intrahepatically into a chimpanzee.  No signs of HCV infection were detected in the 8 mo following the injection.  Inoculation of the same animal with nonmutant RNA transcripts resulted in productive HCV infection, as evidenced by viremia, elevated serum alanine aminotransferase, and HCV-specific seroconversion.  These data suggest that these 4 HCV-encoded enzymic activities and the conserved 3' terminal RNA element are essential for productive replication in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcxsUWOuM9sLVg90H21EOLACvtfcHk0lgjd63VmPFNrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXptlGitA%253D%253D&md5=69facc6778408ae96f31373f78c06600</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1128%2FJVI.74.4.2046-2051.2000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.74.4.2046-2051.2000%26sid%3Dliteratum%253Aachs%26aulast%3DKolykhalov%26aufirst%3DA.%2BA.%26aulast%3DMihalik%26aufirst%3DK.%26aulast%3DFeinstone%26aufirst%3DS.%2BM.%26aulast%3DRice%26aufirst%3DC.%2BM.%26atitle%3DHepatitis%2520C%2520virus-encoded%2520enzymatic%2520activities%2520and%2520conserved%2520RNA%2520elements%2520in%2520the%25203%25E2%2580%25B2%2520nontranslated%2520region%2520are%2520essential%2520for%2520virus%2520replication%2520in%2520vivo%26jtitle%3DJ.%2520Virol.%26date%3D2000%26volume%3D74%26spage%3D2046%26epage%3D2051" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">A review of HCV protease inhibitors</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=821-837&author=K.+X.+Chenauthor=F.+G.+Njoroge&title=A+review+of+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DA%2520review%2520of%2520HCV%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D821%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.,  St</span><span class="NLM_x">; </span><span class="NLM_contrib-group">George, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+Bosauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.+M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagaceauthor=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.+A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=R.+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.+L.+Yongauthor=M.+Llinas-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0lgjd63VmPFNrQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DBos%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.%2BM.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.%2BA.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DGeorge%26aufirst%3DR.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Hinrichsen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benhamou, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedemeyer, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reiser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Calleja, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Forns, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erhardt, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cronlein, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaves, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nehmiz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G. G.</span><span> </span><span class="NLM_article-title">Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">1347</span><span class="NLM_x">–</span> <span class="NLM_lpage">1355</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=1347-1355&author=H.+Hinrichsenauthor=Y.+Benhamouauthor=H.+Wedemeyerauthor=M.+Reiserauthor=R.+E.+Sentjensauthor=J.+L.+Callejaauthor=X.+Fornsauthor=A.+Erhardtauthor=J.+Cronleinauthor=R.+L.+Chavesauthor=C.+L.+Yongauthor=G.+Nehmizauthor=G.+G.+Steinmann&title=Short-term+antiviral+efficacy+of+BILN+2061%2C+a+hepatitis+C+virus+serine+protease+inhibitor%2C+in+hepatitis+C+genotype+1+patients"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHinrichsen%26aufirst%3DH.%26aulast%3DBenhamou%26aufirst%3DY.%26aulast%3DWedemeyer%26aufirst%3DH.%26aulast%3DReiser%26aufirst%3DM.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DCalleja%26aufirst%3DJ.%2BL.%26aulast%3DForns%26aufirst%3DX.%26aulast%3DErhardt%26aufirst%3DA.%26aulast%3DCronlein%26aufirst%3DJ.%26aulast%3DChaves%26aufirst%3DR.%2BL.%26aulast%3DYong%26aufirst%3DC.%2BL.%26aulast%3DNehmiz%26aufirst%3DG.%26aulast%3DSteinmann%26aufirst%3DG.%2BG.%26atitle%3DShort-term%2520antiviral%2520efficacy%2520of%2520BILN%25202061%252C%2520a%2520hepatitis%2520C%2520virus%2520serine%2520protease%2520inhibitor%252C%2520in%2520hepatitis%2520C%2520genotype%25201%2520patients%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3D1347%26epage%3D1355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.+P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.%2BP.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Malcolm, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span> <span class="citation_source-journal">Antimicrobial Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1128%2FAAC.50.3.1013-1020.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=16495264" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD28XisFamtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1013-1020&author=B.+A.+Malcolmauthor=R.+Liuauthor=F.+Lahserauthor=S.+Agrawalauthor=B.+Belangerauthor=N.+Butkiewiczauthor=R.+Chaseauthor=F.+Gheyasauthor=A.+Hartauthor=D.+Heskauthor=P.+Ingravalloauthor=C.+Jiangauthor=R.+Kongauthor=J.+Luauthor=J.+Pichardoauthor=A.+Prongayauthor=A.+Skeltonauthor=X.+Tongauthor=S.+Venkatramanauthor=E.+Xiaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=SCH+503034%2C+a+mechanism-based+inhibitor+of+hepatitis+C+virus+NS3+protease%2C+suppresses+polyprotein+maturation+and+enhances+the+antiviral+activity+of+alpha+interferon+in+replicon+cells"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span></div><div class="casAuthors">Malcolm, B. A.; Liu, R.; Lahser, F.; Agrawal, S.; Belanger, B.; Butkiewicz, N.; Chase, R.; Gheyas, F.; Hart, A.; Hesk, D.; Ingravallo, P.; Jiang, C.; Kong, R.; Lu, J.; Pichardo, J.; Prongay, A.; Skelton, A.; Tong, X.; Venkatraman, S.; Xia, E.; Girijavallabhan, V.; Njoroge, F. G.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1013-1020</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">0066-4804</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Cleavage of the hepatitis C virus (HCV) polyprotein by the viral NS3 protease releases functional viral proteins essential for viral replication.  Recent studies by Foy and coworkers strongly suggest that NS3-mediated cleavage of host factors may abrogate cellular response to alpha interferon (IFN-α).  Blockage of NS3 protease activity therefore is expected to inhibit HCV replication by both direct suppression of viral protein prodn. as well as by restoring host responsiveness to IFN.  Using structure-assisted design, a ketoamide inhibitor, SCH 503034, was generated which demonstrated potent (overall inhibition const., 14 nM) time-dependent inhibition of the NS3 protease in cell-free enzyme assays as well as robust in vitro activity in the HCV replicon system, as monitored by immunofluorescence and real-time PCR anal.  Continuous exposure of replicon-bearing cell lines to six times the 90% effective concn. of SCH 503034 for 15 days resulted in a greater than 4-log redn. in replicon RNA.  The combination of SCH 503034 with IFN was more effective in suppressing replicon synthesis than either compd. alone, supporting the suggestion of Foy and coworkers that combinations of IFN with protease inhibitors would lead to enhanced therapeutic efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpEpdwyo4a_bVg90H21EOLACvtfcHk0lgtHsz85bMnQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XisFamtLY%253D&md5=c21551e6d306f85039888211b1d07479</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1128%2FAAC.50.3.1013-1020.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.50.3.1013-1020.2006%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DB.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DSCH%2520503034%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%252C%2520suppresses%2520polyprotein%2520maturation%2520and%2520enhances%2520the%2520antiviral%2520activity%2520of%2520alpha%2520interferon%2520in%2520replicon%2520cells%26jtitle%3DAntimicrobial%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Chen, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, S. L.</span><span> </span><span class="NLM_article-title">Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2317</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.2174%2F0929867054864769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=16181135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWks7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2317-2342&author=S.+H.+Chenauthor=S.+L.+Tan&title=Discovery+of+small-molecule+inhibitors+of+HCV+NS3-4A+protease+as+potential+therapeutic+agents+against+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection</span></div><div class="casAuthors">Chen, Shu-Hui; Tan, Seng-Lai</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2317-2342</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic infection with hepatitis C virus (HCV) is assocd. with liver cirrhosis that often leads to hepatic failure and hepatocellular carcinoma (HCC).  HCV infection has become a global health threat and the main cause of adult liver transplants in developed nations.  Current approved anti-HCV therapies (interferon and pegylated interferon alone or in combination with ribavirin) are not effective in eliminating the viral infection in a significant population of patients (e.g., those infected with HCV genotype 1).  Furthermore, these therapies are plagued with many undesirable side effects.  Therefore, the HCV epidemic represents a huge unmet medical need that has triggered intensive research efforts towards the development of more effective drugs.  Given its essential role in the process of HCV replication, the viral NS3/4A serine protease is arguably the most thoroughly characterized HCV enzyme and the most intensively pursued anti-HCV target for drug development.  This is further fueled by the successful use of small-mol. inhibitors of the human immunodeficiency virus (HIV) viral protease, which have had an impressive effect on HIV-related morbidity and mortality, offering hope that analogous drugs might also have a similar impact against HCV.  Here, we review the recent progress and development of small-mol. inhibitors of the HCV NS3/4A protease.  In particular, we focus on the discovery of VX-950, the latest HCV NS3-4A protease inhibitor to be advanced to clin. studies.  While the challenges of designing potent inhibitors of the viral protease have been solved, as highlighted by BILN 2061 and VX-950, it is still too early to det. whether these efforts will eventually yield promising drug candidates.  For the emerging small-mol. HCV inhibitors, viral resistance will likely be a big problem.  Thus, combination therapy of different drugs with different targets/mechanisms will be necessary to effectively inhibit HCV replication.  It is also hoped that a detail characterization of how the resistance mutations that affect NS3 inhibitor binding may provide useful information for the design of inhibitors with the potential to treat resistant viruses that may arise during chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPS11RNEtD9LVg90H21EOLACvtfcHk0lgtHsz85bMnQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWks7jN&md5=5c255f47a40c7db2fa951f8727c5a21c</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.2174%2F0929867054864769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867054864769%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.%2BH.%26aulast%3DTan%26aufirst%3DS.%2BL.%26atitle%3DDiscovery%2520of%2520small-molecule%2520inhibitors%2520of%2520HCV%2520NS3-4A%2520protease%2520as%2520potential%2520therapeutic%2520agents%2520against%2520HCV%2520infection%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2317%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Prongay, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosise, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taremi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarosh-Tomaine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senior, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span> </span><span class="NLM_article-title">Discovery of the HCV NS3/4A protease inhibitor (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (Sch 503034) II. Key steps in structure-based optimization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2310</span><span class="NLM_x">–</span> <span class="NLM_lpage">2318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060173k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2310-2318&author=A.+J.+Prongayauthor=Z.+Guoauthor=N.+Yaoauthor=J.+Pichardoauthor=T.+Fischmannauthor=C.+Stricklandauthor=J.+Myersauthor=P.+C.+Weberauthor=B.+M.+Beyerauthor=R.+Ingramauthor=Z.+Hongauthor=W.+W.+Prosiseauthor=L.+Ramanathanauthor=S.+S.+Taremiauthor=T.+Yarosh-Tomaineauthor=R.+Zhangauthor=M.+Seniorauthor=R.+S.+Yangauthor=B.+Malcolmauthor=A.+Arasappanauthor=F.+Bennettauthor=S.+L.+Bogenauthor=K.+Chenauthor=E.+Jaoauthor=Y.+T.+Liuauthor=R.+G.+Loveyauthor=A.+K.+Saksenaauthor=S.+Venkatramanauthor=V.+Girijavallabhanauthor=F.+G.+Njorogeauthor=V.+Madison&title=Discovery+of+the+HCV+NS3%2F4A+protease+inhibitor+%281R%2C5S%29-N-%5B3-amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28Sch+503034%29+II.+Key+steps+in+structure-based+optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1021%2Fjm060173k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060173k%26sid%3Dliteratum%253Aachs%26aulast%3DProngay%26aufirst%3DA.%2BJ.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DFischmann%26aufirst%3DT.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DProsise%26aufirst%3DW.%2BW.%26aulast%3DRamanathan%26aufirst%3DL.%26aulast%3DTaremi%26aufirst%3DS.%2BS.%26aulast%3DYarosh-Tomaine%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSenior%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DR.%2BS.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.%2BT.%26aulast%3DLovey%26aufirst%3DR.%2BG.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520the%2520HCV%2520NS3%252F4A%2520protease%2520inhibitor%2520%25281R%252C5S%2529-N-%255B3-amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528Sch%2520503034%2529%2520II.%2520Key%2520steps%2520in%2520structure-based%2520optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2310%26epage%3D2318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laplante, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Peptide-based inhibitors of the hepatitis C virus serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">1713</span><span class="NLM_x">–</span> <span class="NLM_lpage">1718</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=1713-1718&author=M.+Llinas-Brunetauthor=M.+Baileyauthor=G.+Fazalauthor=S.+Gouletauthor=T.+Halmosauthor=S.+Laplanteauthor=R.+Mauriceauthor=M.+Poirierauthor=M.+A.+Poupartauthor=D.+Thibeaultauthor=D.+Wernicauthor=D.+Lamarre&title=Peptide-based+inhibitors+of+the+hepatitis+C+virus+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLaplante%26aufirst%3DS.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.%2BA.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DPeptide-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D1713%26epage%3D1718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Steinkuhler, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biasiol, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brunetti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Urbani, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pessi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span> </span><span class="NLM_article-title">Product inhibition of the hepatitis C virus NS3 protease</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">8899</span><span class="NLM_x">–</span> <span class="NLM_lpage">8905</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi980313v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=8899-8905&author=C.+Steinkuhlerauthor=G.+Biasiolauthor=M.+Brunettiauthor=A.+Urbaniauthor=U.+Kochauthor=R.+Corteseauthor=A.+Pessiauthor=R.+De+Francesco&title=Product+inhibition+of+the+hepatitis+C+virus+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fbi980313v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi980313v%26sid%3Dliteratum%253Aachs%26aulast%3DSteinkuhler%26aufirst%3DC.%26aulast%3DBiasiol%26aufirst%3DG.%26aulast%3DBrunetti%26aufirst%3DM.%26aulast%3DUrbani%26aufirst%3DA.%26aulast%3DKoch%26aufirst%3DU.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DPessi%26aufirst%3DA.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26atitle%3DProduct%2520inhibition%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%26jtitle%3DBiochemistry%26date%3D1998%26volume%3D37%26spage%3D8899%26epage%3D8905" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deziel, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goulet, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wernic, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Studies on the C-terminal of hexapeptide inhibitors of the hepatitis C virus serine protease</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">8</span><span class="NLM_x">, </span> <span class="NLM_fpage">2719</span><span class="NLM_x">–</span> <span class="NLM_lpage">2724</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=1998&pages=2719-2724&author=M.+Llinas-Brunetauthor=M.+Baileyauthor=R.+Dezielauthor=G.+Fazalauthor=V.+Gorysauthor=S.+Gouletauthor=T.+Halmosauthor=R.+Mauriceauthor=M.+Poirierauthor=M.+A.+Poupartauthor=J.+Rancourtauthor=D.+Thibeaultauthor=D.+Wernicauthor=D.+Lamarre&title=Studies+on+the+C-terminal+of+hexapeptide+inhibitors+of+the+hepatitis+C+virus+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DDeziel%26aufirst%3DR.%26aulast%3DFazal%26aufirst%3DG.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGoulet%26aufirst%3DS.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DPoupart%26aufirst%3DM.%2BA.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWernic%26aufirst%3DD.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStudies%2520on%2520the%2520C-terminal%2520of%2520hexapeptide%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520serine%2520protease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1998%26volume%3D8%26spage%3D2719%26epage%3D2724" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nar, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1356</span><span class="NLM_x">–</span> <span class="NLM_lpage">1360</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1002%2Fanie.200390347" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjtlygsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2003&pages=1356-1360&author=Y.+S.+Tsantrizosauthor=G.+Bolgerauthor=P.+Bonneauauthor=D.+R.+Cameronauthor=N.+Goudreauauthor=G.+Kukoljauthor=S.+R.+LaPlanteauthor=M.+Llinas-Brunetauthor=H.+Narauthor=D.+Lamarre&title=Macrocyclic+inhibitors+of+the+NS3+protease+as+potential+therapeutic+agents+of+hepatitis+C+virus+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of the NS3 protease as potential therapeutic agents of hepatitis C virus infection</span></div><div class="casAuthors">Tsantrizos, Youla S.; Bolger, Gordon; Bonneau, Pierre; Cameron, Dale R.; Goudreau, Nathalie; Kukolj, George; LaPlante, Steven R.; Llinas-Brunet, Montse; Nar, Herbert; Lamarre, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1356-1360</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A novel class of selective inhibitors of the hepatitis C virus NS3 protease, an enzyme which is essential for viral replication in vivo, was developed.  The inhibitors are based on the structure-activity relationship between a substrate-based peptidomimetic ligand and the HCV NS3 serine protease.  The designed HCV inhibitor and its satd. analogs are the first inhibitors of the NS3 protease which inhibit HCV RNA replication in the cell-based replicon assay.  In addn., they are orally absorbed and stable to metabolic breakdown.  Thus, these compds. show many of the desirable properties of a druglike archetype and could lead t a clin. useful antiviral agent for the treatment of hepatitis C viral infections in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCij3shP5tmLVg90H21EOLACvtfcHk0lh44mmwLU9EkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjtlygsrc%253D&md5=e0a3c98ee0096bfc3d058bf0b92b81c3</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1002%2Fanie.200390347&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200390347%26sid%3Dliteratum%253Aachs%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DNar%26aufirst%3DH.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520the%2520NS3%2520protease%2520as%2520potential%2520therapeutic%2520agents%2520of%2520hepatitis%2520C%2520virus%2520infection%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2003%26volume%3D42%26spage%3D1356%26epage%3D1360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand-Maitre, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre-Paquette, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rheaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Structure−activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN 2061</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1608</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0342414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1605-1608&author=M.+Llinas-Brunetauthor=M.+D.+Baileyauthor=G.+Bolgerauthor=C.+Brochuauthor=A.+M.+Faucherauthor=J.+M.+Ferlandauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=C.+Grand-Maitreauthor=T.+Halmosauthor=N.+Lapeyre-Paquetteauthor=F.+Liardauthor=M.+Poirierauthor=M.+Rheaumeauthor=Y.+S.+Tsantrizosauthor=D.+Lamarre&title=Structure%E2%88%92activity+study+on+a+novel+series+of+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3+protease+leading+to+the+discovery+of+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm0342414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0342414%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DFaucher%26aufirst%3DA.%2BM.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGrand-Maitre%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLapeyre-Paquette%26aufirst%3DN.%26aulast%3DLiard%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRheaume%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStructure%25E2%2588%2592activity%2520study%2520on%2520a%2520novel%2520series%2520of%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520BILN%25202061%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1605%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">Peptide-based inhibitors of the hepatitis C virus NS3 protease: structure−activity relationship at the C-terminal position</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2511</span><span class="NLM_x">–</span> <span class="NLM_lpage">2522</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030573x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2511-2522&author=J.+Rancourtauthor=D.+R.+Cameronauthor=V.+Gorysauthor=D.+Lamarreauthor=M.+Poirierauthor=D.+Thibeaultauthor=M.+Llinas-Brunet&title=Peptide-based+inhibitors+of+the+hepatitis+C+virus+NS3+protease%3A+structure%E2%88%92activity+relationship+at+the+C-terminal+position"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fjm030573x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030573x%26sid%3Dliteratum%253Aachs%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DPeptide-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%253A%2520structure%25E2%2588%2592activity%2520relationship%2520at%2520the%2520C-terminal%2520position%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2511%26epage%3D2522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Schechter, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berger, A.</span><span> </span><span class="NLM_article-title">On the size of the active site in proteases. I. Papain</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1967</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">157</span><span class="NLM_x">–</span> <span class="NLM_lpage">162</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1016%2FS0006-291X%2867%2980055-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=6035483" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1967&pages=157-162&author=I.+Schechterauthor=A.+Berger&title=On+the+size+of+the+active+site+in+proteases.+I.+Papain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">On the size of the active site in proteases.  I.  Papain</span></div><div class="casAuthors">Schechter, Israel; Berger, Arieh</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">1967</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">157-62</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    </div><div class="casAbstract">The action of papain on 40 diastereoisomeric peptides of alanine, ranging in length from Ala2 to Ala6, was studied to investigate the size of the active site.  The variations observed in the rates of hydrolysis lead to the conclusion that papain has a large active site which extends over ∼25 A. and can be divided into 7 "subsites," each accommodating 1 amino acid residue of the peptide substrate.  The subsites are located on both sides of the catalytic site, 4 on the one side and 3 on the other.  It is postulated that a long "groove" analogous to that found by x-ray analysis in lysozyme is present.  The substrate is believed to fit into the groove, binding to several subsites of specific geometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_kZeRVAOVyrVg90H21EOLACvtfcHk0lj46WwgVsMAVQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaF2sXktVyhsrg%253D&md5=a58ceccdbb5cc5c021af06912835f77c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2FS0006-291X%2867%2980055-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-291X%252867%252980055-X%26sid%3Dliteratum%253Aachs%26aulast%3DSchechter%26aufirst%3DI.%26aulast%3DBerger%26aufirst%3DA.%26atitle%3DOn%2520the%2520size%2520of%2520the%2520active%2520site%2520in%2520proteases.%2520I.%2520Papain%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D1967%26volume%3D27%26spage%3D157%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Stoltz, J. H.; Stern, J. O.; Huang, Q.; Seidler, R. W.; Pack, F. D.; Knight, B. L.</span><span> </span><span class="NLM_article-title">A 28-day mechanistic time course study in the rhesus monkey with hepatitis C virus protease inhibitor BILN 2061</span>.  <span class="citation_source-journal">Toxicol. Pathol.</span>, submitted 2010.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Stoltz%2C+J.+H.%3B+Stern%2C+J.+O.%3B+Huang%2C+Q.%3B+Seidler%2C+R.+W.%3B+Pack%2C+F.+D.%3B+Knight%2C+B.+L.+A+28-day+mechanistic+time+course+study+in+the+rhesus+monkey+with+hepatitis+C+virus+protease+inhibitor+BILN+2061.+Toxicol.+Pathol.%2C+submitted+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DStoltz%26aufirst%3DJ.%2BH.%26atitle%3DA%252028-day%2520mechanistic%2520time%2520course%2520study%2520in%2520the%2520rhesus%2520monkey%2520with%2520hepatitis%2520C%2520virus%2520protease%2520inhibitor%2520BILN%25202061%26jtitle%3DToxicol.%2520Pathol." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Macrocyclic inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1277</span><span class="NLM_x">–</span> <span class="NLM_lpage">1303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1517%2F13543770903044994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=19563268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1277-1303&author=S.+Venkatramanauthor=F.+G.+Njoroge&title=Macrocyclic+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of HCV NS3 protease</span></div><div class="casAuthors">Venkatraman, Srikanth; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1277-1303</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  HCV NS3 is a serine protease that plays a pivotal role in catalyzing the cleavage of the single polyprotein encoded by HCV after infection of hepatocytes.  Anal. of the X-ray crystal structure of the enzyme reveals a shallow catalytic site located on the surface of the protein, which has made development of inhibitors a formidable task.  Attempts to discover leads by a traditional approach of screening of compd. libraries have proved futile and, therefore, researchers have adopted a structure-based drug design.  Anal. of the X-ray structure of NS3 protease reveals close proximity of S1-S3 and S2-S4 pockets.  Various novel approaches have been used to design preorganized, depeptidized macrocyclic inhibitors linking the P2-P4 groups and P1-P3 residues.  The article summarizes efforts by various groups to develop inhibitors that bind to the active site and inhibit viral replication.  Review of recent patents and scientific literature.  Macrocyclization has proved to be an effective tool for depeptidization of peptidic inhibitors with improved binding and pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbzHliWVL17Vg90H21EOLACvtfcHk0ljgph2WSKFNyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FI&md5=4081e78be8e92b762d50501ca8fcb97c</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1517%2F13543770903044994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903044994%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D1277%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+characteristics+of+the+hepatitis+C+virus+NS3%2F4A+protease+inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520characteristics%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Lin, T. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbinnen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholliers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeiren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">In vitro activity and preclinical profile of TMC435350, a potent hepatitis C virus protease inhibitor</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1377-1385&author=T.+I.+Linauthor=O.+Lenzauthor=G.+Fanningauthor=T.+Verbinnenauthor=F.+Delouvroyauthor=A.+Scholliersauthor=K.+Vermeirenauthor=A.+Rosenquistauthor=M.+Edlundauthor=B.+Samuelssonauthor=L.+Vrangauthor=H.+de+Kockauthor=P.+Wigerinckauthor=P.+Raboissonauthor=K.+Simmen&title=In+vitro+activity+and+preclinical+profile+of+TMC435350%2C+a+potent+hepatitis+C+virus+protease+inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.%2BI.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DFanning%26aufirst%3DG.%26aulast%3DVerbinnen%26aufirst%3DT.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DScholliers%26aufirst%3DA.%26aulast%3DVermeiren%26aufirst%3DK.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DIn%2520vitro%2520activity%2520and%2520preclinical%2520profile%2520of%2520TMC435350%252C%2520a%2520potent%2520hepatitis%2520C%2520virus%2520protease%2520inhibitor%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D1377%26epage%3D1385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">MK-7009, a potent and selective inhibitor of hepatitis C virus NS3/4A protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=305-311&author=N.+J.+Livertonauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=D.+J.+Grahamauthor=D.+Hazudaauthor=M.+K.+Hollowayauthor=S.+W.+Ludmererauthor=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=D.+B.+Olsenauthor=M.+T.+Ruddauthor=M.+Stahlhutauthor=J.+P.+Vacca&title=MK-7009%2C+a+potent+and+selective+inhibitor+of+hepatitis+C+virus+NS3%2F4A+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMK-7009%252C%2520a%2520potent%2520and%2520selective%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D305%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span> </span><span class="NLM_article-title">A systematic approach to the optimization of substrate-based inhibitors of the hepatitis C virus NS3 protease: discovery of potent and specific tripeptide inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">6584</span><span class="NLM_x">–</span> <span class="NLM_lpage">6594</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0494523" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=6584-6594&author=M.+Llinas-Brunetauthor=M.+D.+Baileyauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=M.+Poirierauthor=J.+Rancourtauthor=N.+Goudreau&title=A+systematic+approach+to+the+optimization+of+substrate-based+inhibitors+of+the+hepatitis+C+virus+NS3+protease%3A+discovery+of+potent+and+specific+tripeptide+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm0494523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0494523%26sid%3Dliteratum%253Aachs%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DGoudreau%26aufirst%3DN.%26atitle%3DA%2520systematic%2520approach%2520to%2520the%2520optimization%2520of%2520substrate-based%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%253A%2520discovery%2520of%2520potent%2520and%2520specific%2520tripeptide%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D6584%26epage%3D6594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Faucher, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duceppe, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinas-Brunet, M.</span><span> </span><span class="NLM_article-title">Synthesis of BILN 2061, an HCV NS3 protease inhibitor with proven antiviral effect in humans</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">2901</span><span class="NLM_x">–</span> <span class="NLM_lpage">2904</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol0489907" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvVSkur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2004&pages=2901-2904&author=A.+M.+Faucherauthor=M.+D.+Baileyauthor=P.+L.+Beaulieuauthor=C.+Brochuauthor=J.+S.+Duceppeauthor=J.+M.+Ferlandauthor=E.+Ghiroauthor=V.+Gorysauthor=T.+Halmosauthor=S.+H.+Kawaiauthor=M.+Poirierauthor=B.+Simoneauauthor=Y.+S.+Tsantrizosauthor=M.+Llinas-Brunet&title=Synthesis+of+BILN+2061%2C+an+HCV+NS3+protease+inhibitor+with+proven+antiviral+effect+in+humans"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of BILN 2061, an HCV NS3 Protease Inhibitor with Proven Antiviral Effect in Humans</span></div><div class="casAuthors">Faucher, Anne-Marie; Bailey, Murray D.; Beaulieu, Pierre L.; Brochu, Christian; Duceppe, Jean-Simon; Ferland, Jean-Marie; Ghiro, Elise; Gorys, Vida; Halmos, Ted; Kawai, Stephen H.; Poirier, Martin; Simoneau, Bruno; Tsantrizos, Youla S.; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2901-2904</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of BILN 2061 (I), a hepatitis C virus (HCV) NS3 protease inhibitor with proven antiviral effect in humans, was accomplished in a convergent manner from four building blocks.  The procedure described here was suitable for the prepn. of multigram quantities of BILN 2061 for preclin. pharmacol. evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3e_dv4CxKirVg90H21EOLACvtfcHk0lgqlwgaV0FuZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvVSkur0%253D&md5=cfc1b877b24dc5df86fe3ea7f8996f9c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fol0489907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol0489907%26sid%3Dliteratum%253Aachs%26aulast%3DFaucher%26aufirst%3DA.%2BM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DDuceppe%26aufirst%3DJ.%2BS.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLlinas-Brunet%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520BILN%25202061%252C%2520an%2520HCV%2520NS3%2520protease%2520inhibitor%2520with%2520proven%2520antiviral%2520effect%2520in%2520humans%26jtitle%3DOrg.%2520Lett.%26date%3D2004%26volume%3D6%26spage%3D2901%26epage%3D2904" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Beaulieu, P. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gillard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Duceppe, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, X. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grozinger, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Houpis, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farina, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimroth, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krueger, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnaubelt, J.</span><span> </span><span class="NLM_article-title">Synthesis of (1<i>R</i>,2<i>S</i>)-1-amino-2-vinylcyclopropanecarboxylic acid vinyl-ACCA) derivatives: key intermediates for the preparation of inhibitors of the hepatitis C virus NS3 protease</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">70</span><span class="NLM_x">, </span> <span class="NLM_fpage">5869</span><span class="NLM_x">–</span> <span class="NLM_lpage">5879</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo050468q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlt12nur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2005&pages=5869-5879&author=P.+L.+Beaulieuauthor=J.+Gillardauthor=M.+D.+Baileyauthor=C.+Boucherauthor=J.+S.+Duceppeauthor=B.+Simoneauauthor=X.+J.+Wangauthor=L.+Zhangauthor=K.+Grozingerauthor=I.+Houpisauthor=V.+Farinaauthor=H.+Heimrothauthor=T.+Kruegerauthor=J.+Schnaubelt&title=Synthesis+of+%281R%2C2S%29-1-amino-2-vinylcyclopropanecarboxylic+acid+vinyl-ACCA%29+derivatives%3A+key+intermediates+for+the+preparation+of+inhibitors+of+the+hepatitis+C+virus+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of (1R,2S)-1-Amino-2-vinylcyclopropanecarboxylic Acid Vinyl-ACCA) Derivatives: Key Intermediates for the Preparation of Inhibitors of the Hepatitis C Virus NS3 Protease</span></div><div class="casAuthors">Beaulieu, Pierre L.; Gillard, James; Bailey, Murray D.; Boucher, Colette; Duceppe, Jean-Simon; Simoneau, Bruno; Wang, Xiao-Jun; Zhang, Li; Grozinger, Karl; Houpis, Ioannis; Farina, Vittorio; Heimroth, Heidi; Krueger, Thomas; Schnaubelt, Juergen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5869-5879</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">(1R,2S)-1-Amino-2-vinylcyclopropanecarboxylic acid (vinyl-ACCA) is a key building block in the synthesis of BILN 2061, a potent inhibitor of hepatitis C virus NS3 and was recently shown to dramatically reduce viral load after administration to patients infected with HCV genotype 1.  The authors developed a scalable process that delivered derivs. of (1R,2S)-vinyl-ACCA in >99% enantiomeric excess.  The strategy included dialkylation of a glycine Schiff base using (E)-1,4-dibromo-2-butene as an electrophile to produce racemic vinyl-ACCA, which was subsequently resolved using a readily available, inexpensive esterase enzyme (Alcalase 2.4L).  Factors that affect diastereoselection in the initial dialkylation steps were examd. and the conditions were optimized to deliver the desired diastereomer selectively.  Product inhibition, which was encountered during the enzymic resoln. step, initially resulted in prolonged cycle times.  Enrichment of racemic vinyl-ACCA through a chem. resoln. via diastereomeric salt formation or the use of forcing conditions in the enzymic reaction both led to improvements in throughput and the development of a viable process.  Thus, multi-kilogram quantities of (1R,2S)-vinyl-ACCA were produced.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMTSBIrZEPk7Vg90H21EOLACvtfcHk0lgqlwgaV0FuZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlt12nur4%253D&md5=2165443a83201467dc3f8404758425cf</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjo050468q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo050468q%26sid%3Dliteratum%253Aachs%26aulast%3DBeaulieu%26aufirst%3DP.%2BL.%26aulast%3DGillard%26aufirst%3DJ.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBoucher%26aufirst%3DC.%26aulast%3DDuceppe%26aufirst%3DJ.%2BS.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DX.%2BJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DGrozinger%26aufirst%3DK.%26aulast%3DHoupis%26aufirst%3DI.%26aulast%3DFarina%26aufirst%3DV.%26aulast%3DHeimroth%26aufirst%3DH.%26aulast%3DKrueger%26aufirst%3DT.%26aulast%3DSchnaubelt%26aufirst%3DJ.%26atitle%3DSynthesis%2520of%2520%25281R%252C2S%2529-1-amino-2-vinylcyclopropanecarboxylic%2520acid%2520vinyl-ACCA%2529%2520derivatives%253A%2520key%2520intermediates%2520for%2520the%2520preparation%2520of%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%2520protease%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2005%26volume%3D70%26spage%3D5869%26epage%3D5879" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Unangst, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Connor, D. T.</span><span> </span><span class="NLM_article-title">Synthesis and transformations of 2,6-bis(1,1-dimethylethyl)-4-[2-(thiazolyl)ethenyl]phenols</span> <span class="citation_source-journal">J. Heterocycl. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x">, </span> <span class="NLM_fpage">1097</span><span class="NLM_x">–</span> <span class="NLM_lpage">1100</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1992&pages=1097-1100&author=P.+C.+Unangstauthor=D.+T.+Connor&title=Synthesis+and+transformations+of+2%2C6-bis%281%2C1-dimethylethyl%29-4-%5B2-%28thiazolyl%29ethenyl%5Dphenols"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DUnangst%26aufirst%3DP.%2BC.%26aulast%3DConnor%26aufirst%3DD.%2BT.%26atitle%3DSynthesis%2520and%2520transformations%2520of%25202%252C6-bis%25281%252C1-dimethylethyl%2529-4-%255B2-%2528thiazolyl%2529ethenyl%255Dphenols%26jtitle%3DJ.%2520Heterocycl.%2520Chem.%26date%3D1992%26volume%3D29%26spage%3D1097%26epage%3D1100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Manns, M. P.; Bourlière, M.; Benhamou, Y.; Pol, S.; Bonacini, M.; Trepo, C.; Wright, D.; Berg, T.; Calleja, J. L.; White, P. W.; Stern, J. O.; Steinmann, G.; Yong, C. L.; Kukolj, G.; Scherer, J.; Boecher, W. O.</span><span> </span><span class="NLM_article-title">Potency, safety and pharmacokinetics of the NS3/4A protease inhibitor BI201335 in patients with chronic HCV genotype-1 infection</span>.  <span class="citation_source-journal">J. Hepatol.</span>, submitted 2010.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Manns%2C+M.+P.%3B+Bourli%C3%A8re%2C+M.%3B+Benhamou%2C+Y.%3B+Pol%2C+S.%3B+Bonacini%2C+M.%3B+Trepo%2C+C.%3B+Wright%2C+D.%3B+Berg%2C+T.%3B+Calleja%2C+J.+L.%3B+White%2C+P.+W.%3B+Stern%2C+J.+O.%3B+Steinmann%2C+G.%3B+Yong%2C+C.+L.%3B+Kukolj%2C+G.%3B+Scherer%2C+J.%3B+Boecher%2C+W.+O.+Potency%2C+safety+and+pharmacokinetics+of+the+NS3%2F4A+protease+inhibitor+BI201335+in+patients+with+chronic+HCV+genotype-1+infection.+J.+Hepatol.%2C+submitted+2010."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26atitle%3DPotency%252C%2520safety%2520and%2520pharmacokinetics%2520of%2520the%2520NS3%252F4A%2520protease%2520inhibitor%2520BI201335%2520in%2520patients%2520with%2520chronic%2520HCV%2520genotype-1%2520infection%26jtitle%3DJ.%2520Hepatol." title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Massariol, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhao, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marquis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span> </span><span class="NLM_article-title">Protease and helicase activities of hepatitis C virus genotype 4, 5, and 6 NS3-NS4A proteins</span> <span class="citation_source-journal">Biochem. Biophys. Res. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">391</span><span class="NLM_x">, </span> <span class="NLM_fpage">692</span><span class="NLM_x">–</span> <span class="NLM_lpage">697</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=391&publication_year=2010&pages=692-697&author=M.+J.+Massariolauthor=S.+Zhaoauthor=M.+Marquisauthor=D.+Thibeaultauthor=P.+W.+White&title=Protease+and+helicase+activities+of+hepatitis+C+virus+genotype+4%2C+5%2C+and+6+NS3-NS4A+proteins"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMassariol%26aufirst%3DM.%2BJ.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DMarquis%26aufirst%3DM.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26atitle%3DProtease%2520and%2520helicase%2520activities%2520of%2520hepatitis%2520C%2520virus%2520genotype%25204%252C%25205%252C%2520and%25206%2520NS3-NS4A%2520proteins%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2010%26volume%3D391%26spage%3D692%26epage%3D697" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bousquet, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gingras, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagace, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maurice, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, P. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor BILN 2061</span> <span class="citation_source-journal">J. Virol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">78</span><span class="NLM_x">, </span> <span class="NLM_fpage">7352</span><span class="NLM_x">–</span> <span class="NLM_lpage">7359</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm100690x&amp;key=10.1128%2FJVI.78.14.7352-7359.2004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm100690x&amp;key=15220408" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm100690x&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlvFShtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2004&pages=7352-7359&author=D.+Thibeaultauthor=C.+Bousquetauthor=R.+Gingrasauthor=L.+Lagaceauthor=R.+Mauriceauthor=P.+W.+Whiteauthor=D.+Lamarre&title=Sensitivity+of+NS3+serine+proteases+from+hepatitis+C+virus+genotypes+2+and+3+to+the+inhibitor+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Sensitivity of NS3 serine proteases from hepatitis C virus genotypes 2 and 3 to the inhibitor BILN 2061</span></div><div class="casAuthors">Thibeault, Diane; Bousquet, Christiane; Gingras, Rock; Lagace, Lisette; Maurice, Roger; White, Peter W.; Lamarre, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Virology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">7352-7359</span>CODEN:
                <span class="NLM_cas:coden">JOVIAM</span>;
        ISSN:<span class="NLM_cas:issn">0022-538X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) displays a high degree of genetic variability.  Six genotypes and more than 50 subtypes have been identified to date.  In this report, kinetic profiles were detd. for NS3 proteases of genotypes 1a, 1b, 2ac, 2b, and 3a, revealing no major differences in activity.  In vitro sensitivity studies with BILN 2061 showed a decrease in affinity for proteases of genotypes 2 and 3 (Ki, 80 to 90 nM) compared to genotype 1 enzymes (Ki, 1.5 nM).  To understand the reduced sensitivity of genotypes 2 and 3 to BILN 2061, active-site residues in the proximity of the inhibitor binding site were replaced in the genotype-1b enzyme with the corresponding genotype-2b or -3a residues.  The replacement of five residues at positions 78, 79, 80, 122, and 132 accounted for most of the reduced sensitivity of genotype 2b, while replacement of residue 168 alone could account for the reduced sensitivity of genotype 3a.  BILN 2061 remains a potent inhibitor of these non-genotype-1 NS3-NS4A proteins, with Ki values below 100 nM.  This in vitro potency, in conjunction with the good pharmacokinetic data reported for humans, suggests that there is potential for BILN 2061 as an antiviral agent for individuals infected with non-genotype-1 HCV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-UbNAzXUCMLVg90H21EOLACvtfcHk0lilfjhHAWntzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlvFShtLg%253D&md5=fa11f0c178a5559fb3fbaa03c827391a</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1128%2FJVI.78.14.7352-7359.2004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJVI.78.14.7352-7359.2004%26sid%3Dliteratum%253Aachs%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DBousquet%26aufirst%3DC.%26aulast%3DGingras%26aufirst%3DR.%26aulast%3DLagace%26aufirst%3DL.%26aulast%3DMaurice%26aufirst%3DR.%26aulast%3DWhite%26aufirst%3DP.%2BW.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DSensitivity%2520of%2520NS3%2520serine%2520proteases%2520from%2520hepatitis%2520C%2520virus%2520genotypes%25202%2520and%25203%2520to%2520the%2520inhibitor%2520BILN%25202061%26jtitle%3DJ.%2520Virol.%26date%3D2004%26volume%3D78%26spage%3D7352%26epage%3D7359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Vaillancourt, F. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pilote, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lippens, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liuzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bethell, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span> </span><span class="NLM_article-title">Identification of a lipid kinase as a host factor involved in hepatitis C virus RNA replication</span> <span class="citation_source-journal">Virology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">5</span><span class="NLM_x">–</span> <span class="NLM_lpage">10</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=5-10&author=F.+H.+Vaillancourtauthor=L.+Piloteauthor=M.+Cartierauthor=J.+Lippensauthor=M.+Liuzziauthor=R.+C.+Bethellauthor=M.+G.+Cordingleyauthor=G.+Kukolj&title=Identification+of+a+lipid+kinase+as+a+host+factor+involved+in+hepatitis+C+virus+RNA+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVaillancourt%26aufirst%3DF.%2BH.%26aulast%3DPilote%26aufirst%3DL.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DLippens%26aufirst%3DJ.%26aulast%3DLiuzzi%26aufirst%3DM.%26aulast%3DBethell%26aufirst%3DR.%2BC.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DKukolj%26aufirst%3DG.%26atitle%3DIdentification%2520of%2520a%2520lipid%2520kinase%2520as%2520a%2520host%2520factor%2520involved%2520in%2520hepatitis%2520C%2520virus%2520RNA%2520replication%26jtitle%3DVirology%26date%3D2009%26volume%3D387%26spage%3D5%26epage%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i46"><a href="/doi/suppl/10.1021/jm100690x">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_61617"></div></div></div></div></div><hr /></hr><p class="last">Full <sup>1</sup>H and <sup>13</sup>C NMR characterization and assignments provided for <b>29</b>. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm100690x/suppl_file/jm100690x_si_001.pdf">jm100690x_si_001.pdf (1.55 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm100690x&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm100690x%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-17%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm100690x" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1022KB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998913dcc9d952","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
